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TOTAL SYNTHESES OF (±)-FAWCETTIMINE, (±)-FAWCETTIDINE, (±)-
LYCOFLEXINE, AND (±)-LYCOPOSERRAMINE B 
 
        The total syntheses of (±)-fawcettimine, (±)-lycoflexine, (±)-fawcettidine, and (±)-
lycoposerramine B have been accomplished through an efficient, unified, and 
stereocontrolled strategy that required sixteen, sixteen, seventeen, and seventeen steps, 
respectively, from commercially available materials. The key transformations involve: 1) 
a Diels-Alder reaction between a 1-siloxy diene and an enone to construct the cis-fused 
6,5-carbocycles with one all-carbon quaternary center, and 2) a Fukuyama-Mitsunobu 
reaction to form the azonine ring. Access to the enantioselective syntheses of these 
alkaloids can be achieved by kinetic resolution of the earliest intermediate via a Sharpless 
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        Lycopodium (sensu lato) is a genus of club mosses also known as ground pines or 
creeping cedar, in the family Lycopodiaceae, a family of fern-allies.1 There are more than 
500 species for Lycopodium (s. l.), of which only about 50 species have been studied thus 
far. These low, evergreen, coarsely moss-like plants produce a large number of 
structurally related, yet diverse quinolizine-, pyridine-, or α-pyridone-type alkaloids.2 By 
July 2008, about 250 Lycopodium alkaloids had been isolated3 and the numbers continue 
to grow.4 Some of the alkaloids, in particular Huperzine A (hupA), which was isolated by 
J. Liu and coworkers from the Chinese folk medicinal herb Qian Ceng Ta (whole plant of 
Huperzia serrata (H. serrata) (Thunb. Ex Murray) Trev., see Figure 1.1), were found to 
possess potent acetylcholinesterase inhibition activity,5 and showed promising results for 








Huperzia serrata (Thunb. ex Murray) Trev.
O
 
Figure 1.1. H. serrata (Thunb. Ex Murray) Trev.7 and structure of hupA. 
        According to Ayer, A.W., Lycopodium alkaloids can be grouped into four classes: 
the lycopodine class, the lycodine class, the fawcettimine class and the miscellaneous 
class (Figure 1.2).8 Representative compounds for these classes are lycopodine, lycodine, 















































































Figure 1.2. Representative compounds of the four classes of Lycopodium alkaloids. 
        The carbon numbering notation for the Lycopodium alkaloids is based on Conroy’s 
biogenetic proposal, in which the skeletons of lycopodine and other Lycopodium 
alkaloids were suggested to be made up of two molecules of 3,5,7-triketooctanoic acid or 
its equivalent (Scheme 1.1).9  








































1.1 1.2  
 
1.2 Fawcettimine Class 
        Since the isolation of the first member, fawcettimine (also known as Burnell’s base), 
by Burnell, R. H. from Lycopodium fawcettii collected in the Blue Mountain Range of 
 4 
Jamaica in 1959,10 more than 80 alkaloids in this class have been isolated.2,4c,11 Some of 




































































































Figure 1.3. Selected fawcettimine class alkaloids. 
        Typically, members in this class contain a cis-fused 6,5-carbocyclic ring core 
connected to an azonine ring with an all-carbon quaternary center. The N atom of azonine 
ring can be methylated (for example: lycoposerramine A,12 B13) or connected to C-13 to 
form carbinolamine (for example: fawcettimine, lycojapodine A4). For most of the 
alkaloids, the methyl group at C-15 adopted a R configuration. The only known exception 
is  lycopoclavamine A, whose configuration at C-15 is S.4c 
 5 
        From those fawcettimine class alkaloids, lycoposerramine A was chosen as our 
ultimate target for total synthesis. Lycoposerrramine A was isolated by Takayama, H. and 
coworkers from Lycopodium serratum Thunb = Huperzia serrata (Thunb.) Trev. in 2001 
(Figure 1.4).12 Its densely fused pentacyclic ring system (containing 5-, 6-, and 9-
membered rings), as well as the 6 stereocenters (2 of them are quaternary centers) render 
it a challenging and charming target for total synthesis.14 It is also the first natural product 




























Figure 1.4. Lycoposerramine A and its X-ray structure.15 
        The absolute configuration of lycoposerramine A was not determined in the 
isolation paper (ORD (c 0.00058 g/mL, CHCl3) [Φ]589 −16°, [Φ]339 −154°, [Φ]256 −632°, 
[Φ]245 0°, [Φ]230 +342°, [Φ]213 +89°).  The authors suggested that lycoposerramine A 
could be biosynthetically derived from fawcettimine via N-methylation, selective 
hydroxylamine and imine formation followed by cyclization (Scheme 1.2). Thus, the 
absolute configuration of lycoposerramine A should be the same as fawcettimine.12  
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1.3 Bioactivities of Lycopodium Alkaloids 
        To date, the Lycopodium alkaloids are best known for their acetylcholinesterase 















Figure 1.5. Some lycodine class alkaloids possessing AChE inhibitory activity. 
        Among those about 250 alkaloids, only a few members belonging to the lycodine 
class, such as huperzine A (hupA), huperzine B,5 and N-methylhuperzine B,16 were found 
to possess this activity (Figure 1.5).2 In particular, hupA was found to be a reversible, 
potent, and selective acetylcholinesterase inhibitor (AChEi) and showed promise in the 
treatment of Alzheimer’s disease (AD) and myasthenia gravis (MG).5,6 
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Figure 1.6. Schematic figure showing the principal interactions between TcAChE and 
hupA.18 
        The X-ray crystal structure of Torpedo californica AChE (TcAChE)-hupA complex 
shows that hupA binds tightly and specifically to the active-site gorge of AChE by direct 
hydrogen bonds, water molecule mediated hydrogen bonds, cation-π interactions, as well 
as hydrophobic interactions (Figure 1.6).17  
        The Tang group compared the inhibitory effects of hupA on AChE and BuChE with 



























Figure 1.7. Some drugs used to treat Alzheimer’s disease (AD). 
        It was found that hupA inhibited the activity of AChE in the rat cortex al low as 10 
nM. The 50% inhibitory concentration (IC50) was estimated to be 82 nM (Table 1.1).  
More significantly, hupA showed the highest BuChE/AChE ratio, which is desirable for 
anti-AD drugs that target the cholinergic system.19 
Table 1.1. Effects of HupA and other cholinesterase inhibitors on AChE activity in the 
rat cortex and BuChE activity in rat serum in vitro.20 
Cholinesterase inhibitor 
IC50a (µM) Ratio of IC50 





















a The cortex homogenate was preincubated for 5 min. with iso-OMPA 0.1 mM. The rate 
of color production was measured spectrophotometrically at 440 nm.  
 
        Double-blind and placebo-controlled clinical trials demonstrated that hupA 
produced significant improvements in memory deficiencies in aged patients and patients 
with AD. Furthermore, both animal and clinical safety testings showed that hupA was 
 9 
devoid of unexpected toxicity, particularly the dose-limiting hepatotoxicity induced by 
tacrine.21 
        HupA has been approved as the drug for treatment of AD in China, and is marketed 
in USA as a dietary supplement (as powdered H. serrata in tablet or capsule format).2 
        Besides the inhibition of AChE, some anti-microbial activities22 and anti-cancer 
activity23 were also reported for some of the Lycopodium alkaloids. However, no 
significant bioactivity was reported for our target molecule: lycoposerramine A.12  
         
1.4 Biosynthesis of Lycopodium Alkaloids 
        To date, very few biosynthetic studies have been performed with Lycopodium 
alkaloids due to the difficulties in growing these plants. Club mosses are not abundant, 
grow very slowly and are only found in very specialized habitats. Wild plants that are 
transferred to greenhouse or other growth environments grow very slowly and do not 
survive for more than a few months.2 In vitro tissue propagation of some of the species 
has just been achieved recently.24  
        Despite these limitations, several feeding experiments were conducted on club 
mosses grown in the wild and have shed light on the biosynthetic route for this important 
group of alkaloids.  It was found that the entry point of the biosynthetic pathway is the 
decarboxylation of L-lysine (by lysine decarboxylase, enzyme A) to form cadaverine. 
This could be converted to 5-aminopentanal (by diamine oxidase, enzyme B) followed by 











A B ! H2O
! CO2 N
∆1-piperideine  
        Alternatively, a Claisen condensation of two molecules of malonyl CoA could 
afford one molecule of acetonedicarboxylic acid CoA ester (by a ketosynthase, enzyme 
C), which could either be hydrolyzed to the free acid (1.6) or further activated to its 
bisCoA thioester (1.7) (eq. 1, Scheme 1.4).26  
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4PAA X = OH













        After condensation of 1.6 or 1.7 with Δ1-piperideine by an unknown enzyme D, 4-
(2-piperidyl)acetoacetate (4PAA) or 4-(2-piperidyl)acetoacetyl CoA (4PAACoA) could 
be formed.  This could then be decarboxylated to give pelletierine (eq. 2, Scheme 1.4),26 
the first general intermediate to Lycopodium alkaloids.2  
        Pelletierine and 4PAA/4PAACoA or derivatives thereof, could then be coupled (by 
unknown enzyme(s) F) to afford phlegmarine, from which other Lycopodium alkaloids 




















        For example, phlegmarine could be cyclized to form lycodane, which could be 
oxidized to lycodine class alkaloids or rearranged to lycopodine class alkaloids (Scheme 
1.6).27 The conversion of lycopodine class to fawcettimine class alkaloids was also 
proposed.28 


































        The Lycopodium alkaloids are a large group of structurally related, yet diverse 
quinolizine-, pyridine-, or α-pyridone-type alkaloids isolated from club moss 
Lycopodium (sensu lato). Some of the alkaloids, especially Huperzine A (hupA), were 
found to possess potent acetylcholinesterase inhibitory activity, and showed promising 
results in the treatment of Alzheimer’s disease (AD). Due to the difficulties in growing 
club mosses, very few biosynthetic studies have been performed on the Lycopodium 
alkaloids. Some feeding experiments have showed that they are L-lysine derived 
alkaloids. From those Lycopodium alkaloids, lycoposerramine A was chosen as our 
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Synthetic studies of Fawcettimine Class Alkaloids  












        The fawcettimine class of Lycopodium alkaloids presents significant challenges for 
total synthesis and has been attracting increasing attention from the synthetic 
community.1 For lycoposerramine A, our ultimate target, no total synthesis has been 
achieved. There is only a single reported synthesis of the tetracyclic core.2 The total 
syntheses of other members of the family, such as fawcettimine, fawcettidine, 
lycoposeerramine B, lycoflexine, etc., have been accomplished. In particular, 
fawcettimine, the representative compound of this family, has inspired substantial interest 
from synthetic groups, resulting in five total (two racemic,4a,4b,5 three 
enantioselective7,9,13) and two formal syntheses3.  
        From a strategic vantage, the critical challenge in contemplating the synthesis of 
those fawcettimine class alkaloids is the formation of the cis-fused 6,5-carbocyclic core 
containing one all-carbon quaternary center.  Some of the representative syntheses or 
synthetic approaches are selected and presented below. 
 
2.2 Inubushi’s syntheses of (±)-fawcettimine and (±)-8-deoxyserratinine 
        In 1979, the Inubushi group reported the first total syntheses of (±)-fawcettimine and 
(±)-8-deoxyserratinine (Scheme 2.1).4a,4b Their syntheses started with a Diels-Alder 
reaction (D-A) between enone 2.1 and 1,3-butadiene (2.2) to make D-A adduct 2.3, with 
concurrent formation of the all-carbon quaternary center. The addition of 2.2 was found 
to take place stereoselectively from the opposite face of the C-5 methyl group of enone 
2.1.4c This strategy, using the C-5 methyl group to control the facial selectivity of 
 19 
cyclohex-2-en-1-ones, was widely adopted in later syntheses of fawcettimine and many 
other family members (vide infra). 
Scheme 2.1. Total syntheses of (±)-fawcettimine and (±)-8-deoxyserratinine by the 
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        The D-A adduct 2.3 was then converted to dialdehyde 2.4, from which a selective 
intra-molecular aldol condensation followed by a Horner-Wadsworth-Emmons reaction 
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provided the cis-fused 6,5-carbocylcle 2.5. Carbocycle 2.5 contains all of the carbon 
skeleton for fawcettimine and 8-deoxyserratinine, with the formation of the azonine ring 
being the main hurdle. To this end, 2.5 was converted to amino acid 2.7, from which an 
intra-molecular lactam formation afforded the tricycle 2.8 in moderate yield. Tricycle 2.8 
was then transformed to (±)-fawcettimine and (±)-8-deoxyserratinine in several steps, via 
the common intermediate epoxide 2.9. 
        The Inubushi group accomplished the first total synthesis of (±)-fawcettimine in 26 
steps, with a 0.1% overall yield from commercially available materials.  
 
2.3 Heathcock’s total synthesis of (±)-fawcettimine 
        In 1986, the Heathcock group reported a much more efficient synthesis of (±)-
fawcettimine (Scheme 2.2).5 Their synthesis began with a Sakurai reaction between 
cyano enone 2.116 and allylsilane 2.12. The C-5 methyl group of enone 2.11 guided the 
addition of 2.12 from the opposite face. The allylic alcohol 2.13 thus obtained was then 
oxidized to aldehyde 2.14, which was converted to cis-fused 6,5-carbocylcle 2.16 by a 
one-pot Horner-Wadsworth-Emmons reaction and an intra-molecular Michael addition. 
After several steps, the cis-fused 6,5-carbocylcle 2.16 could be transformed to N,O-
ditosyl derivative 2.17, which set the stage for the construction of the azonine ring. When 
2.17 was treated with tetra-n-butylammonium hydroxide in toluene under highly diluted 
condition, the intra-molecular SN2 reaction took place smoothly, with azonine 2.18 
isolated in good yield. Azonine 2.18 was then converted to the diketo amine perchlorate 
salt 2.19, from which the stereocenter of C-4 was inverted and (±)-fawcettimine was 
 21 
obtained. The total synthesis required 17 steps from commercially available materials and 
was achieved in 9.7% overall yield. 



































































        From their experiment, the Heathcock group concluded that the control of 
stereochemistry at C-4 is not necessary, since fawcettimine is the sole thermodynamic 
product. This landmark observation was exploited in the later reported syntheses of 
fawcettimine and many other family members, which dramatically improved the 




2.4 Toste’s total synthesis of (+)-fawcettimine 
        In 2007, the Toste group reported the first total synthesis of (+)-fawcettimine.7 Their 
synthesis commenced with enantioenriched enone (−)-2.1 (88% e.e.), which could be 
synthesized from 2.21 and 2.22 by a one-pot organocatalytic Robinson annulation and 
decarboxylation.8  
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2.28 2.29 d.r. 10:1
CH2Cl2, !78 °C DMF, 0 °C
5
1) PPTS, acetone
2) BH3 then H2O2
3) DMP 4S
 
        From enone (−)-2.1, a C-5 methyl group directed, TBSOTf initiated conjugate 
addition of allenyltributylstannane (2.23) afforded TBS enol ether 2.24 stereoselectively, 
which was transformed to the cis-fused 6,5-carbocycle 2.26 by a sequential iodination 
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and gold(I)-catalyzed cyclization. The cis-fused 6,5-carbocylcle 2.26 obtained was then 
converted to iodide 2.27 via several steps. Subsequent SN2 reaction provided the azonine 
2.28 in good yield, which was next converted to diketone 2.29 by a 3-step sequence: ketal 
deprotection, hydroboration/oxidation, and Dess-Martin oxidation.  
        It is worthy of note that the hydroboration step was found not to be stereoselective, 
which afforded a mixture of alcohols after H2O2 mediated oxidation. However, upon 
oxidation to ketone stage, a diastereomeric ratio (d.r.) of 10:1, in favor of the desired 4S 
epimer 2.29 was observed, which is consistent with the studies of the Heathcock group.  
        Finally, removal of the Boc group on 2.29 completed the first asymmetric synthesis 
of (+)-fawcettimine. This very efficient synthesis requires just 14 steps from 
commercially available materials and gives a 13.1% overall yield.  
 
2.5  Mukai’s syntheses of (+)-fawcettimine and (+)-lycoposerramine B 
        In 2010, the Mukai group reported their total synthesis of (+)-fawcettimine, as well 
as the first total synthesis of (+)-lycoposerramine B.9 Their asymmetric synthesis relied 
on an intra-molecular Pauson-Khand reaction of enyne 2.31 to forge the 6,5-carbocycle 
2.32, which contains the desired stereochemistry at C-7 (fawcettimine numbering).10a The 
enyne 2.31 was obtained from (+)-diethyl L-tartrate (2.30) via several steps, which is a 
widely available and very cheap chiral source.10b 
        Installation of the all-carbon quaternary center for fawcettimine and 
lycoposerramine B on 6,5-carbocycle 2.32 followed a 3-step sequence: selective 
deprotection of one of the TBS ethers, acid catalyzed mixed ketal formation, and an intra-
molecular radical cyclization/allyl coupling reaction cascade. Tricycle 2.34 obtained was 
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converted to nosylate 2.35, which was cyclized under Fukuyama-Mitsunobu reaction 
conditions (PPh3, DEAD, PhMe, r.t.) to afford azonine 2.36 in 96% yield.  
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        Azonine 2.36 was next converted to enone 2.37 via several steps, which upon 
treatment with Me2Cu(CN)Li2 provided the conjugate addition product 2.38. The addition 
of Me2Cu(CN)Li2 was found to be highly stereoselective, with 2.38 isolated as a single 
diastereomer, whose stereochemistry at C-15 is the desired R configuration. Tricycle 2.38 
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serves as the common intermediate, from which both (+)-fawcettimine and (+)-
lycoposerramine B were synthesized. 
        Mukai’s total syntheses of (+)-fawcettimine and  (+)-lycoposerramine B require 26 
and 28 steps respectively from enyne 2.31. 
 
2.6 Ramharter’s syntheses of (+)-lycoflexine 
        In 2010, the Ramharter group reported the first total synthesis of (+)-lycoflexine 
(Scheme 2.5).11 Their synthesis started with a tandem Sakurai/aldol sequence that 
converted enone (–)-2.39 into alcohol 2.41. The C-5 methyl group of enone 2.39 
controlled the addition of allyltrimethylsiliane (2.40) so that the stereochemistry at C-3 is 
secured. Oxidation followed by alkylation of 2.41 afforded carbamate 2.42, with 
concurrent formation of the all-carbon quaternary center. The acyl group of 2.42 was next 
converted to an alkyne by a 2-step sequence: enol triflate formation and elimination. The 
dienyne 2.44 obtained was then submitted to an impressive one-pot dienyne ring-closing 
metathesis (RCM) and selective hydrogenation conditions, which provided azonine 2.46 
in admirable 52% yield.  
        From 2.46, a one-pot hydroboration and oxidation afforded diketone 2.29, the same 
intermediate as in Toste’s (+)-fawcettimine synthesis (Scheme 2.3), which was converted 
to (+)-lycoflexine by a one-pot Boc deprotection and biomimetic12 Mannich reaction.  
        This remarkably concise total synthesis of (+)-lycoflexine requires only 8 steps from 









































































 2.7 Yang’s syntheses of (–)-8-deoxyserratinine, (+)-fawcettimine, and 
(+)-lycoflexine. 
        Quite recently, Yang Y. and coworkers reported their unified total synthesis of (–)-
8-deoxyserratinine, (+)-fawcettimine, and (+)-lycoflexine (Scheme 2.6, 2.7).13 The 
syntheses commenced with the conjugate addition of Grignard reagent 2.47 to enone (–)-
2.1, the same enone used by the Toste group in their (+)-fawcettimine synthesis. Again, 
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the C-5 methyl group of enone controlled the newly formed stereochemistry at C-3. The 
TMS enol ether obtained above, upon treatment with warm 2N HCl, underwent a cascade 
desilylation, acetal hydrolysis, and intra-molecular aldol cyclization to give cis-fused 6,5-
carbocycle 2.49 (d.r. 2.5:1) with one all-carbon quaternary center in good yield. After 
several steps, 2.49 was converted to diiodide 2.51, which could then be cyclized to afford 
azonine 2.52 in good yield.  
        Azonine 2.52 was next converted to epoxide 2.9, the same epoxide employed by 
Inubushi and coworkers in their (±)-8-deoxyserratinine synthesis. Following the 
procedures described by Inubushi, (–)-8-deoxyserratinine was synthesized.   
























































        Azonine 2.52 also serves as the common intermediate to (+)-fawcettimine and (+)-
lycoflexine (Scheme 2.7). In two steps, 2.52 was converted to carbamate 2.53, which 
upon treatment with OsO4 in pyridine provided, unexpectedly, lactol 2.54. From 2.54, the 
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synthesis of (+)-fawcettimine was completed in a 3-step sequence: Ley oxidation, SmI2 
mediated reduction and TFA triggered Boc removal/cyclization. The Yang group 
accomplished the total synthesis of (+)-fawcettimine in 15 steps from (–)-2.1, with a 
6.9% overall yield. From (+)-fawcettimine, a biomimetic Mannich reaction12 afforded 
(+)-lycoflexine. 








































15 steps, 6.9% yield
from (–)-2.22  
        The conversion of carbamate 2.53 to (–)-lycojapodine A was also attempted 
(Scheme 2.8).14 To this end, the alkene moiety of 2.53 was cleaved by a combination of 
RuCl3 and NaIO4 to give keto acid 2.55. However, subsequent biomimetic cyclization15 
of 2.55 by treatment of 2.55 in aqueous acetic acid at elevated temperature resulted in no 
formation of desired (–)-lycojapodine A. Instead, the unnatural alkaloid 2.56 was isolated 
in 45% yield. The mechanism for the formation of 2.56 was also proposed, in which the 
free amine of 2.57 attacked the C-3 but not the C-13 carbonyl to afford hemiaminal 2.58. 
Hemiaminal 2.58 then underwent dehydration to form enamine 2.59, which cyclized onto 
the ester side chain and rearranged to give 2.56.14 
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2.8 Dake’s total synthesis of (+)-fawcettidine 
        In 2008, Dake G. R. and coworkers reported the first total synthesis of (+)-
fawcettidine (Scheme 2.9).16 Their asymmetric synthesis employs (R)-(+)-pulegone as the 
chiral source. In 5 steps, (R)-(+)-pulegone was transformed to enone 2.61, which upon 
treatment with Grignard reagent 2.62 in the presence of CuBr·DMS followed by TBAF 
mediated desilylation afforded alkyne 2.63 in good yield. Again, the methyl group of 
enone 2.61 controlled the highly stereoselective formation of C-7 (fawcettimine 
numbering) stereocenter. Alkyne 2.63 obtained was then condensed with amine salt 2.64 
to give enamide 2.65, which underwent an intra-molecular annulation of enamide to 
alkyne upon treatment with catalytic amount of PdCl2. Tricycle 2.66 was obtained in 
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excellent yield, with concurrent formation of one all-carbon quaternary center. Tricycle 
2.66 was next converted to sulfone 2.67 in a 3-step sequence: SeO2 mediated allylic 
oxidation, NaOH triggered carbamate removal/conjugate addition, and m-CPBA 
promoted oxidation of sulfide to sulfone. From sulfone 2.67, a Ramberg-Bäcklund 
reaction provided alkene 2.68 in moderate yield, from which (+)-fawcettidine was 
synthesized. 
        The Dake group accomplished the first total synthesis of (+)-fawcettidine in 16 
steps, with a 1.0% overall yield.  
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2.9 Overman’s total synthesis of (+)-sieboldine A 
        In 2010, the Overman group reported the first total synthesis of (+)-sieboldine A 
(Scheme 2.10).17 Their asymmetric synthesis began with the Tsuji-Trost reaction between 
3-acetoxycyclopentene (2.69) and dimethyl malonate (2.70).18 The alkylation product 
2.71 obtained (96% e.e.) was then converted to cyclopentafuranone 2.72 under reported 
conditions.19  Subsequent methylcuprate promoted SN2' alkylation of 2.72 followed by 
iodolactonization afforded iodide 2.73, which was transformed to cyclopentanone 2.74 in 
3 steps. Addition of vinyl lithium reagent 2.75 to a solution of 2.74 in THF at –78 ºC 
delivered allylic alcohol 2.76 as a single diastereomer in excellent yield. Swern oxidation 
of the primary silyl ether of 2.76, followed by condensation of the resulting aldehyde 
with Ohira-Bestmann reagent (2.77) afforded alkyne 2.78, which upon treatment with 
cationic gold(I) catalyst produced the pinacol-terminated cyclization cascade product 
2.79 in 78% yield. Bicycle 2.79 contains the cis-fused 6,5-carbocyclic core as well as the 
all-carbon quaternary center of sieboldine A. 
        From 2.79, ozonolysis of the exomethylene group followed by DBU triggered 
elimination provided enone 2.80, which was cyclized with ethyl vinyl ether (2.81) in the 
presence of catalytic amount of Eu(fod)3 to give dihydropyran 2.82. Reduction of the 
ketone group of 2.82, followed by epoxidation and BF3 promoted rearrangement in the 
presence of EtSH gave rise to thioglycoside 2.84 in 53% yield over 3 steps. Removal of 
the TBDPS group of 2.84, followed by Fukuyama-Mitsunobu reaction and removal of the 
Ns group afforded MOM protected hydroxylamine 2.85, which set the stage for the 
azonine ring formation. 
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5 mol% AgSbF6, i-PrOH, CH2Cl2
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 DMDO, CH2Cl2, 0 °C
then BF3·OEt2, EtSH
53% over 3 steps
2.83 2.84
2.86
1) cat. TPAP, NMO
2) Me2BBr
59% over 2 steps
79%
1) Swern oxidation, 86%
2) N2=C(COMe)PO(OMe)2 2.77
    K2CO3, MeOH, 90%
1) TBAF, 91%
2) NsNH–OMOM
    Ph3P, DEAD, 88%














        Exposure of 2.85 to dimethyl(methylthio)sulfonium triflate (DMTST) in the 
presence of 2,6-di-t-butyl-4-methylpyridine (DTBMP) at –20 ºC in acetonitrile provided 
azonine 2.86, from which a Ley oxidation and removal of the MOM protecting group 
completed the first total synthesis of (+)-sieboldine A.  
 
2.10 Tu’s syntheses of (±)-alopecuridine and (±)-sieboldine A 
        In 2011, Tu Y. and coworkers reported the first total synthesis of (±)-alopecuridine 
as well as the biomimetic transformation of (±)-alopecuridine to (±)-sieboldine A.20 Their 
synthesis began with the preparation of fragment 2.89 and 2.93 (Scheme 2.11). The 
fragment 2.89 was made from known iodide 2.87 in a 3-step sequence: Luche reduction 
of the enone, acetylation of the newly formed allylic alcohol, and BF3 catalyzed 
allylation. The other fragment 2.93 was prepared from commercially available azepine 
2.90 through a Tiffeneau-Demjanov type reaction with diazoacetic ester 2.91 and 
subsequent decarboxylation. After lithium iodide exchange, the resulting lithium salt of 
2.89 was first transformed to cerium salt and then coupled to 2.93 followed by 
epoxidation to afford epoxide 2.94 as a mixture of inseparable diastereomers 
(2.94a:2.94b 3.5:1).  When the diastereomers were treated with BF3·Et2O in Et2O at low 
temperature, a semipinacol reaction took place, with the desired azonine 2.95a isolated in 
45% yield. The undesired isomer 2.95b could be readily separated from the reaction 
mixture. 
        Azonine 2.95a already contains the all-carbon quaternary center required for 
alopecuridine and sieboldine A syntheses. From 2.95a, protection of the free alcohol as 
MOM ether followed by ozonolysis afforded keto aldehyde 2.96.  
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Et2O, –30 to –15 °C














66% over 2 steps
86% over 2 steps
42%
1) NaBH4, CeCl3, 100%
2) Ac2O, Et3N, 97%
 
        Upon treatment of 2.98 with SmI2 at 0 ºC, a stereoselective intra-molecular pinacol 
coupling took place, with diol 2.97 isolated in 60% yield. Diol 2.97 contains the two 
contiguous quaternary centers for alopecuridine and sieboldine A. After some adjustment 
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of the oxidation state as well as removal of the protecting groups, the first total synthesis 
of (±)-alopecuridine was accomplished. 









1) m-CPBA, CH2Cl2, r.t.
2) HgO, MeOH, 35 °C







































        Based on Kobayashi’s biosynthetic proposal,21 Tu Y. and coworkers also achieved 
the biomimetic conversion of (±)-alopecuridine to (±)-sieboldine A (Scheme 2.12). In 
their 2-step oxidation sequence, (±)-alopecuridine TFA salt was first oxidized to the 
corresponding N-oxide 2.98 by m-CPBA. Intermediate 2.98 was found to be unstable 
during purification and was used in the next oxidation directly. Upon treatment of crude 
2.98 or its equilibrating hydroxylamine form 2.99 with HgO in MeOH at elevated 
temperature, (±)-sieboldine A was isolated in 60% yield. In this second oxidation step, 
hydroxylamine 2.99 may undergo dehydration to form imine 2.100, followed by 
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oxidation to give nitrone 2.101, from which an intra-molecular cyclization led to (±)-
sieboldine A. The direct oxidation of 2.99 to 2.101 is another possibility.  
 
2.11 Elliott’s synthetic approach to lycoposerramine A 
        In 2009, The Elliott group reported their synthetic route to lycoposerramine A 
(Scheme 2.13).2 Their synthesis started with diol 2.102, from which a selective protection 
of the primary hydroxyl group as TBS ether followed by a radical cyclizaiton afforded 
the cis-fused 6,5-carbocycle 2.104 in moderate yield. The alkene functionality of 2.104 
was then transformed to an enone moiety by a 3-step sequence: epoxidation, one-pot 
epoxide opening/selenoxide elimination, and allylic oxidation. The enone 2.107 obtained 
was then subjected to conjugate addition conditions (Cu(OTf)2, Me3Al, PhMe) to install 
the C-15 methyl group (fawcettimine numbering). However, an inseparable mixture of 
2.108a and 2.108b was obtained with a diastereomeric ratio (d.r.) of 3:1, in favor of the 
desired stereoisomer 2.108a. The mixture was carried on to the next Mitsunobu reaction. 
The hydroxylamine derivative 2.109 obtained above could be converted to 
dioxazolidinone 2.110 by DBU triggered Fmoc deprotection/cyclization process. 
However, all efforts to construct the oxadiazolidinone moiety, the challenging motif for 















































































        The fawcettimine class of Lycopodium alkaloids has been attracting significant 
attention from the synthetic community in the past 30 years, resulting in the total 
synthesis of several of the family members.  In particular, fawcettimine, the parent 
compound of this family, has witnessed five total and two formal syntheses. From a 
strategic vantage, most of the reported syntheses of fawcettimine, as well as other 
members in the same group, adopted the strategy developed by the Inubushi group in 
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their pioneering fawcettimine synthesis to construct the cis-fused 6,5-carbocyclic core 
with one all-carbon quaternary center. For lycoposerramine A, our ultimate target, no 
total synthesis has been achieved. There is only a single reported synthetic approach to 
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3.1 Retrosynthetic Analysis 
        As stated early in chapter one, we chose lycoposerramine A as our ultimate target 
for total synthesis. Given the structural similarity between lycoposerramine A and many 
other family members, a diversity oriented synthetic strategy that could target many of 
those alkaloids was pursued. Guided by the proposed biosynthetic pathway of 
lycoposerramine A,1 we chose diketoamine 3.2 as the key intermediate in our synthetic 
route (Scheme 3.1). We envisioned that the 1,2,4-oxadiazolidin-5-one moiety could be 
assembled through a 1,3-dipolar cycloaddition between intermediate nitrone 3.1 and 
isocyanic acid (HNCO).2 Nitrone 3.1 could be derived from diketoamine 3.2, in which a 
selective oxime formation followed by reduction to form hydroxylamine are the key 
transformations. Diketoamine 3.2 could cyclize to afford lycothunine, from which the 
reduction of the C=C bond by PtO2 and H2 to form fawcettimine was reported.3 
Fawcettimine itself was viewed as the biosynthetic precursor to several other family 
members,1,4 and the conversion of fawcettimine to fawcettidine5 and lycoflexine6 was 
already documented. Thus, our divergent oriented synthetic approach should enable us 
access to multiple targets of this family. 
        We envisioned that diketoamine 3.2 could be derived from amide 3.3, in which an 
intra-molecular ring-closing metathesis (RCM) reaction was chosen to form the azonine 
ring. Amide 3.3 could be derived from lactone 3.4 with inversion of the stereocenter at C-
4 (fawcettimine numbering). The ladder-like 6,5,6-fused rings of 3.4 suggested a Diels-
Alder reaction between diene 3.5 and enone 3.6 to construct the cis-fused 6,5 carbocycles 
with one all-carbon quaternary center, which is characteristic to all of the fawcettimine 
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class alkaloids. Enone 3.6 could be obtained from lactone 3.7, which in turn could be 
made by Baeyer-Villiger (B-V) oxidation of known cyclopentanone 3.87. 
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        In our synthetic plan, the absolute stereochemistry of lycoposerramine A is 
controlled by the formation of cis-fused 6,5 carbocycles (intermediate 3.4), which in turn 
is determined by the formation of C-4 stereogenic center (fawcettimine numbering) of 
cyclopentanone 3.8. Thus, starting with the enantiomerically pure form of 3.8, the 
asymmetric synthesis should also be achieved (vide infra). We chose racemic 3.8 to 
explore the proposed synthetic route first. 
 
3.2 Attempt Synthesis of Enone 3.6 
        Our synthesis began with the known cyclopentanone 3.8, which was readily 
synthesized in two steps from commercially available isoprene (3.9) and cyclopentenone 
ethylene ketal (3.10) under the reported procedures (Scheme 3.2).7 














        The subsequent Baeyer-Villiger (B-V) oxidation8 on cyclopentanone 3.8 to make 
lactone 3.7 was found to be difficult because of the competing epoxidation on the alkene 
moiety. When 3.8 was treated with m-CPBA, the most commonly resorted oxidant in this 
kind of reaction, only epoxide 3.12 was isolated (entry 1, 2, Table 3.1). NaBO3·4H2O9 in 
AcOH solvent gave a mixture of products, and no desired lactone 3.7 was isolated (entry 
3). No reaction took place when H2O2 was employed as the oxidant, either at acidic or 
basic conditions (entry 4–6). We then turned our attention to bis(trimethylsilyl) peroxide 
((TMS)2O2). In 1982, Noyori and coworkers reported that (TMS)2O2 and a catalytic 
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amount of TMSOTf could react with ketones selectively in the presence of alkenes to 
afford B-V products in moderate yield.10a The Takai group found that a stoichiometric 
amount of SnCl4 or BF3·OEt2 could catalyze this (TMS)2O2 mediated B-V oxidation.10b 
Later, Shibasaki reported that amine ligands such as trans-1,2-diaminocyclohexane (DA) 
could significantly improve the yields, with only a catalytic amount of SnCl4 needed.10c 
We tried these (TMS)2O2 mediated B-V oxidations (entry 7– 9), and were pleased to find 
that the desired lactone 3.7 could be isolated in moderate yield under Shibasaki’s 
conditions (entry 9).  
















Entry Conditions Resultsa 
1 m-CPBA, CH2Cl2, NaHCO3, r.t. 90% 3.12 
2 m-CPBA, AcOH, r.t. 94% 3.12 
3 NaBO3·4H2O, AcOH, r.t. messy, no 3.7 
4 H2O2, NaOH, MeOH, r.t. n.r. 
5 H2O2, (n-Bu)4NOH, PhH/H2O, r.t. n.r. 
6 H2O2, CH3COOH, THF, r.t. n.r. 
7 (TMS)2O2, BF3·Et2O, CH2Cl2, –78 °C messy, no 3.7 
8 (TMS)2O2, SnCl4, CH2Cl2, 0 °C messy, no 3.7 
9 (TMS)2O2, cat. SnCl4, DA, 4Å MS, CH2Cl2 0 °C 50% 3.7, 59.5% brsm 
         a Isolated yield. 
        From lactone 3.7, the synthesis of keto aldehyde 3.13 is straightforward, which just 
need cleavage of the C=C bond (route a, Scheme 3.3). However, during the screening of 
suitable oxidant to do a B-V oxidation on cyclopentanone 3.8, we also envisioned an 
alternative approach to 3.13 (route b). The new route relied on a dihydroxylation of 3.8 to 
temporally mask the interfering alkene moiety. Subsequent B-V oxidation of the 
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dihydroxylation product 3.14, followed by diol cleavage could afford 3.13. Since route b 
proved to be practical, the conversion of 3.7 to 3.13 via route a was not tried.  


























        Dihydroxylation of cyclopentanone 3.8 under conditions reported by Kobayashi,11 
using a catalytic amount of polymer supported OsO4 (P-OsO4) and NMO as the 
stoichiometric oxidant could afford diol 3.14 in good yield (entry 1, Table 3.2).  
Trimethylamine N-oxide dihydrate (Me3NO·2H2O) worked less efficiently than NMO 
(entry 2). KMnO4 in phase transfer catalysis conditions was also examined,12 which only 
gave very low yield of desired product (entry 3).  











Entry Conditions Resultsa 
1 5 mol% P-OsO4, NMO, CH3CN/acetone/H2O, r.t. 82%, 88% brsm 
2 5 mol% P-OsO4, Me3NO·2H2O, CH3CN/acetone/H2O, r.t. 24%, 26% brsm 
3 KMnO4, BnEt3NCl, CH2Cl2, r.t., then 3% NaOH 20%  
 a Isolated yield. 
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        The following B-V oxidation of diol 3.14 went smoothly with m-CPBA as the 
oxidant, and gave lactone 3.15 in 70% yield (Scheme 3.4). Subsequent treatment of 3.15 
with NaIO4 could cleave the diol into keto aldehyde 3.13 in 95% yield.   






















        With keto aldehyde 3.13 in hand, the intra-molecular aldol condensation 
/dehydration process to form enone 3.6 was examined next. Unfortunately, 3.13 turned 
out to be prone to β-elimination, with α, β-unsaturated aldehyde 3.16 isolated as the sole 
product either at basic or acidic conditions (entry 2, 3, Table 3.3). 

















Entry Conditions Resultsa 
1 NaOH, 10 mol% (n-Bu)4BF4, PhH, reflux messy, no 3.6 
2 5 mol% t-BuOK, THF, r.t. 60% 3.16 
3 5 mol% p-TsOH, CH3CN, r.t. 45% 3.16 
                 a Crude yield. 
 
        Realizing that β-elimination was unavoidable to keto aldehyde 3.13, we didn’t 
invest more time on its conversion to 3.6 and decided to put the B-V oxidation step off to 
a later stage (vide infra). 
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3.3 Synthesis of Enone 3.18 and Its Diels-Alder Reaction 
        Our new synthesis started with the cleavage of the C=C bond of ketal 3.11. 
Surprisingly, the Lemieux-Johnson reagent (OsO4 and NaIO4)13a gave very low yield of 
desired keto aldehyde 3.17 (entry 1, Table 3.4). The yield could not be improved by 
addition of a catalytic amount of NMO (entry 2).13b Polymer supported OsO4 (P-OsO4) 
totally failed this time (entry 3, 4). We then turned our attention to ozonolysis14. When 
MeOH was used as the solvent, only trace amount of 3.17 was detected. CH2Cl2 as 
cosolvent or solvent could improve the yield slightly (entry 6, 7). Ph3P worked less 
efficiently than Me2S as the reducing reagent (entry 8). The acid labile ethylene ketal 
moiety of 3.11 may be responsible for the low yields obtained for above reactions.7  











Entry Conditions Resultsa 
1 1 mol% OsO4, NaIO4, THF/H2O, r.t. 15% 
2 1 mol% OsO4, 10 mol% NMO, NaIO4, MeCN/H2O, r.t. 12%, 20% brsm 
3 3 mol% P-OsO4, NaIO4, THF/H2O, r.t. 0% 
4 3 mol% P-OsO4, NaIO4, dioxane/H2O, r.t. 0% 
5 O3, MeOH, –78 °C then Me2S trace 
6 O3, MeOH/CH2Cl2, –78 °C then Me2S <10% 
7 O3, CH2Cl2, –78 °C then Me2S 30% 
8 O3, CH2Cl2, –78 °C then Ph3P 25% 
9 3.5 mol% RuCl3·xH2O, NaIO4, (ClCH2)2/H2O, r.t. 59% 
  10b 1 mol% RuCl3·xH2O, NaIO4, (ClCH2)2/H2O, r.t. 75% 
a Isolated yield. b Using mechanical stirrer. 
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        To our delight, when Yang’s conditions (cat. RuCl3·xH2O, NaIO4, (ClCH2)2/H2O)15 
were attempted, 3.17 could be isolated in 59% yield. The yield could be further improved 
to 75% when a mechanical stirrer was employed (entry 9, 10). 
        Compared to keto aldehyde 3.13, the intra-molecular aldol condensation/dehydration 
of 3.17 was met with less difficulty. When 3.17 was treated with KOH in H2O at room 
temperature for 3 hours, desired enone 3.18 and undesired α, β-unsaturated aldehyde 
3.19 (3.18:3.19 = 1:2.27) were isolated as an inseparable mixture in 91% combined yield 
(entry 1, Table 3.5). It was quickly found that 3.18 is the thermodynamic product and 
3.19 is the kinetic product. The ratio of 3.18 could be increased either by elongated 
reaction time or elevated temperature. However, the yield dropped with those factors 
because of the unwanted inter-molecular reactions. The optimal result could be obtained 
by treatment of 3.17 with 4 equiv. of KOH in reflux H2O for 15 hours (entry 7).  


















Entry Conditions 3.18:3.19a,b,c 
1 20 equiv. KOH, H2O, r.t., 3h 1:2.27 (91%) 
2 20 equiv. KOH, H2O, r.t., 25h 1:1.56 (83%) 
3 20 equiv. KOH, H2O, r.t., 14d 1:0.31 (78%) 
4 20 equiv. KOH, H2O, 60−70 °C, 11h 1:0.14 (67%) 
5 20 equiv. KOH, H2O, 60−70 °C, 25h 1:0.02 (60%) 
6 20 equiv. KOH, 20 mol% pyrogallol, MeOH/H2O, 60−70°C, 25h 1:0.05 (45%) 
7 4 equiv. KOH, H2O, reflux, 15h 1:0.02 (79%) 
8 2 equiv. KOH, H2O, reflux, 15h 1:0.04 (68%) 
9 25 mol% KOH, H2O, 60−70 °C, 18h 1:1.38 (76%) 
a Ratio was determined by 1H NMR. b Yield in parenthesis was combined yield for 3.18 
and 3.19. c Isolated yield. 
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        It is worth noting that O2 is detrimental to this reaction and thus must be carefully 
removed.16 A catalytic amount of pyrogallol was added with the hope that it could act as 
O2 scavenger, but no beneficial effect was observed (entry 6).  
        Although undesired 3.19 could not be separated from 3.18 at this moment, it was 
found that 3.19 did not participate in the next Diels-Alder reaction and could be removed 
in that step (vide infra). 
        The Diels-Alder reaction (D-A)17 between enone 3.18 and two commercially 
available dienes: 1-(trimethylsiloxy)-1,3-butadiene (3.20) and 1-acetoxy-1,3-butadiene 
(3.21) was investigated next. When 3.18 was treated with 3.20 in refluxing toluene for 10 
hours, no reaction took place (entry 1, Table 3.6). Microwave heating at 120 °C in 
CH2Cl2 for 1 hour also gave no reaction (entry 2). On the other hand, Lewis acids such as 
ZnCl2 or EtAlCl2 could either decompose the diene 3.20 or remove the ketal protecting 
group of enone 3.18 (entry 3, 4). With these initial failures, we focused on more harsh 
thermal conditions. The breakthrough was made by heating enone 3.18 with a large 
excess of diene 3.20 in xylene in a sealed tube for elongated time. Desired adduct 3.22 
could be isolated in low yield together with most of enone 3.18 recovered (entry 5). The 
yield could be improved by running the reaction under neat conditions (entry 6, 7). 
However, higher temperatures (> 190 °C) resulted in significant loss of yield, presumably 












3.20 R = TMS








3.22 R = TMS
3.23 R = OAc  
Entry Conditions Resultsa 
1 2.4 equiv. 3.20, PhMe, reflux, 10h n.r. 
2 2 equiv. 3.20, CH2Cl2, MW, 120 °C, 1h n.r. 
3 6 equiv. 3.20, 25 mol% ZnCl2, CH2Cl2, 0 °C, 3h 3.20 decomposed  






 5b 10 equiv. 3.20, xylene, 170 °C, 4d 15% 3.22, 75% brsm 
 6b 10 equiv. 3.20, neat, 160 °C, 7d 36% 3.22, 65% brsm 
 7b 10 equiv. 3.20, neat, 190 °C, 3d 30% 3.22, 67% brsm 
 8b 10 equiv. 3.20, neat, 240 °C, 10h 9% 3.22 
 9b 10 equiv. 3.20, neat, MW, 190 °C, 9h 48% 3.22, 69% brsm 
 10b 10 equiv. 3.20, neat, MW, 200 °C, 16h 37% 3.22, 55% brsm 
11 1.5 equiv. 3.21, PhMe, reflux, 3d 3.21 decomposed 
12 10 equiv. 3.21, neat, MW, 200 °C, 4h 3.21 polymerized 







 a Isolated yield. b Sealed tube reaction. 
        To our delight, compared to reactions conducted under elevated temperatures, 
microwave (MW)18 shortened the Diels-Alder reaction time and improved the yield 
dramatically. Thus, the optimal result was obtained by running the reaction in a 
microwave reactor at 190 °C for 9 hours with adduct 3.22 isolated in 48% yield (69% 
brsm) (entry 9). Moreover, when a mixture of enone 3.18 and α, β-unsaturated aldehyde 
3.19 (3.18:3.19 = 1:1.56) was subjected to this optimized condition, only adduct 3.22 was 
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isolated, with no adduct between 3.20 and 3.19 was detected (Scheme 3.5). Thus, 3.19 
could be removed from 3.18 at this step. 























        Compared to 1-(trimethylsiloxy)-1,3-butadiene (3.20), 1-acetoxy-1,3-butadiene 
(3.21) gave no desired adduct 3.23 when heated with 3.18 in toluene or neat by 
microwave. Diene 3.21 was found to be unstable in both conditions (entry 11, 12). 
Ethylene glycol (EG) was also tested, which was reported to be a good solvent for inter-
molecular Diels-Alder reactions involving relatively hydrophobic dienes and 
dienophiles.19 However, when 3.21 and 3.18 was heated in EG at 145 °C for 3 days, only 
diethylene ketal 3.25 was isolated (entry 13). 


























        Besides a Diels-Alder reaction, the possibility of successive Michael addition/aldol 
condensation between diene 3.20 and enone 3.18 to form adduct 3.27 was also tested.20 It 
was hoped that when diene 3.20 was treated with MeLi or LiF, the butadienolate 
generated could add to enone 3.18 to form intermediate 3.26, followed by an intra-
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molecular aldol condensation to afford 3.27 (Scheme 3.6). Unfortunately, no trace of 
desired 3.27 was observed.  
 
3.4 Synthesis of Alkene 3.34 
        With the D-A adduct 3.22 in hand, we had already constructed the cis-fused 6,5-
carbocycles with one all-carbon quaternary center, which is characteristic to all of the 
fawcettimine class alkaloids. Efforts were then focused on the formation of the azonine 
ring. As illustrated in our retrosynthetic analysis (Scheme 1), a ring-closing metathesis 
(RCM) was planned to fulfill the task. Before this step, however, a Baeyer-Villiger 
oxidation to convert cyclopentanone to lactone is necessary. The time to introduce this 
critical reaction in our synthetic route definitely needed careful consideration.   





completely consumption of 
3.29 in the presence of 3.28+
 
        Since alkenes are nucleophilic and carbonyls are electrophilic, we envisioned that 
the conjugation of these two groups should render the resulting enone less reactive 
towards either nucleophiles or electrophiles. A model study using a mixture of cyclohex-
2-enone (3.28) and 2-methylcyclopentanone (3.29) further verified our consideration. 
When a mixture of 3.28 and 3.29 was subjected to m-CPBA in CH2Cl2 at room 
temperature, TLC showed that cyclopentanone 3.29 was completely consumed while 
cyclopentenone 3.28 was totally remained (Scheme 3.7). Hence, the selective Baeyer-
Villiger oxidation of cyclopentanone in the presence of cyclohexenone is possible.  
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        Encouraged by this preliminary result, we decided to put the Baeyer-Villiger 
reaction on the ketoenone oxidation state of our substrate (Scheme 3.8). To this end, 
Diels-Alder adduct 3.22 was first reduced to diol 3.30 by LiAlH4 reduction. The 
subsequent selective allylic oxidation of diol 3.30 to enone 3.31 could be achieved by 
treatment of 3.30 with activated MnO2 in CH2Cl2 (82% over 2 steps). After removal of 
the ethylene ketal protecting group, the resulting ketoenone 3.32 was tested for the 
selective Baeyer-Villiger reaction. To our delight, when 3.32 was treated with m-CPBA 
in CH2Cl2 at room temperature in the presence of NaHCO3, desired lactone 3.33 was 
isolated as the sole product in 91% yield over 2 steps. Since the enone moiety is close to 
the all-carbon quaternary center, the steric hindrance may also play a role in this highly 
selective Baeyer-Villiger reaction.  
Scheme 3.8. Synthesis of lactone 3.33. 
CH2Cl2, r.t.








































        With lactone 3.33 in hand, efforts were then put on its dehydration to form alkene 
3.34. When 3.33 was subjected to Martin sulfurane21 in benzene at room temperature or 
Burgess reagent22 in different solvents at elevated temperatures, no desired alkene 3.34 
was detected (entry 1−4, Table 3.7). No reaction was observed when 3.33 was treated 
with SOCl2 in pyridine solvent at room temperature (entry 5).23 Moreover, Mitsunobu 
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dehydration conditions24 (entry 6) and Monson’s conditions25 (entry 7) were also tested, 
with no alkene 3.34 formed in both cases. Apparently, the neighboring all-carbon 
quaternary center rendered the secondary hydroxyl group so hindered that bulky reagents 
could not access it.  











Entry Conditions Results 
1 Martin sulfurane, PhH, r.t. no 3.34 
2 Burgess reagent, CH3CN, 60 °C no 3.34 
3 Burgess reagent, PhMe, 60 °C no 3.34 
4 Burgess reagent, THF, 60 °C no 3.34 
5 SOCl2, pyridine, r.t. n.r. 
6 Ph3P, DEAD, THF, reflux no 3.34 
7 HMPA, 180 °C no 3.34 
 
        Since there was no way to perform the dehydration on 3.33 directly, we then turned 
our attention to those two steps approaches. Treatment of lactone 3.33 with mesyl 
chloride (MsCl) in pyridine at room temperature gave mesylate 3.35 in 95% yield 
(Scheme 3.9).  
















        Subsequent elimination of mesylate 3.35 to form alkene 3.34 was met with failure, 
initially. When 3.35 was treated with DBU in toluene at room temperature, no reaction 
took place. At reflux temperatures, the reaction turned very messy and no trace of 3.34 
was detected (entry 1, 2, Table 3.8). Other bases, such as t-BuOK or AcONa26a, also 
failed to deliver 3.34 (entry 3−5). No reaction was observed when 3.35 was subjected to 
silica gel26b or (CH3CN)2PdCl226c (entry 6, 7).   












Entry Conditions Resultsa 
1 DBU, PhMe, r.t. n.r. 
2 DBU, PhMe, reflux no 3.34 
3 t-BuOK, DMSO, r.t. no 3.34 
4 t-BuOK, t-BuOH/THF, 0 °C no 3.34 
5 AcONa, AcOH, reflux no 3.34 
6 Silica gel, CH2Cl2, r.t. n.r. 
7 (CH3CN)2PdCl2, PhH, reflux n.r. 






34% 3.34 + 25%
 
9 Li2CO3, LiBr, DMF, reflux, 5h 41% 3.34 + 15% 3.36 
10 Li2CO3, LiBr, DMF, 130 ˚C, 20h 61% 
11 Li2CO3, DMF, reflux, 6h < 20% 
12 Li2CO3, LiBr, DMF, 210 ˚C, MW, 8min. 65% 
  a Isolated yield. 
        It was reported that LiBr in DMF could act as a strong base to trigger the elimination 
of secondary mesylates to form alkenes.27 Gratifyingly, when 3.35 was treated with LiBr 
and Li2CO3 in refluxing DMF for 1 hour, desired alkene 3.34 could be isolated in 34% 
yield together with bromide 3.36 in 25% yield (entry 8). After 5 hours, the yield of alkene 
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3.34 increased to 41% while the yield of bromide 3.36 dropped to 15% (entry 9). The 
reaction was pushed to completion at 130 °C for 20 hours, with 3.34 isolated as the sole 
product in 61% yield (entry 10).  
        The conversion of 3.35 to 3.34 possibly goes through the substitution of 3.35 by 
LiBr to form bromide 3.36 first, followed by elimination of HBr to form 3.34. Bromide 
3.36 as the reactive intermediate was verified by our control experiment, which showed 
that when 3.36 was subjected to the reaction condition, alkene 3.34 could be obtained 
(Scheme 3.10). However, direct elimination of methanesulfonic acid (MsOH) from 3.35 
is still possible, since in the absence of LiBr, alkene 3.34 was still isolated in lower yield 
(entry 11).  
        Finally, it was found that the reaction time could be shortened greatly by microwave 
(MW) heating, with the reaction completed in 8 minutes and the yield slightly improved 
to 65% (entry 12). This microwave assisted procedure stands out as our optimized 
reaction condition.  













         Compared to the mesylate formation/elimination sequence, the xanthate formation/ 
elimination28 and Grieco elimination29 were also attempted (Scheme 3.11). However, no 


































3.5 Installation of C-15 Methyl Group 
        With alkene 3.34 in hand, the installation of C-15 methyl group (fawcettimine 
numbering) was investigated next. A Michael addition using Me2CuLi to add the methyl 
group from the convex face of the 6,5-carbocycle was planned originally and expected to 
deliver ketone 3.39 with the required R configuration at C-15 (Scheme 3.12). However, 
the C-12 vinyl group may block the approach of Me2CuLi from that face so that the facial 
selectivity can be eroded.   












        On the other hand, since we already obtained alkene 3.34 by mesylate elimination, 
we envisioned that the mesylate group could be utilized further to block the convex face 
of the fused 6, 5-carbocycle (Scheme 3.13). Thus, hydrogenation of mesylate 3.40 could 
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only take place from the more available concave face to provide ketone 3.41 with correct 
R configuration at C-15.  




















        To make enone 3.40, diene 3.43 needs to substitute diene 3.20 in the corresponding 
Diels-Alder reaction (vide infra). Diene 3.43 (mixtures, E:Z = 80:20) is a known 
compound and can be easily made in one step from commercially available 3-methyl-2-
butenal (3.41) under reported conditions (Scheme 3.14).30 









( E:Z = 80:20)
 
        The following Diels-Alder reaction between diene 3.43 and enone 3.18 went 
smoothly under the above optimized conditions for diene 3.20, affording adduct 3.43 in 
moderate yield together with recovered enone 3.18 (entry 1, Table 3.9). Further 
optimization was focused on reaction temperature, time and equivalency of diene used 
(entry 2−6). The best result was obtained when enone 3.18 was treated with 2.5 
equivalent of diene 3.42 in a microwave reactor without solvent at 180 °C for 9 hours, 
with adduct 3.43 (d.r. = 1.0 (endo): 0.4 (exo)) isolated in 74% yield (92.5% brsm) (entry 
5). 
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Entry Conditions Resultsa, b 
1c 10 equiv. 3.43, neat, MW, 195 °C, 6h 35%, 76% brsm 
2c 10 equiv. 3.43, neat, MW, 200 °C, 16h 18%, 28% brsm 
3c 6 equiv. 3.43, neat, MW, 185 °C, 9h 56%, 65% brsm 
4c 6 equiv. 3.43, neat, MW, 130 °C, 10h 18%, 51% brsm 
5d 2.5 equiv. 3.43, neat, MW, 180 °C, 9h 74%, 92.5% brsm 
6d 2 equiv. 3.43, neat, MW, 180 °C, 10h 58%, 89% brsm 
             a Isolated yield. b Sealed tube reaction. c Reaction performed on < 0.5 g scale of   
         3.18. d Reaction performed on > 1.0 g scale of 3.18. 
 
        From Diels-Alder adduct 3.44, the synthesis of enone 3.39 can follow the same 
sequence as for enone 3.35 (Scheme 3.15).  

















































54% over 5 steps
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        Reduction of 3.44 by LiAlH4 followed by allylic oxidation by MnO2, provided 
enone 3.46. The ketal group of 3.46 was then removed by a catalytic amount of p-TsOH 
in acetone. Cyclopentanone 3.47 obtained was then subjected to a Baeyer-Villiger 
reaction to afford lactone 3.48. Treatment of 3.48 with MsCl in pyridine provided 
mesylate 3.40 in 54% overall yield over above 5 steps.  
        With mesylate 3.40 in hand, the idea of hydrogenation of the enone moiety to set the 
C-15 methyl group (fawcettimine numbering) could now be tested. To our delight, the 
desired hydrogenation could be effected by treatment of 3.40 with a catalytic amount of 
Pd/C under atmospheric pressure of H2 in EtOAc at room temperature. Mesylate 3.41 
obtained was then subjected directly to above optimized conditions for mesylate 
elimination (LiBr, Li2CO3, DMF, 210 ˚C, MW, 8min.). To our delight, alkene 3.39 was 
isolate as a single diastereomer in 75% yield and the stereochemistry at C-15 
(fawcettimine numbering) was confirmed to be R by NOESY.  






































3.6 Attempted RCM Approach to Form the Azonine Ring 
        With alkene 3.39 in hand, the formation of the azonine ring could now be focused 
on.31 As illustrated early in our retrosynthetic analysis (Scheme 3.1, vide supra), a ring-
closing metathesis (RCM) was conceived to fulfill the task. To this end, alkene 3.39 was 
reacted with allyl amine (3.49) in the presence of AlMe332 to give diene 3.50 in 70% yield 
(Scheme 3.17). It is worth noting that diene 3.50 contains all of the carbon skeletons for 
fawcettimine. Only azonine formation and several oxidation state adjustment steps are 
required to complete the synthesis of this alkaloid.  

















        From diene 3.50, the essential RCM reaction to construct the azonine ring was 
investigated. The literature search revealed that there are only limited reports about 
formation of medium-sized heterocycles via RCM reactions. For example, Lemcoff and 
Bittner reported that treatment of quinone derivative 3.51 with 5 mol% Grubbs 2nd 
generation catalyst (G2) in toluene at elevated temperature could deliver the diazonine 
fused quinone 3.52 in 89% yield (eq. 1, Scheme 3.18).33a Hsung also showed that azonine 
fused triazole 3.54 could be obtained in moderate yield when triazole derivative 3.53 was 
subjected to 10 mol% G2 in CH2Cl2 at reflux temperature for 12 hours (eq. 2).33b 
Moreover, the Bewley group demonstrated that N-allyl amide side chain of 3.55 could 
take part in the RCM reaction to form 12-membered lactam 3.56 in good yield (eq. 3).33c  
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        With those precedents, diene 3.50 was subjected to standard RCM conditions (cat. 
G2, solvent, ∆). It was found that in refluxing CH2Cl2, no reaction took place when 15 
mol% G2 was used (entry 1, Table 3.10). When much harsher conditions (30 mol% G2, 
PhMe, reflux, 4h) were employed, alkene 3.39 was detected as the only product (entry 2). 
Even at lower temperature, the formation of 3.39 still dominated (entry 3).  























Entry Conditions Resultsa 
1 15 mol% G2, CH2Cl2, reflux, 6h n.r. 
2 30 mol% G2, PhMe, reflux, 4h 3.38 only 
3 30 mol% G2, PhMe, 50 °C, 5h 3.38 only 
            a Determined by crude 1H NMR or TLC. 
        The occurrence of alkene 3.39 was the result of the loss of allylamine moiety from 
diene 3.50. One possible explanation is that G2 serves as the Lewis acid catalyst to 
activate the amide carbonyl group toward attack of the nearby hydroxyl group. To 
prevent this unwanted lactone formation, efforts were then put on the protection of the 
hydroxyl group and subsequent azonine formation via RCM.  
        The mask of the secondary hydroxyl group on diene 3.50 as a silyl ether was 
attempted first. When 3.50 was treated with TESCl in pyridine, the TES ether 3.58 could 
be isolated in 90% yield (Scheme 3.19). Compared to TES ether, the corresponding TMS 
ether was too unstable to be isolated. 
















        With the secondary hydroxyl group on diene 3.58 now protected, RCM to form the 
azonine was then examined. However, to our surprise, when 3.58 was subjected to 20 
mol% G2 in toluene at 40∼50 °C for 2 days, alkene 3.39 was the only product detected 
from the crude reaction mixture (entry 1, Table 3.11). The Hoveyda-Grubbs 2nd 
generation catalyst (HG2) was also tested on diene 3.58. Under the reaction conditions 
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(20 mol% HG2, PhMe, 50 °C, 5h), the complete consumption of 3.58 was observed. 
Unfortunately, no desired azonine 3.59 was formed (entry 2).  























Entry Conditions Resultsa 
1 20 mol% G2, PhMe, 40∼50 °C, 2d 3.39 only 
2 20 mol% HG2, PhMe, 50 °C, 5h no 3.59 
           a Determined by crude 1H NMR. 
        The loss of the TES group prompted us to use other protecting groups. Benzoyl (Bz) 
group was tried next, since the corresponding benzoyl ester should be more stable to 
Lewis acid conditions than the TES ether. The protection could be done by treatment of 
diene 3.50 with benzoyl chloride in pyridine at room temperature for one day, with 
desired diene 3.60 isolated in low yield (Scheme 3.19). Efforts were not put on the 
optimization of this reaction at this moment.  

















        The following RCM on diene 3.60 proved to be unfruitful. When 3.60 was treated 
with 25 mol% G2 in toluene at 80 °C for 6h, no reaction took place (entry 1, Table 3.12). 
Total consumption of starting material was observed when the reaction was heated at 
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reflux for 1 day. Again, alkene 3.39 was observed as the major product from crude 1H 
NMR, with no trace of desired 3.61 detected (entry 2).   
















Entry Conditions Resultsa 
1 25 mol% G2, PhMe, 80 °C, 6h n.r. 
2 25 mol% G2, PhMe, reflux, 1d 3.39 only 
           a Determined by crude 1H NMR or TLC. 
        In light of the easy formation of alkene 3.39, we turned our attention to oxidation of 
the hydroxyl group of 3.50 to a ketone group. Treatment of 3.50 with Dess-Martin 
periodinane (DMP) in CH2Cl2 gave diketone 3.62 in moderate yield (entry 1, Table 3.13). 
To our surprise, under Ley oxidation conditions (10 mol% TPAP, NMO, 4Å MS, 
CH2Cl2, r.t., 1h), alkene 3.39 was still isolated, together with desired diketone 3.62 (entry 
2). The basic 4-methylmorpholine generated may catalyze the formation of alkene 3.39. 















Entry Conditions Resultsa 
1 1.5 equiv. DMP, CH2Cl2, r.t., 2h 57% 3.62 
2 10 mol% TPAP, NMO, 4Å MS, CH2Cl2, r.t., 1h  50% 3.62 + 37% 3.38 
       a Isolated yield. 
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        Unfortunately, the subsequent RCM failed again on diene 3.62. Under the reaction 
conditions (25 mol% G2, PhMe, reflux, 12h), the starting material was completely 
consumed and provided a byproduct without the allylic side chain, with no desired 
azonine 3.63 observed (Scheme 3.21).  


















        The synthesis of diene 3.65, which has a N-Me group, was also attempted. When 
alkene 3.38 was treated with N-allylmethylamine (3.64) in the presence of AlMe3 in 
CH2Cl2, desired diene 3.65 could be isolated in moderate yield. However, it was found 
that 3.65 was not stable and could lose the N-allylmethylamine moiety to regenerate the 
starting alkene 3.39 upon standing at room temperature (Scheme 3.22). The repulsion 
between the crowded vinyl group and the amide side chain on diene 3.65 may account for 
the labile amide group. In light of the instability of diene 3.65, RCM was not tested on 
this substrate. 



















        From above unsuccessful RCM attempts, we realized that the vinyl group close to 
the all-carbon quaternary center is too hindered to react with the ruthenium catalyst. One 
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potential solution is to use Hoye’s relay ring-closing metathesis (RRCM) strategy 
(Scheme 3.23).34 However, since the installation of the additional side chain may need 
several additional steps and the prospect of this RRCM is still unclear for substrate like 
3.66, this route was not pursued. Instead, we turned our attention to homologation on 
alkene 3.39 (vide infra). 













R = protecting group
RRCM
3.66 3.67  
 
3.7 Attempted Homologation on Alkene 3.39 
        A cross metathesis (CM) between alkene 3.39 and acrylamide (3.68) was tried first, 
with the hope that the nitrogen atom belonging to the azonine ring could be 
simultaneously installed (Scheme 3.24). However, when 3.39 and 3.68 was treated with 
15 mol% G2 in refluxing toluene for 5 hours, no CM product was observed, with alkene 
3.39 completely recovered.  


















        The Chang group reported a novel chelation-assisted hydroesterification of alkenes 
via ruthenium catalyst. For example, when 3,3-dimethyl-1-butene (3.70) and 2-pyridyl-
methyl formate (3.71) were treated with a catalytic amount of Ru3(CO)12 and TBAI in 
DMF at 70 °C for 12 hours, almost quantitative yield of ester 3.72 could be obtained 
(Scheme 3.25).35  







DMF, 70 °C, 12h t-Bu
CO2CH2Py
99%
3.70 3.71 3.72  
        We applied these hydroesterification conditions to alkene 3.39, however, no desired 
ester 3.73 was obtained, with alkene 3.39 totally recovered (entry 1, Table 3.14). The 
same results were achieved when the reaction was conducted in DMSO at 110 °C with an 
increased load of catalysts Ru3(CO)12 and TBAI (entry 2). Further increasing the amount 
of 3.71 and raising the reaction temperature brought no beneficial effect (entry 3). 
Finally, the neat reaction condition with a large excess of 2-pyridyl-methyl formate (3.71) 
was tested. Unfortunately, no trace amount of desired ester 3.73 could be detected (entry 
4).  



















Entry Conditionsa Results 
1 5 mol% Ru3(CO)12, 15 mol% TBAI,  1.5 equiv. 3.71, DMF, 70−80 °C, 12h 
no 3.73 
3.39 recovered 
2 20 mol% Ru3(CO)12, 25 mol% TBAI,  1.5 equiv. 3.71, DMSO, 110 °C, 12h 
no 3.73 
3.39 recovered 
3 20 mol% Ru3(CO)12, 25 mol% TBAI,  4 equiv. 3.71, DMSO, 140 °C, 16h 
no 3.73 
3.39 recovered 
4 5 mol% Ru3(CO)12 20 equiv. 3.71, neat, 140 °C, 12h 
no 3.73 
3.39 recovered 
           a Sealed tube reaction. 
        For all of the above screened hydroesterification reaction conditions, alkene 3.39 
was completely recovered and the conversion of 3.71 to 2-pyridinemethanol (3.74) was 
observed. The appearance of 3.74 is not surprising, since the Ru insertion intermediate 
(3.75) may give 3.74 upon work up or lose one molecule of CO followed by reductive 
elimination to provide 3.74 (Scheme 3.26).35a The complete recovery of 3.39 showed that 
the vinyl group attached to the C-12 all-carbon quaternary center is too hindered to react 
with Ru insertion intermediate 3.75. In view of the steric requirement for most of the 
organometallic catalysts, metal catalyzed homologation of alkene 3.39, such as 
hydroformylation, were not further attempted. 



















        Lastly, a two-step sequence involving addition of acetonyl radical (3.77) to alkene 
3.39 followed by Baeyer-Villiger oxidation (B-V) of adduct 3.78 to form acetate 3.79 
was envisioned and tested (Scheme 3.27).  




















        However, no reaction took place when 3.39 was treated with excess of acetone in the 
presence of reported catalysts such as Ce(SO4)2·4H2O36a, Ag(II)O36b, or 
Mn(III)(OAc)3·2H2O36c. In all of the cases, alkene 3.39 was totally recovered (entry 1−3, 
Table 3.15).  












Entry Conditions Results 
   1 2.0 equiv. Ce(SO4)2·4H2O,  acetone/H2O (v/v 7:1), reflux, 20h 
n.r. 
2a 2.0 equiv. Ag(II)O, acetone, reflux, 12h n.r. 
  3a,b 2.5 equiv. Mn(III)(OAc)3·2H2O, acetone, MW, 120 °C, 5h n.r. 




3.8 Towards asymmetric synthesis 
        As stated early in our retrosynthetic analysis (Scheme 1, vide supra), the asymmetric 
version of our synthesis can be achieved if enantiomeric pure 3.8 is employed. A search 
of literature shows that there is no reported asymmetric synthesis of cyclopentanone 3.8 
or its ketal 3.11. Some close related examples are shown in Scheme 3.28.  










































        For instance, Anderson and coworkers reported the asymmetric Diels-Alder reaction 
(D-A) between 2,3-dimethyl-1,3-butadiene (3.80) and chiral ketal 3.81 to afford adduct 
3.82 and 3.83 (d.r. 2:1) (eq. 1).37 The Corey group showed that their proline derived 
oxazaborolidine catalyst could catalyze the asymmetric Diels-Alder reaction (D-A) 
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between 3.80 and cyclopent-2-enone (3.84), with excellent yield of 3.85 in good e.e. 
obtained (eq. 2).38a,b,c Shibatomi and Yamamoto also demonstrated that their valine 
derived oxazaborolidine catalyst was effective towards the reaction between 3.80 and 2-
bromocyclopent-2-enone (3.86) to give 3.87 in excellent yield and e.e. (eq. 3).39  
        The chiral auxiliary strategy was attempted first. To this end, (S, S)-hydrobenzoin 
derived chiral ketal 3.88 was treated with excess of isoprene (3.9) and a catalytic amount 
of TMSOTf in CH2Cl2 at −78 °C, the conditions used by Anderson, J.C. and coworkers.37 
Excellent yield of D-A adduct 3.89a and 3.89b were obtained. However, the 
diastereoselectivity is not satisfactory (entry 1, Table 3.16). Higher concentration of 3.88 
could slightly improve the diastereoselectivity, which is in agreement with Anderson’s 
observation (entry 2).  
        TiCl4 as the Lewis acid catalyst was tried next and unsatisfactory d.r. was again 
observed. However, the diastereoselectivity was reversed at this moment (entry 3). 
Finally, the (S, S)-hydrobenzoin derived titanium catalyst ((S, S)-cat.) was used with the 
hope that a chiral auxiliary could bring some beneficial effect. Unfortunately, no 
improvement in d.r. was observed. It is interesting to note that the diastereoselectivity can 
be reversed with higher temperature (entry 4, 5).  



























Entry Conditions Yielda,b d.r.(3.89a:3.89b) 
1 10 mol% TMSOTf, CH2Cl2, 0.1 M, −78 °C, 25h 
100% 
(90%) 2.08:1 
2 10 mol% TMSOTf, CH2Cl2, 1.0 M, −78 °C, 25h 
100% 
(96%) 2.76:1 
3 10 mol% TiCl4, CH2Cl2, −78 °C, 2h 15% 0.67:1 
4 20 mol% (S, S)-cat., CH2Cl2, −78 °C, 1d 6% 0.53:1 
5 20 mol% (S, S)-cat., CH2Cl2,0−4 °C, 2d 41% 1.18:1 
 a Yield is determined by crude 1H NMR. b Yield in parenthesis is isolated yield.  
        The D-A adducts 3.89a and 3.89b were found to be inseparable by chromatography 
or crystallization. Their subsequent conversion to keto aldehydes was problematic, with 
very low yield of desired products 3.90a and 3.90b obtained, which were found also to be 
inseparable upon chromatography (Scheme 3.29).  































        In view of above encountered difficulties, this chiral auxiliary strategy was not 
pursued any further. Instead, efforts were put on Corey’s oxazaborolidine catalyzed 
Diels-Alder reaction (D-A) of isoprene (3.9) and cyclopent-2-enone (3.84).38 To our 
delight, when 3.84 and excess of 3.9 were treated with 20 mol% of (S)-(–)-o-Tolyl-CBS-
oxazaborolidine ((S)-CBS1) in the presence of 18 mol % of Tf2NH38c as an activator in 
toluene at −25 °C for 3 days, (+)-3.8 was isolated in 52% yield and 73.5% e.e. (entry 1, 
Table 3.17). The temperature around −25 °C was found to be optimal, since no reaction 
took place at −40 °C while e.e. dropped to 48.6% at room temperature (entry 2, 3).  
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        Switching the solvent from PhMe to CH2Cl2 brought little impact on yield and e.e. 
(entry 4). Compared to (S)-CBS1, (S)-CBS2 gave slightly better e.e. of (+)-3.8, which is 
in agreement with the reported results (entry 5).38c Since there is no significant 
improvement for the yield or the e.e. of (+)-3.8 when (S)-CBS2 was employed, further 
optimization was focused on the use of (S)-CBS1, which is commercially available as 0.5 
M solution in toluene. 









(S)-CBS1, Ar = Ph








(5 equiv.) (1 equiv.)
 
Entry Catalyst Equiv. 
(mol %) 






1 (S)-CBS1/Tf2NH 20 PhMe 3d −25 73.5 52 
2 (S)-CBS1/Tf2NH 20 PhMe 1d −40 − n.r. 
3 (S)-CBS1/Tf2NH 20 PhMe 40h r.t. 48.6 15 
4 (S)-CBS1/Tf2NH 20 CH2Cl2 3d −20  71.6 56 
5 (S)-CBS2/Tf2NH 20 CH2Cl2 7d −20 73.5 60 
6 (S)-CBS1/Tf2NH 20 CH2Cl2 10d −30 77.3 38 
7 (S)-CBS1/Tf2NH 10 CH2Cl2 4d −20 37.2 40 
8 (S)-CBS1/Tf2NH 5 CH2Cl2 3d −20 3.8 49 
9 (S)-CBS1/AlBr3 5 PhMe 3d −20 70.6 14 
10 (S)-CBS1/AlBr3 5 CH2Cl2 4d −30 65.4 5 
11 (S)-CBS1/AlBr3 5 PhMe/CH2Cl2 30h −42 81.9 7 
12 (S)-CBS1/AlBr3 5 PhMe/Et2O 4d −20 63.9 21 
13 (S)-CBS1/AlBr3 5 PhMe/CH3CN 4d −20 75.2 9 
14 (S)-CBS1/TMSOTf 10 PhMe 1d −78 65.9 24 
15 (S)-CBS1/TfOH 20 PhMe 1d −30 73.8 3 
a Isolated yield. b Yield is not accurate because of the low boiling point of  (+)-3.8.  
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        In CH2Cl2, running the reaction at −30 °C could improve the product e.e. to 77.3%. 
However, the reaction became extremely sluggish at this temperature, which provided 
(+)-3.8 in only 38% yield for 10 days (entry 6). When less amounts of catalyst were used, 
sharp drop of e.e.s were observed (entry 7, 8). Interestingly, the product yields were not 
affected. 
        AlBr3 as the activator for (S)-CBS1 was reported to give a more efficient catalyst, in 
which the load of catalyst could be decreased to 4 mol% without erosion of yield or 
enantioselectivity.38d The use of (S)-CBS1/AlBr3 as catalyst was thus examined in 
regards to different solvent as well as temperatures (entry 9−13). Unfortunately, no 
significant improvement for enantioselectivity was detected. Isoprene (3.9) was found to 
be incompatible with this catalyst system, which polymerized in all of the conditions 
examined. As a complementary to Tf2NH or AlBr3, TMSOTf or TfOH38e as the activator 
to (S)-CBS1 was also attempted. Both gave unsatisfactory results (entry 14, 15).  
        The further possible direction for optimization of this catalyzed asymmetric Diels-
Alder reaction (D-A) between 3.9 and 3.84, is to use other oxazaborolidines such as (S)-
CBS3 or (S)-CBS4 (Figure 3.1). Due to time constraints, those two oxazaborolidines 





(S)-CBS3, Ar = Naphthyl
(S)-CBS4, Ar = 3,5-bis(trifluoromethyl)phenyl
 
Figure 3.1. Other potential oxazaborolidines. 
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        It is worthy of note that according to the model proposed by Corey and coworkers 
(Figure 3.2),38a,b,c the absolute stereochemistry of the above (S)-CBS1 or (S)-CBS2 










Figure 3.2. Proposed model of complexation of 3.84 with (S)-CBS1. 
        In the previous synthesis of 3.11, a catalytic amount of (1S)-(+)-camphorsulfonic 
acid (CSA) was added as the catalyst (Scheme 3.2, vide supra). We noticed that the 
adduct 3.11 is not a true racemate. In fact, a 1.0% e.e. was detected, which is in 
agreement with Chapuis’ observation.40 We wondered if other chiral acids could catalyze 
this ionic Diels-Alder reaction (D-A) and improve the enantioselectivity. To this end, 
chiral phosphoric acids (P1 and P2) were attempted (Table 3.18). Unfortunately, no 
significant e.e. improvement was achieved even at −78 °C, which showed that the proton 
itself catalyzed the reaction and the counter chiral anion had little effect.  

















P1, R = H
P2, R = 3,5-Di-t-Butylphenyl
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Entry Catalyst Equiv. (mol %) T (°C) e.e. (%) 
1 P1 0.25 r.t. <1.0 
2 P1 0.25 −78 °C <1.0 
3 P2 0.05 −30 °C 2.0 
 
        Finally, we came up with the idea that a Sharpless asymmetric dihydroxylation  
(Sharpless AD)41 could be employed to afford kinetic resolution42 on substrate (±)-3.11. 
One advantage of this kinetic resolution is that the dihydroxylation product can be 
converted to ketoaldehyde and reenter our synthetic route (vide infra). 





















Entry Time (h) e.e. of (+)-3.11b,c e.e. of (−)-3.91c,d 
1 1 13.0% n.d. 
2 2 24.2% n.d. 
3 3 42.1% n.d. 
4 4 56.8% n.d. 
5 5 76.3% n.d. 
6 6 89.0% n.d. 
7 7 96.9% n.d. 
8 8 98.5% n.d. 
9 13 > 99.4% (33%) n.d. (67%) 
              a Reaction was performed on 67 mg of (±)-3.11. b e.e. was measured by GC.  
                    c Yield in parenthesis is isolated yield. d e.e. was determined by conversion  
             of (−)-3.91 to (−)-3.17 and measured e.e. by HPLC.  
 
        To our delight, when (±)-3.11 (67 mg scale) was subjected to the Sharpless AD 
conditions (AD-mix-β, MeSO2NH2, K2CO3, t-BuOH/H2O (v/v 1:1), 0−4 °C), an increase 
of e.e. for (+)-3.11 was observed along with reaction time (Table 3.19). At 13 hours, (+)-
3.11 was isolated in 33% yield and greater than 99.4% e.e.  
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0!4 °C, 7 h
36%, > 99.8% e.e. 60%, 52% e.e.1.94 g  
        More satisfyingly, when this kinetic resolution was performed on a larger scale (1.94 
g of (±)-3.11), (+)-3.11 in 33% yield and greater than 99.8% e.e. was isolated at 7 hour 
(Scheme 3.30). The corresponding diol (−)-3.91 was obtained in 60% yield. Since direct 
measurement of e.e. for (−)-3.91 was met with failure by GC, HPLC or 1H NMR analysis 
(using Eu(hfc)3), (−)-3.91 was converted to (−)-3.17, from which the e.e. of (−)-3.91 was 
determined to be 52% (Scheme 3.31). The enantioenriched (−)-3.17 could be used in the 
syntheses of the antipode of alkaloids.  















52% e.e.  
        The absolute stereochemisty of the above kinetic resolution product (+)-3.11 was 
assigned to be as shown by conversion of (+)-3.11 to (+)-3.8 and comparison of its 
optical rotation with the above (S)-CBS1 mediated asymmetric Diels-Alder adduct 



















        The AD-mix-α catalyzed kinetic resolution of (±)-3.11, which should afford (−)-
3.11 and (+)-3.91 in theory, was not studied due to time constraints.  
 
3.9 Conclusion 
        For our first generation synthetic approach, a unified and diversity oriented strategy 
that can target lycoposerramine A as well as several other family members was presented.  
Through a microwave assisted Diels-Alder reaction between silyoxydiene and enone, the 
cis-fused 6,5-cycle with one all-carbon quaternary center was constructed in high yield. 
The stereoselective introduction of the C-15 methyl group was achieved via a mesylate 
controlled hydrogenation of an enone moiety. However, due to the steric hindrance 
brought by the neighboring all-carbon quaternary center, all efforts to form the azonine 
ring by RCM reaction were met with failure.  The one-carbon elongations of the hindered 
vinyl group were also not successful. The asymmetric version of our synthetic approach 
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4.1 Modified Retrosynthetic Analysis 
        In light of the failures encountered in our first generation synthetic approach 
(Chapter 3), the steric hindrance brought by the C-12 all-carbon quaternary center 
(fawcettimine numbering) was appreciated in our modified synthetic approach.  











































































        As shown in Scheme 4.1, a homologation of D-A adduct 3.44 (Chapter 3) or its 
derivatives, followed by cyclization to afford azonine 4.2 was the key strategic change to 
our second-generation retrosynthetic analysis. The advantage of this early step 
homologation is that the azonine formation site is now three-carbons away from the C-12 
all-carbon quaternary center so that the steric hindrance can be minimized. Azonine 4.2, 
with the R configuration at C-4, could be converted to lycoposerramine B. When this 
stereocenter is inverted, 4.2 could serve as the common intermediate to lycoposerramine 
A and fawcettimine. Since the conversion of fawcettimine to fawcettidine or lycoflexine 
has already been documented,1 our synthetic route should enable us the access to those 
two alkaloids as well.  
 
4.2 Homologation 
        The homolotation of D-A adduct 3.44 could be effected by treatment of 3.44 with 
NaH in THF at room temperature in the presence of ethyl formate (HCO2Et)2a , with 
formate 4.4 (enol form) isolated in 47% yield (entry 1, Table 4.1). The trimethylsilyl 
group of 3.44 was found to be incompatible with the reaction conditions. The yield of 4.4 
could be improved dramatically if less sterically demanding methyl formate (HCO2Me)2b 
was employed (entry 2).  




















Entry Conditions Resultsa 
1 6 equiv. NaH, 10 equiv. HCO2Et, THF, r.t. 47% 
2 15 equiv. NaH, 40 equiv. HCO2Me, THF, r.t. 80% 
           a Isolated yield. 
        Formate 4.4, when treated with NaBH4 in ethanol at room temperature was 
converted to triol 4.5 (Scheme 4.2). Unfortunately, the selective allylic oxidation of triol 
4.5 to form enone 4.6 could not be realized this time by treatment of 4.5 with activated 
MnO2 in CH2Cl2 even with prolonged reaction time.  































        On the other hand, the selective protection of the primary hydroxyl group of triol 4.5 
as the pivolate could be effected by treatment of 4.5 with pivaloyl chloride in pyridine 
solvent at room temperature (Scheme 4.3).  


















 over 2 steps
PivCl, py, r.t.
 
        The selective allylic oxidation of 4.7 was attempted. However, under standard 
reaction conditions (MnO2 or BaMnO4, CH2Cl2, r.t.), no reaction took place (entry 1, 2, 
Table 4.2). When PDC was used, the oxidation of C-11 hydroxy group (fawcettimine 
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numbering) was observed, with no desired enone 4.8 detected from the reaction mixture 
(entry 3). 



















Entry Conditions Resultsa 
1 MnO2, CH2Cl2, r.t., 2d n.r. 
2 BaMnO4, CH2Cl2, r.t., 1d n.r. 
3 PDC, CH2Cl2, r.t., 8h no 4.8 
           a Determined by crude 1H NMR.  
        The unfruitful selective allylic oxidation of triol 4.5 and pivolate 4.7 was again 
attributed to the steric hindrance brought by the neighboring C-12 all-carbon quaternary 
center.  
        To avoid the troublesome selective allylic oxidation problem, we decided to put the 
homologation to a later stage. To this end, D-A adduct 3.44 was subjected to K2CO3 in 
MeOH solvent at room temperature to give allylic alcohol 4.9 (Scheme 4.4). Subsequent 
allylic oxidation by MnO2 afforded enone 4.10 in 79% yield over 2 steps.   




























O79% over 2 steps
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        It was found that the conversion of 3.44 to 4.10 can be done more conveniently in a 
one-pot manner by treatment of 3.44 with TBAF to remove the TMS group followed by 
in-situ oxidation of the newly formed allylic alcohol by Dess-Martin periodinane 
(DMP)3. Enone 4.10 was isolated in 95% yield for this one-pot procedure (Scheme 4.5).        





















        With enone 4.10 in hand, the selective homologation of the acetyl group could now 
be investigated. The previous homologation conditions for D-A adduct 3.44 (15 equiv. 
NaH, 40 equiv. 4.11, THF) were tested first. It was found that no reaction took place at 
room or elevated temperature, with enone 4.10 totally recovered (entry 1−2, Table 4.3). 
Carbonates such as dimethyl carbonate (4.12) and diethyl carbonate (4.13) were 
examined next. However, the only promising result was obtained when enone 4.10 was 
treated with excess NaH in the presence of 4.12 in DMF, with trace of β-keto ester 4.20 
detected from the crude 1H NMR. In most of the cases, no reaction took place and enone 
4.10 was totally recovered (entry 3−7). 
        We then turned our attention to the more electrophilic methyl chloroformate (4.14). 
When enone 4.10 was subjected to excess of NaH and 4.14 in refluxing THF for 5 hours, 
no reaction took place (entry 8). To our surprise, when 4.10 was treated with 1.2 equiv. of 
KHMDS in THF at −78 °C followed by quenching with 4.14, enol carbonate 4.21, 
instead of homologation product 4.20, was isolated in 70% yield (entry 9).  
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        Mander’s reagent (methyl cyanoformate, 4.15)4, which was reported to give superior 
yields of C-acylation products for sterically hindered substrates, was examined next. To 
our delight, under the reaction conditions (1.1 equiv. LiHMDS, 1.2 equiv. 4.15, THF, −78 
°C to r.t., 10h), desired β-keto ester 4.20 was isolated in 18% yield together with some 
recovered starting material (entry 10). The yield of 4.20 could be greatly improved if 
Et2O was used as the solvent (entry 12). Other bases such as NaHMDS or LDA gave 
relatively lower yields of 4.20 (entry 11, 13).  
        It is worth noting that under the same conditions as for methyl cyanoformate (4.15), 
methyl chloroformate (4.14) totally failed to afford trace amount of desired 4.20 (entry 
14). Other cyanoformates, such as Ethyl cyanoformate (4.16) and benzyl cyanoformate 
(4.17) were also screened, however, both cyanoformate were found to be less efficient 
than 4.15 (entry 15, 16). 































4.11 4.12 4.13 4.14
4.15 4.16 4.17 4.18
R = CHO
    = CO2Me
    = CO2Et
    = CO2Bn









Entry Conditions Resultsa,b 
1 15 equiv. NaH, 40 equiv. 4.11, THF, r.t., 3h n.r. 
2 15 equiv. NaH, 40 equiv. 4.11, THF, reflux, 6h n.r. 
3 6 equiv. NaH, 10 equiv. 4.12, THF, reflux, 5h n.r. 
 4c 3 equiv. KHMDS, 10 equiv. 4.12, THF, −78 °C to r.t., 19h no 4.20 
5 3 equiv. NaH, 6 equiv. 4.12, DMF, r.t., 5h trace 4.20 
6 10 equiv. NaH, 20 equiv. 4.13, PhMe, reflux, 30h n.r. 
 7c 2.5 equiv. KHMDS, 2 equiv. 4.13, THF, −78 °C to r.t., 
30h n.r. 
8 15 equiv. NaH, 40 equiv. 4.14, THF, reflux, 5h n.r. 










 10e 1.1 equiv. LiHMDS, 1.2 equiv. 4.15, THF, −78 °C to r.t., 10h 18% (42%) 4.20 
 11d 1.1 equiv. NaHMDS, 1.2 equiv. 4.15, THF, −78 °C to r.t., 12h 23% (38%) 4.20 
 12e 1.1 equiv. LiHMDS, 1.2 equiv. 4.15, Et2O, −78 °C to r.t., 7h 41% (68%) 4.20 
13 1.1 equiv. LDA, 1.2 equiv. 4.15, Et2O, −78 °C to r.t., 5h 37% (59%) 4.20 
 14e 1.1 equiv. LiHMDS, 1.2 equiv. 4.14, Et2O, −78 °C to r.t., overnight no 4.20 
 15e 1 equiv. LiHMDS, 1 equiv. 4.16, Et2O, −78 °C to r.t., 4h 33% (62%) 4.22 
 16e 1 equiv. LiHMDS, 1 equiv. 4.17, Et2O, −78 °C to r.t., 6h 24% (34%) 4.23 
 17e 1.1 equiv. LiHMDS, 1.1 equiv. 4.18, Et2O, −78 °C to r.t., 6h 23% (26%) 4.24 
 18f 1.2 equiv. LiHMDS, 1.2 equiv. 4.15, Et2O, −78 °C to r.t., overnight 60% (94%) 4.20 
 a Isolated yield. b Yield in parenthesis is based on recovered 4.10. c KHMDS (0.5   M in 
toluene) solution was used. d NaHMDS (1.0 M in THF) solution was used. e LiHMDS 
(1.0 M in THF) solution was used. f LiHMDS solid was used. 
 
        Instead of forming a β-keto ester, tosyl cyanide (4.18) was also attempted with the 
hope that the nitrogen atom belonging to the azonine ring could be simultaneously 
installed. However, the desired β-keto cyanide 4.24 was obtained in very low yield (entry 
17). 
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        Finally, we were pleased to find that solid LiHMDS, instead of LiHMDS solution 
(1.0 M in THF), could improve the yield of 4.20 dramatically (entry 18). Under these 
optimized conditions, β-keto ester 4.20 could be obtained in 60% yield (94% based on 
recovered starting material). 
 
4.3 Azonine formation by Fukuyama-Mitsunobu cyclization  
        With the homologation product 4.20 now secured, efforts were then put on the 
azonine formation, before which, the C-15 stereocenter (fawcettimine numbering) needs 
to be installed. To avoid significant strategic changes, the previous developed mesylate 
group controlled hydrogenation of enone (Scheme 3.16, Chapter 3) was adopted here to 
set the required stereochemistry of C-15. To this end, the selective reduction of β-keto 
ester 4.20 to β-hydroxy ester 4.25 in the presence of an enone moiety needs to be 
realized.  
        In 1988, Ward and coworkers reported the use of excess NaBH4 in MeOH/CH2Cl2 
(v/v 1:1) at −78 °C to reduce ketones selectively in the presence of enones.5 This 
conditions was applied to our β-keto ester 4.20. We were pleased to find that desired β-
hydroxy ester 4.25 was obtained in 40% yield with some recovered starting material 
(entry 1, Table 4.4). The reaction was found to be extremely sluggish when 1 equiv. of 
ZnCl2 was added (entry 2). Finally, by running the temperature at −42 °C, the reaction 
was found to complete in 4.5 hours, with 4.25 isolated in 83% yield (entry 3). This 



















4.20 4.25  
Entry Conditions Resultsa 
1 10 equiv. NaBH4, CH2Cl2/MeOH (v/v 1:1), 
−78 °C, 10h 40% 
2 200 wt. % NaBH4, 1 equiv. ZnCl2, CH2Cl2/MeOH (v/v 1:1), −78 °C, 5h 
< 10% 
3 100 wt. % NaBH4, CH2Cl2/MeOH (v/v 1:1), −42 °C, 4.5h 83% 
           a Isolated yield. 
        From β-hydroxy ester 4.25, mesylate formation went smoothly to give mesylate 
4.26, which set the stage for the hydrogenation to install the C-15 stereocenter 
(fawcettimine numbering) (Scheme 4.6). 





















        Under the same conditions (5 wt.% Pd/C, 1 atm. H2, EtOAc, r.t.) for previous 
reduction of substrate 3.40 (Chapter three), no reduction of mesylate 4.26 was observed 
this time. Fortunately, the reduction went smoothly under 80 psi of H2 and afforded 
























        Since the mesylate of 4.27 is located at the β-position of the ester group, we 
envisioned that a base could trigger the β-elimination to deliver α, β-unsaturated ester 
4.28. This β-elimination should be superior to our previous developed microwave 
assisted mesylate elimination conditions (Li2CO3, LiBr, DMF, 210 ˚C, MW, 8min). To 
our delight, when 4.27 was treated with 1.2 equiv. of DBU in EtOAc at room temperature 
overnight, the desired α, β-unsaturated ester 4.28 (Z form only) could be obtained as 
anticipated (Scheme 4.8).  




















        From α, β-unsaturated ester 4.28, subsequent hydrogenation went smoothly without 
incident. Subjection of 4.28 to standard hydrogenation conditions (cat. Pd/C, H2, 1 atm., 
EtOAc, r.t.) provided ester 4.29 as a single diastereomer in 63% yield over 4 steps 





















63% over 4 steps
 
        To our delight, the more convenient one-pot conversion of mesylate 4.26 to ester 
4.29 could also be achieved without erosion of efficiency, provided that a catalytic 
amount of Rh/Al2O3 was added as a co-catalyst (Scheme 4.10). Control experiments 
showed that in the absence of Rh/Al2O3, the in-situ hydrogenation of α, β-unsaturated 
ester 4.28 to ester 4.29 was very sluggish.  









5 wt. % Pd/C, 5 wt. % Rh/Al2O3








H2, 80 psi, EtOAc, r.t., 24h
90% for one-pot
 
        From ester 4.29, LiAlH4 mediated reduction followed by acidic workup delivered 
diol 4.30 (Scheme 4.11).  The unmasked cyclopentanone was then subjected to standard 
Baeyer-Villiger oxidation conditions (m-CPBA, NaHCO3, CH2Cl2, r.t.) afforded lactone 






























91% over 2 steps
 
        With lactone 4.31 in hand, Fukuyama-Mitsunobu reaction6 to install the N-atom 
belonging to the azonine ring was eagerly attempted. Unfortunately, when 4.31 was 
treated with 2-nitrobenzenesulfonamide (NsHH2), Ph3P and DEAD in anhydrous toluene 
at room temperature, no desired nosyl amide 4.32 was isolated (Scheme 4.12). The intra-
molecular ether formation turned out to be a significant side reaction, which necessitates 
the protection of the reactive secondary hydroxyl group.  


















        The selective protection of the secondary hydroxyl group was achieved by a 3-step 
sequence (Scheme 4.13). That is, the primary hydroxyl group was first protected as its 
TBS ether. The secondary hydroxyl group was then treated with acetic anhydride (Ac2O) 
in pyridine with catalytic amount of DMAP as catalyst to form the corresponding acetate. 
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Finally, the primary TBS protecting group was removed by TBAF. The whole sequence 
went smoothly without incident, with 4.33 isolated in 90% yield over 3 steps.  














1) TBSCl, imid., CH2Cl2, r.t.
2) Ac2O, py., r.t.
3) TBAF, THF, r.t.
90% over 3 steps
 
        As anticipated, with the protection of the secondary hydroxyl group as its acetate, 
the intended Fukuyama-Mitsunobu reaction of primary alcohol 4.33 took place smoothly, 
providing nosyl amide 4.34 in 77% yield (Scheme 4.14).  














PhMe/THF (v/v 2:1), r.t.
77%
 
        We were intrigued by the possibility of an intra-molecular amine to lactone addition 
to form the 9-membered lactam. To this end, both of the acetyl and the nosyl group of 
4.34 were removed (Scheme 4.15). Amino lactone 4.35 obtained was then heated with 
Hünig base ((i-Pr)2NEt) in DMF with the hope that an intra-molecular lactam formation 






































        Without deviation from this unsuccessful intra-molecular lactam formation, we 
turned our attention to a second Fukuyama-Mitsunobu reaction to form the azonine ring.7 
The sequence used before to differentiate primary and secondary hydroxyl groups was 
resorted to again (Scheme 4.16). Thus, the lactone moiety of nosyl amide 4.34 was 
reduced, and the newly formed primary alcohol was temporarily protected as its TBS 
ether 4.37.  
Scheme 4.16. Synthesis of triacetate 4.38.  






















cat. DMAP, Ac2O, py., r.t.
4.38
2) TBSCl, imid., CH2Cl2, r.t.
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        The secondary hydroxyl group of 4.37 was then treated with acetic anhydride in 
pyridine in the presence of a catalytic amount of DMAP. Unexpectedly, the nosyl amide 
was also acylated under the reaction conditions, with triacetate 4.38 isolated in 75% yield 
over this 3-step sequence. 
        Fortunately, under the conditions to remove the primary TBS group (TBAF, THF, 
r.t.), the acetyl on the nosyl amide group of 4.38 could be removed simultaneously, 
providing nosylamino alcohol 4.39 in 64% yield (Scheme 4.17). 



















        To our delight, when the diluted solution of nosylamino alcohol 4.39 was treated 
with excess of Ph3P and DEAD at room temperature in CH3CN, the desired azonine 4.40 
could finally be isolated in 54% yield (Scheme 4.18).  


















        With azonine 4.40 in hand, the total synthesis of fawcettimine is just steps away, 
which only requires removal of the acetyl and nosyl protecting groups as well as the 
oxidation of the resulting diol to diketone. However, the current synthesis of 4.40 is quite 
lengthy, which requires 20 steps from commercially available materials. To avoid those 
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tedious protecting and deprotecting steps, efforts were then put on the double Fukuyama-
Mitsunobu approach to form azonine 4.40.  
 
4.4 Azonine formation by double Fukuyama-Mitsunobu reaction  
        To improve the efficiency of our synthesis, we envisioned that a double (inter- then 
intra-molecular) Fukuyama-Mitsunobu reaction6b,6c on diol 4.41 could be utilized to 
construct the azonine 4.42 (Scheme 4.19).  














p = protecing group
NsNH2
 
        The strategy developed before to install the C-15 stereocenter (fawcettimine 
numbering) is totally adopted here (Scheme 4.20). Thus, a one-pot selective reduction of 
β-keto ester 4.20 under modified Ward’s conditions (100 wt. % NaBH4, MeOH/CH2Cl2 
(v/v 1:1), −42 °C, 4.5h), followed by acidic work up gave β-hydroxy ester 4.43 in 81% 
yield. Subsequent Baeyer-Villiger oxidation and mesylate formation afforded mesylate 
4.45, which was then subjected to our optimized one-pot enone hydrogenation/β-
elimination/α, β-unsaturated ester hydrogenation process to give lactone 4.46 in 93% 






















then acetone, 1M HCl
80% for one-pot
m-CPBA, NaHCO3




















0 °C to rt
5 wt. % Pd/C, 5 wt. % Rh/Al2O3
then DBU, H2, 80 psi, r.t. 12h









        As the structure of 4.46 now secured, we turned out attention to a double (inter- then 
intra-molecular) Fukuyama-Mitsunobu reaction to construct the azonine ring. Instead of 
the 3-step sequence (TBS ether formation/acetylation/TBS removal) used above for the 
synthesis of primary alcohol 4.33 (Scheme 4.12, vide supra), Otera’s selective 
deacetylation8 was attempted (Scheme 4.21). To this end, lactone 4.46 was fully reduced 
(LiAlH4, THF, reflux) and then protected as the tetraacetate (Ac2O, cat. DMAP, py., r.t.). 
When tetraacetate 4.47 obtained was subjected to Otera’s conditions (5 mol% [t-
Bu2Sn(OH)Cl]2, MeOH/THF (v/v 1:1), r.t., 30h), we were pleased to find that desired diol 
4.48 could be isolated in 85% yield over 3 steps from 4.46. The side products of the 






















MeOH/THF (v/v 1:1), r.t.









1) LiAlH4, THF, reflux
 
        The subsequent double Fukuyama-Mitsunobu reaction to form azonine 4.40 from 
diol 4.48 was then subjected to extensive screening of reaction conditions. The effect of 
different solvents was compared first. It was found that the reaction performed best in 
DMSO or acetonitrile (CH3CN) (entry 1−7, Table 4.5). To our surprise, no desired 
azonine 4.40 was observed when the reaction was conducted in DMSO solvent at 80 °C, 
with diol 4.48 totally recovered (entry 8). Compared to a 40% DEAD solution (40 wt. % 
in toluene), pure DEAD (97% DEAD) or DIAD gave lower yields of 4.40 (9−11). Other 
phosphines, such as (n-Bu)3P, (Me2N)3P, or Diphos failed to yield any Fukuyama-
Mitsunobu reaction product under the same conditions as Ph3P did (entry 12−14).  
        The combination of (n-Bu)3P and 1,1’-(Azodicarbonyl)dipiperidine (ADDP), which 
was reported to have enhanced reactivity over Ph3P and DEAD,9 was also examined. 
However, no reaction was observed (entry 15).  
        Finally, the relative ratios of NsNH2, Ph3P and DEAD to diol 4.48 were adjusted. 
The usage of 4 equiv. NsNH2, 6 equiv. Ph3P and 6 equiv. DEAD was found to be optimal 
(entry 7, 16−20).  
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Table 4.5. Optimization of double Fukuyama-Mitsunobu reaction to form azonine 4.40. 
reagents (equiv.)















Entry Reagent (equiv.) Solvent T (°C) Yielda 
1 NsNH2 (4), Ph3P (6), 40% DEAD (6) THF/PhMe r.t. 23% 
2 NsNH2 (4), Ph3P (6), 40% DEAD (6) THF r.t. 24% 
3 NsNH2 (4), Ph3P (6), 40% DEAD (6) CH2Cl2 r.t. 20% 
4 NsNH2 (4), Ph3P (6), 40% DEAD (6) CH3CN r.t. 36% 
5 NsNH2 (4), Ph3P (6), 40% DEAD (6) DMF r.t. 33% 
 6b NsNH2 (4), Ph3P (6), 40% DEAD (6) py. r.t. 25% 
7 NsNH2 (4), Ph3P (6), 40% DEAD (6) DMSO r.t. 38% 
 8b NsNH2 (4), Ph3P (6), 40% DEAD (6) DMSO 80 n.r. 
9 NsNH2 (4), Ph3P (6), 97% DEAD (6) DMSO r.t. 16% 
10 NsNH2 (4), Ph3P (6), DIAD (6) DMSO r.t. 28% 
11 NsNH2 (4), Ph3P (6), DIAD (6) CH3CN r.t. 19% 
 12b NsNH2 (4), (n-Bu)3P (6), 40% DEAD (6) DMSO r.t. n.r. 
 13b NsNH2 (4), (Me2N)3P (6), 40% DEAD (6) DMSO r.t. n.r. 
 14b NsNH2 (4), Diphos (6), 40% DEAD (6) DMSO r.t. n.r. 
 15b NsNH2 (4), (n-Bu)3P (6), ADDP (6) DMSO r.t. n.r. 
16 NsNH2 (4), Ph3P (10), 40% DEAD (10) DMSO r.t. 26% 
17 NsNH2 (6), Ph3P (6), 40% DEAD (6) DMSO r.t. 23% 
18 NsNH2 (4), Ph3P (5), 40% DEAD (5) DMSO r.t. 26% 
19 NsNH2 (3), Ph3P (6), 40% DEAD (6) DMSO r.t. 20% 
20 NsNH2 (2), Ph3P (4), 40% DEAD (4) DMSO r.t. 16% 
a Yield was determined by 1H NMR and was not accurate. b Diol 4.48 was recovered. 
        The major byproduct from this double Fukuyama-Mitsunobu reaction is nosylamide 
4.49, which failed to yield enen trace amounts of azonine 4.40 when resubmitted to the 























        All efforts to convert 4.49 to mesylate 4.50 or chloride 4.51 were not successful 
(entry 1−2, Table 4.6). Attempted Dess-Martin oxidation of 4.49 to aldehyde 4.52 was 
also met with failure (entry 3). The primary hydroxyl group of 4.49 was found to be too 
hindered to take part in those reactions.  














4.50 R = CH2OMs
4.51 R = CH2Cl
4.52 R = CHO  
Entry Conditions Resultsa 
1 4 equiv. MsCl, py., r.t., 4d n.r. 
2 20 equiv. SOCl2, PhMe, r.t., 3d n.r. 
3 1.5 equiv. DMP, NaHCO3, CH2Cl2, r.t., 2d n.r. 
           a Nosylamide 4.49 totally recovered. 
        Another issue worthy of note is that azonine 4.40 co-spotted with NsNH2 upon 
column chromatography, which rendered its isolation a significant challenge. To avoid 
this isolation problem, azonine 4.40 was in-situ deacylated by addition of excess K2CO3 
and methanol followed by heating the resulting mixture at 70−80 °C overnight. Diol 4.53 
was thus isolated in 38% yield for this one-pot procedure (entry 1, Table 4.6).  
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        Although pyridine (py.) was not identified as the ideal solvent from our above 
solvent screening, it was noticed that less byproducts were formed in this solvent (entry 
6, Table 4.5, vide supra). We were thus intrigued by the possible beneficial effect of 
pyridine as the co-solvent and conducted another survey for solvent combinations. Even 
though no favorable effect was observed when pyridine was added to DMSO as co-
solvent (entry 2−4, Table 4.7), we were pleased to find that the combination of CH3CN 
and pyridine improved the yield of azonine significantly (entry 5−8). The highest yield of 
4.53 (50%) was achieved when a 5:1 (v/v) combination of CH3CN and pyridine was used 
as the solvent (entry 7).  




















Entry Solvent (v/v) Yielda 
1 DMSO 38% 
2 DMSO/py. (1:1) 30% 
3 DMSO/py. (3:1) 35% 
4 DMSO/py. (6:1) 25% 
5 CH3CN/py. (1:1) 27% 
6 CH3CN/py. (3:1) 48% 
7 CH3CN/py. (5:1) 50% 
8 CH3CN/py. (6:1) 47% 






4.5 Synthesis of (±)-fawcettimine, (±)-fawcettidine, (±)-lycoflexine, and 
(±)-lycoposerramine B  
        With a concise synthesis of diol 4.53 now achieved (14 steps from commercially 
available materials), efforts were then put on its conversion to a variety of fawcettimine 
class alkaloids. The synthesis of (±)-fawcettimine itself proved to be straightforward. 
Dess-Martin oxidation of diol 4.53 provided diketone 4.54, which upon treatment with 
PhSH under basic conditions removed the nosyl group to afford (±)-fawcettimine 
(Scheme 4.23). It was noticed that the inversion of C-4 stereogenic center occurred at the 
stage when the (±)-fawcettimine hydrobromide salt was made, which is in agreement 
with Heathcock’s observation that a trace amount of acid is crucial to this inversion.10  


























        From (±)-fawcettimine, the dehydration by POCl3/pyridine to form (±)-fawcettidine 
was already reported.1a However, no yield and experimental details were given for this 
procedure. In a similar transformation, acetylaposerratinine (4.55) was dehydrated to give 
anhydroacetylaposerratinine (4.56), in which the dehydration with oxalic acid in acetic 
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acid solvent at elevated temperature gave better yield of 4.56 than POCl3/pyridine 
(Scheme 4.24).11 








POCl3, Py, r.t., ! 40%
or (CO2H)2, AcOH
     150 °C, ! 80%
 
        We applied the oxalic acid mediated dehydration conditions (oxalic acid, AcOH, 
160 °C, 12h) to (±)-fawcettimine and were pleased to find that (±)-fawcettidine could be 
isolated in 80% yield (Scheme 4.25). In contrast, Burgess reagent,12 the commonly 
utilized dehydration agent for tertiary alcohols, failed to give trace amounts of (±)-
fawcettidine.  
Scheme 4.25. Synthesis of (±)-fawcettidine. 
(±)-fawcettidine
(CO2H)2










        The conversion of (±)-fawcettimine to (±)-lycoflexine via a Mannich reaction was 
reported by Ayer, W. A. and coworkers in 1973 (Scheme 4.26).1b This biomimetic 
transformation was adopted in two recently reported total syntheses of this alkaloid.13 
















        In our case, we were pleased to find that the deprotection of the nosyl group and 
subsequent Mannich reaction could be done in one-pot manner to afford (±)-lycoflexine 
in 91% yield (Scheme 4.27).  



















        Since diol 4.53 contains the R configuration at C-4 (fawcettimine numbering), its 
conversion to lycoposerramine B was executed next.  
        In their lycoposerramine B isolation paper, the Takayama group reported that a 
selective oxime formation on diketoamine 4.57a could afford lycoposerramine B in 46% 
yield together with its isomer 4.58 in 19% yield (Scheme 4.28).14 This strategy was also 
utilized in the recent reported total synthesis of (+)-lycoposerramine B.15  

























        Thus, our synthesis of lycoposerramine B can now be reduced to the formation of 
known diketoamine 4.57a. To this end, the nosyl group on 4.49 needs to be removed and 
a methyl group must be installed. We were pleased to find that those two steps could be 
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conveniently conducted in a one-pot manner, with tertiary amine 4.59 isolated in 90% 
yield (Scheme 4.29).  



















        With 4.59 in hand, an oxidation was all that remained for the conversion of 4.59 to 
diketoamine 4.57a. However, this oxidation proved to be a nontrivial step. Oxidants, such 
as Dess-Martin periodenane (DMP), PCC,16 CrO317 or TPAP/NMO (Ley oxidation) all 
failed to give the desired oxidation product (entry 1−4, Table 4.8). Finally, it was found 
that the Swern oxidation could provide 4.57a in high yield (entry 5). Since 4.57a is prone 
to be oxidized in the air or by column chromatography, the crude was used directly in the 
next selective oxime formation step.  














Entry Conditions Resultsa 
1 DMP, CH2Cl2, r.t. no 4.57a 
2 PCC, CH2Cl2, r.t. no 4.57a 
3 CrO3, AcOH/H2O (v/v 4:1), r.t. no 4.57a 
4 cat. TPAP, NMO, 4Å MS, CH2Cl2, r.t. no 4.57a 
5 (COCl)2, DMSO, CH2Cl2, −78 °C, then NEt3 4.57a obtained 
           a Determined by TLC and crude 1H NMR. 
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        Following the procedure described by Takayama and coworkers,14 (±)-
lycoposerramine B was isolated in 40% yield over 2 steps from 4.59 together with some 
of its isomer, 4.58 (Scheme 4.30). 



















4.6 Synthetic Efforts Towards lycoposerramine A 
        Our synthetic efforts towards lycoposerramine A followed the hypothetical 
biogenetic route proposed by Takayama and coworkers.18 From diketoamine 4.57a, the 
inversion of C-4 stereogenic center was investigated first.  
        In their synthesis of lycoposerramine B from serratinine, the Takayama group found 
that when 4.57b was treated with t-BuOK in t-BuOH at room temperature, the epimer 
4.57a could be isolated in 30% yield together with recovered 4.57b in 32% yield 
(Scheme 4.31).14  













t-BuOK, t-BuOH, r.t., 3h
30% 4.57a + 32% 4.57b 4R4S
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        However when these conditions (t-BuOK, t-BuOH, r.t.) were applied to the crude 
4.57a obtained from above Swern oxidation of 4.59, the reaction was found to be 
extremely sluggish. Fortunately, during our attempted purification of 4.57a, we observed 
the epimerization of 4.57a on basic aluminum oxide (Al2O3) column. Thus, basic Al2O3 
in CH2Cl2 was tested on crude 4.57a (Scheme 4.32).  To our delight, an equilibrium of 
4.57a and 4.57b (near 1:1 ratio) was arrived at after one day. Due to the issue of difficult 
separation of these two epimers, the equilibrated mixture was used in the next step 
directly. 
















        When a mixture of 4.57a and 4.57b was treated with NH2OH·HCl in the presence of 
excess Et2NH, both the desired oxime 4.60 and (±)-lycoposerramine B were obtained and 
easily separated, together with some other isomers (Scheme 4.33).  
Scheme 4.33. Synthesis of oxime 4.60 and  (±)-lycoposerramine B from a mixture of 


























        From 4.60, the selective reduction of the oxime moiety in the presence of ketone 
was expected to be a trivial step, given the steric hindrance of the ketone brought by the 
neighboring all-carbon quaternary center. To our surprise, when 4.60 was treated with 
NaBH3CN in acetic acid at room temperature, the standard selective oxime reduction 
conditions, only hydroxyloxime 4.61 was isolated (Scheme 4.34). The formation of 
desired hydroxylamine 4.1 was not observed. The reduction of 4.60 needs further 
investigation.  























        From oxime 4.60, the urethane formation was also attempted. Unfortunately, under 
the reported conditions (NaOCN and CF3CO2H in CH2Cl219a or TMSNCO in THF19b), no 
desired 4.62 was obtained (Scheme 4.35).  

















NaOCN, CF3CO2H, CH2Cl2, r.t.




4.7 Future work 
        Our future plan for the synthesis of (±)-lycoposerramine A from 4.60 is shown in 
Scheme 4.36. As mentioned early, the conditions for the selective reduction of the oxime 
moiety in the presence of the ketone need to be screened. Once the structure of 
hydroxylamine 4.1 is secured, treatment of 4.1 with liquid ammonia should trigger the 
imine formation and a cascade intra-molecular cyclization to afford aminal 4.63, which 
could then react with phosgene to provide (±)-lycoposerramine A.  






























(±)-lycoposerramine A  
        Alternatively, (±)-fawcettimine with the C-13 ketone already protected as its 
hemiaminal form could react with NH2OH·HCl to give oxime 4.64 (Scheme 4.37). When 
4.64 is treated with NaBH3CN, the reduction of the hemiaminal moiety is expected to be 
slower than the oxime and hydroxylamine 6.65 should be obtained. Subsequent treatment 
of 4.65 with liquid ammonia should trigger the opening of hemiaminal and the ketone 
liberated could condense with ammonia to form an imine followed by an intra-molecular 
cyclization to give aminal 4.66. The loss of water may be the driving force for this 
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cascade reaction. From 4.66, cyclization with phosgene to construct the oxadiazolidinone 
moiety followed by reductive amination to install the N-Me group should finish the 
synthesis of (±)-lycoposerramine A.  











































        Through the homologation of enone 4.10, the steric hindrance brought by the all-
carbon quaternary center was minimized and the azonine formation was realized by a 
Fukuyama-Mitsunobu reaction. Thus, the total syntheses of (±)-fawcettimine, (±)-
lycoflexine, (±)-fawcettidine, and (±)-lycoposerramine B have been accomplished 
through an efficient, unified, and stereocontrolled strategy that required sixteen, sixteen, 
seventeen, and seventeen steps, respectively, from commercially available materials. 
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Combined with the successful kinetic resolution of the earliest intermediate by a 
Sharpless asymmetric dihydroxylation (Chapter 3), the enantioselective syntheses of 
these alkaloids can also be achieved. The synthesis of other family members, especially 
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5.1 General Considerations 
        All reactions were performed in single-neck round bottom flasks fitted with rubber 
septa under positive pressure of argon, unless otherwise noted. Organic solutions were 
concentrated under reduced pressure by rotary evaporation below 50 °C at 20 mmHg. 
Analytical and preparative thin-layer chromatography (PTLC) was performed using glass 
plates pre-coated with a 0.25-mm layer of silica gel impregnated with a fluorescent 
indicator (254 nm). Reaction progress was followed by TLC analysis and visualized by 
UV light and/or submersion in standard TLC stains (KMnO4, Vanillin, Anisaldehyde, 
etc.) followed by heating on a hot plate (~200 °C). Flash column chromatography was 
conducted as described by Still and coworkers using 60 Å (230-400 mesh), standard 
grade silica gel purchased from Sorbtech. 1H and 13C NMR spectra were obtained using 
Varian 300 MHz or 400 MHz spectrometers. The chemical shifts are given in parts per 
million (ppm) relative to TMS at δ 0.00 ppm or to residual CDCl3 δ 7.27 ppm for proton 
spectra and relative to CDCl3 at δ 77.23 ppm for carbon spectra, unless otherwise noted. 
IR spectra were recorded on a Perkin-Elmer 1600 FTIR as thin films in CH2Cl2. Mass 
spectra were obtained using a Fisons VG Autospec spectrometer. Enantiomeric Excess 
(e.e.) values were measured on a Varian 3800 Gas Chromatograph or Agilent 1100 series 
HPLC device. Optical rotations were recorded on a Perkin-Elmer 24 polarimeter at a 
wavelength of 589 nm. Melting points were measured on a MELTEMP capillary melting 
point apparatus and are uncorrected. Microwave assisted reactions were performed on 
CEM Discover Reactor. LiClO4 was purchased from Aldrich (ACS reagent, ≥95.0%) and 
heated in oven (120 ºC) for three days before use. (S)-(–)-o-Tolyl-CBS-oxazaborolidine 
solution (0.5 M in toluene) was purchased from Aldrich. ClCH2CH2Cl was purchased 
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from Mallinckrodt Baker, Inc. (ACS grade). Anhydrous ethanol (EtOH) was purchased 
from Pharmco-Aaper. Dess-Martin periodinane,1 and Otera’s catalyst2 were prepared 
according to the literature procedures. All other materials were obtained from Aldrich or 
VWR and used without further purification. Dichloromethane (CH2Cl2), tetrahydrofuran 
(THF), toluene (PhMe), benzene (PhH), N,N-dimethylforamide (DMF), acetonitrile 
(CH3CN), triethylamine (Et3N), N,N-diisopropylamine, pyridine, dimethyl sulfoxide 
(DMSO) and methanol (MeOH) were all purified by a LabContour solvent purification 
system.  
 












Compound 3.11. Following the procedure described by Hailes,3 to an oven dried 500 mL 
round-bottomed flask with reflux condenser, LiClO4 (136.18 g, 1.28 mol) and Et2O (320 
mL) was added. After stirring at room temperature for 1.5 h, isoprene (3.9) (32 mL, 320 
mmol, 4.0 equiv.), 2-cyclopenten-1-one ethylene ketal (3.10) (9.46 mL, 80 mmol, 1.0 
equiv.) and camphorsulfonic acid in THF (0.5 M, 0.37 mL, 0.23 mol%) were added. The 
resulting solution was stirred for additional 50 minutes before NEt3 (0.40 mL) was added 
to quench the reaction. Cold water (200 mL) was added cautiously and the organic layer 
was separated. The aqueous layer was extracted with Et2O (2 x 200 mL). The combined 
organic layer was dried over anhydrous MgSO4, filtered and concentrated at reduced 
pressure (~15 mmHg, rotavap water bath temp. 0–5 ºC). The crude obtained was purified 
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by flash column chromatography (hexanes/EtOAc 50:1) to afford title compound (14.76 
g, 95%) as a colorless oil (Rf = 0.57, hexanes/EtOAc 10:1). 1H NMR (300 MHz, CDCl3): 
δ 5.36–5.40 (m, 1H), 3.80–3.96 (m, 4H), 2.26–2.37 (m, 1H), 1.66–2.18 (m, 8H), 1.64 (S, 
3H), 1.39–1.52 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 132.2, 119.8, 119.2, 64.9, 64.0, 
41.4, 35.0, 34.0, 31.9, 27.1, 24.1, 22.3.  










Compound 3.8. Following the procedure described by Hailes,3 to a 50-mL round-
bottomed flask, 3.11 (0.740 g, 3.81 mmol, 1.0 equiv.) was dissolved in MeOH (ACS 
grade, 20 mL) at 0 ºC (ice-water bath). aq. HCl solution (2.7 M, 1.18 mL) was added 
drop by drop. The resulting mixture was stirred at 0 ºC for 2.5 hours before sat. NaHCO3 
(30mL) was added. The mixture was extracted with hexanes (3 x 50 mL). The combined 
organic layer was washed with brine (20 mL), dried over anhydrous Na2SO4. After 
filtration and concentration at reduced pressure (~15 mmHg, rotavap water bath temp. 0–
5 ºC), the crude obtained was purified by flash column chromatography (hexanes/EtOAc 
50:1) to afford 3.8 (0.488 g, 85%, contains ca. 7% isomer) as a colorless oil (Rf = 0.38, 
hexanes/EtOAc 10:1). 1H NMR (300 MHz, CDCl3): δ 5.31 (br s, 1H), 2.44–2.55 (m, 
1H), 1.93–2.39 (m, 8H), 1.72–1.81 (m, 1H), 1.61 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
220.0, 132.4, 118.9, 46.7, 34.3, 33.0, 30.9, 26.6, 24.1, 21.9. 
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DA, 4Å MS, CH2Cl2, 0 °C
50%, 59.5% brsm
 
Compound 3.7. To a 10-mL round-bottomed flask with magnetic stirring bar (flame-
vacuo-Ar dried) was added CH2Cl2 (3 mL), (±)-trans-1,2-diaminocyclohexane (DA) (0.5 
M in THF, 0.20 mL, 0.1 mmol, 32 mol%), SnCl4 (1.0 M in CH2Cl2, 98 µL, 98 µmol, 32 
mol%). The resulting mixture was stirred at 0 °C (ice-water bath) and (TMS)2O2 (1.0 M 
in CH2Cl2, 0.62 mL, 0.62 mmol, 2.0 equiv.) was added. After 10 minutes, 3.8 (0.0465 g 
in 2 mL CH2Cl2, 0.31 mmol, 1.0 equiv.) was added slowly via syringe. The ice-water 
bath was removed and the reaction was stirred at room temperature for 5 days. Solid 
Na2SO3 (0.117 g) was added to quench the reaction and the suspension was stirred for 3 
hours before filtered over a short pad of silica and washed with EtOAc (25 mL). The 
filtrate was concentrated at reduced pressure (~15 mmHg, rotavap water bath temp. 0–5 
ºC) and the crude obtained was purified by flash column chromatography 
(hexanes/EtOAc 4:1) to afford recovered 3.8 (0.0076 g, 16%) and 3.7 (0.0255 g, 50%, 
contains ca. 7% isomer) as a colorless oil (Rf = 0.31, hexanes/EtOAc 2:1). 1H NMR (300 
MHz, CDCl3): δ 5.24–5.28 (m, 1H), 4.56 (td, J = 4.5, 3.0 Hz, 1H), 2.52–2.68 (m, 2H), 
2.13–2.49 (m, 3H), 1.83–2.08 (m, 3H), 1.68–1.80 (m, 1H), 1.66 (app s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 132.57, 116.72, 76.18, 31.79, 30.51, 29.90, 27.19, 23.51. 
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Compound 3.12. To a stirred solution of 3.8 (0.0458 g, 0.305 mmol, 1.0 equiv.) in 
AcOH (ACS grade, 1.5 mL) was added m-CPBA (77%, 0.0752 g, 0.336 mmol, 1.1 
equiv.). The reaction was stirred at room temperature for 40 minutes and then sat. 
Na2S2O3 (1 mL) and sat. NaHCO3 (40 mL) were added. The mixture was extracted with 
EtOAc (3 x 10 mL) and the combined organic layer was washed with brine (10 mL), 
dried over dried over anhydrous MgSO4. After filtration and concentration, the crude 
obtained was purified by flash column chromatography (hexanes/EtOAc 6:1) to afford 
3.12 (0.475 g, d.r. 1: 0.13, 94%) as a colorless oil (Rf = 0.27 (major), 0.16 (minor), 
hexanes/EtOAc 4:1). 1H NMR (major isomer, 300 MHz, CDCl3): δ 2.90 (d, J = 3 Hz, 
1H), 2.53–2.63 (m, 1H), 2.08–2.45 (m, 5H), 1.91–2.02 (m, 2H), 1.68–1.76 (m, 1H), 1.30–
1.35 (m, 1H), 1.26 (s, 3H); 13C NMR (major isomer, 75 MHz, CDCl3) δ 219.14, 57.59, 
45.31, 33.31, 31.72, 31.55, 25.34, 23.07, 20.78; 1H NMR (minor isomer, 300 MHz, 
CDCl3): δ 2.96 (d, J = 3.3 Hz, 1H), 2.58–2.67 (m, 1H), 2.34–2.52 (m, 2H), 1.90–2.22 (m, 
5H), 1.65–1.74 (m, 2H), 1.27 (s, 3H). 
(1H NMR filename: panpan01-01-1, panpan01-01-2; 13C NMR filename: panpanct01-05; 















Compound 3.14. To a solution of 3.8 (0.0586 g, 0.39 mmol, 1.0 equiv.) in 
H2O/CH3COCH3/CH3CN (v/v/v 1:1:1, 4 mL) was added NMO (0.1828 g, 1.56 mmol, 4.0 
equiv.) and OsO4 on poly(4-vinylpyridine) (0.23 mmol/g, 0.0848 g, 5 mol%). The 
suspension was stirred at room temperature for 2 days and then filtered over sintered 
glass funnel, washed with MeOH (5 mL). To the filtrate was added water (20 mL) and 
the resulting mixture was extracted with hexanes (2 x 5 mL). The hexanes layer was 
combined and concentrated at reduced pressure (~15 mmHg, rotavap water bath temp. 0–
5 ºC) to give recovered 3.8 (0.0043 g, 7%). The water layer was concentrated to dryness 
and the crude obtained was purified by flash column chromatography (hexanes/EtOAc 
1:2) to afford 3.14 (0.587 g, 82%, 88% brsm) as a colorless oil (inseparable 
diastereomers, d.r. 1:0.13; Rf = 0.17, hexanes/EtOAc 1:2). 1H NMR (300 MHz, CDCl3): 
δ 3.41 (dd, J = 11.1, 4.8 Hz, 0.15H), 3.22 (dd, J = 11.4, 5.1 Hz, 1H), 2.63–2.74 (m, 1H), 
2.43–2.56 (m, 0.32H), 1.93–2.40 (m, 10H), 1.34–1.87 (m, 5.1H), 1.20 (s, 2.9H), 1.19 (s, 
0.5H), 0.98 (dd, J = 14.4, 12.9 Hz, 1.2H); 13C NMR (major isomer, 75 MHz, CDCl3) δ 
219.82, 71.63, 71.33, 50.14, 39.32, 34.19, 31.92, 27.38, 26.89, 24.98. 


















Compound 3.14. (Note: open flask reaction) To a 25-mL round-bottomed flask equipped 
with reflux condenser, 3.14 (0.0201 g, 0.11 mmol, 1.0 equiv.) was dissolved in CH2Cl2 
(ACS grade, 5 mL). The solution was stirred at room temperature and NaHCO3 (0.0739 
g, 0.88 mmol, 8.0 equiv.) was added followed by m-CPBA (70%, 0.0538 g, 0.22 mmol, 
2.0 equiv.). After 2 days at room temperature, Na2SO3 (0.0555 g) was added to quench 
the reaction. The mixture was filtered over a cotton plug to remove all of the salts and 
washed with CH2Cl2 (5 mL). The filtrate was concentrated and the crude obtained was 
purified by flash column chromatography (CH2Cl2/MeOH 97:3) to afford 3.15 (0.0154 g, 
70%) as a pale yellow oil (inseparable diastereomers, d.r. 1:0.17; Rf = 0.19, 
CH2Cl2/MeOH 94:6). 1H NMR (300 MHz, CDCl3): δ 4.55–4.58 (m, 0.97H), 3.75 (dd, J 
= 11.4, 5.1 Hz, 1H), 3.56–3.59 (m, 0.15H), 3.48 (dd, J = 11.7, 4.8 Hz, 0.17H), 2.46–2.54 
(m, 2.4H), 2.31–2.41 (m, 2.3H), 2.04–2.20 (m, 3.7H), 1.86–1.97 (m, 2H), 1.44–1.67 (m, 
4.2H), 1.23–1.29 (m, 5.3H); 13C NMR (major isomer, 75 MHz, CDCl3) δ 78.90, 71.24, 
69.98, 37.34, 34.28, 27.49, 27.24, 26.47, 23.67. 

















Compound 3.13. To a stirred solution of 3.15 (0.0136 g, 68 µmol, 1.0 equiv.) in 
MeOH/H2O (v/v 1:1, 3 mL) was added NaIO4 (0.0458 g, 210 µmol, 3.1 equiv.). After 
stirring at room temperature for 3 h, EtOAc (20 mL) was added. The mixture was washed 
with brine (2 x 10 mL). The organic layer was dried over anhydrous Na2SO4, filtered and 
concentrated to give 3.13 (0.0130 g, 95%) as a colorless oil, which is pure enough and 
used in the next step without further purification. (Rf = 0.23, EtOAc). 1H NMR (300 
MHz, CDCl3): δ 9.76 (t, J = 1.2 Hz, 1H), 5.01 (ddd, J = 8.1, 5.1, 3.0 Hz, 1H), 2.33–2.82 
(m, 8H), 2.18 (s, 3H), 1.60–1.71 (m, 1H); 13C NMR (75 MHz, CDCl3) δ 206.09, 198.28, 
170.87, 76.18, 45.89, 41.88, 30.63, 29.84, 27.08, 24.64. 
















Compound 3.16. To a stirred solution of 3.13 (0.0099 g, 50 µmol, 1.0 equiv.) in THF 
was added t-BuOK (0.1 M in THF, 25 µL, 2.5 µmol, 5 mol%). After stirring at room 
temperature for 5 h, the mixture was filtered over a short pad of silica, washed with 
EtOAc (14 mL). The filtrate was concentrated to give crude 3.16 (0.0062 g) as a pale 
yellow oil. (Rf = 0.10, EtOAc). The crude 1H NMR (300 MHz, CDCl3): δ 9.49 (d, J = 7.5 
Hz, 1H), 6.68 (dd, J = 15.6, 8.4 Hz, 1H), 6.12 (ddd, J = 15.6, 7.8, 1.2 Hz, 1H) shows the 
presence of the trans-unsaturated aldehyde moiety.  
















Compound 3.17. To a 2000-mL three-neck round-bottomed flask equipped with 
mechanical stirrer, 3.11 (5.06 g, 26.05 mmol, 1.0 equiv.), and RuCl3·xH2O (0.054g, 0.26 
mmol, 1.0 mol%) were dissolved in ClCH2CH2Cl (130 mL) and H2O (104 mL). The 
resulting mixture was stirred vigorously at room temperature. NaIO4 (11.142g, 52.09 
mmol, 2.0 equiv.) was then added in portions over 5 minutes. After 3 hours at room 
temperature, sat. Na2S2O3 (50 mL) was added. The organic layer was separated and the 
aqueous layer was extracted with EtOAc (3 x 100 mL). The combined organic layer was 
dried over anhydrous MgSO4. After filtration and concentration, the crude obtained was 
purified by flash column chromatography (hexanes/EtOAc, 2:1) to afford 3.17 (4.42 g, 
75%) as a colorless oil. (Rf = 0.23, hexanes/EtOAc 2:1). IR (thin film): 3413, 2956, 2888, 
1716, 1413, 1358, 1289, 1121 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.70 (dd, J = 2.7, 1.5 
Hz, 1H), 3.73–3.91 (m, 4H), 2.60–2.74 (m, 2H), 2.30–2.48 (m, 3H), 2.16–2.24 (m, 1H), 
2.10 (s, 3H), 1.71–2.02 (m, 3H), 1.23–1.36 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 
208.13, 202.17, 117.73, 65.00, 64.51, 45.44, 43.66, 39.71, 34.56, 34.16, 30.39, 27.67; 
HRMS (ESI) calcd. for C12H19O4 [M+H]+ 227.1278 found 227.1276. 
(1H NMR filename: panpan102-012; 13C NMR filename: panpan102-t008; notebook #: 















Compound 3.18. To a 1000-mL round-bottomed flask equipped with reflux condenser, 
was added keto aldehyde 3.17 (3.30g, 58.86 mmol, 1.0 equiv.) and H2O (740 mL). The 
mixture was stirred at room temperature and oxygen was removed under reduced 
pressure (~15 mmHg) for 20 minutes. The flask was refilled with Ar and the vacuo-Ar 
cycle was repeated for three times. Solid KOH (3.30g, 51.2 mmol, 3.5 equiv.) was added 
and the vacuo-Ar cycle was repeated for another two times. The resulting pale yellow 
solution was gently refluxed for 15 hours, cooled to room temperature, and extracted with 
EtOAc (3 x 100 mL). The combined organic layer was washed with brine (50 mL), dried 
over anhydrous Na2SO4. After filtration and concentration, the crude obtained was 
purified by flash column chromatography (hexanes/EtOAc, 4:1) to afford 3.18 (2.44 g, 
79.5%) as a yellow oil. (Rf = 0.17, hexanes/EtOAc 4:1). IR (thin film): 2960, 2883, 1708, 
1666, 1619, 1435, 1373, 1107 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.61–6.62 (m, 1H), 
3.77–4.00 (m, 4H), 3.45–3.55 (m, 1H), 2.48–2.78 (m, 3H), 2.28 (s, 3H), 1.90–2.11 (m, 
1H), 1.51–1.70 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 196.56, 147.52, 144.11, 118.51, 
65.13, 64.19, 47.15, 47.09, 35.20, 33.55, 28.44, 27.29; HRMS (ESI) calcd. for C12H17O3 
[M+H]+ 209.1172 found 209.1176. 




















Compound 3.22. To a 10-mL CEM Discover reaction vessel with magnetic stirring bar, 
enone 3.18 (g,  mmol, 1.0 equiv.) and diene 3.20 (g,  mmol, 2.5 equiv.) were added. The 
vessel was flushed with Ar, capped and put in a microwave reactor. The mixture was 
heated to 190 ºC and kept at this temperature with high speed stirring for 9 hours. After 
cooling to room temperature, the pale yellow solution was transferred to a 25-mL round-
bottomed flask by pipette. A short-path distillation head was attached and the volatiles 
(contain diene 3.20 and crotonaldehyde) were removed (∼100 ºC/4 mmHg for 0.5 hour). 
The residue was purified by flash column chromatography (hexanes/EtOAc, 7:1 to 2:1) to 
afford recovered 3.18 (g, %) and 3.22 ( g, %, % brsm) as a pale yellow oil (inseparable 
diastereomers, d.r. 1:0.6; Rf = 0.21, hexanes/EtOAc 6:1). IR (thin film): 3029, 2957, 
2883, 1697, 1426, 1350, 1251, 1222, 1093 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.70–
5.77 (m, 0.67H), 5.58–5.68 (m, 1.5H), 5.39–5.45 (m, 0.94H), 4.34 (app d, J = 5.1 Hz, 
0.57H), 4.13–4.19 (m, 1H), 3.84–3.98 (m, 6H), 3.01 (dt, J = 8.7, 6.9 Hz, 0.97H), 2.82 (q, 
J = 8.7 Hz, 0.6H), 2.35–2.61 (m, 4.7H), 2.14 (s, 2.6H), 2.11 (s, 1.6H), 1.98–2.08 (m, 
0.74H), 1.59–1.96 (m, 8H), 1.41 (td, J = 13.2, 10.8 Hz, 1.2H), 1.01–1.19 (m, 1.7H), 0.18 
(s, 7.5H), 0.16 (s, 4.8H); 13C NMR (75 MHz, CDCl3): δ 211.32, 210.02, 129.55, 128.62, 
127.92, 125.91, 118.39, 118.24, 70.18, 66.48, 65.16, 65.08, 64.88, 64.40, 64.35, 49.18, 
48.49, 46.84, 46.78, 36.41, 36.04, 35.47, 33.87, 32.39, 31.85, 31.81, 28.24, 27.08, 26.20, 
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26.04, 0.64, 0.35; HRMS (ESI) calcd. for C19H30NaO4Si [M+]+ 373.1806 found 
373.1803. 
(1H NMR filename: panpan104-005-2, pan104-016; 13C NMR filename: pan104-t016; 


























82% over 2 steps
 
Compound 3.31. To a stirred solution of 3.22 (0.0782 g, 0.223 mmol, 1.0 equiv.) in THF 
(3.6 mL) at 0 ºC (ice-water bath) was added LiAlH4 (1.0 M in THF, 0.49 mL, 0.49 mmol, 
2.2 equiv.). The mixture was stirred at 0 ºC for 10 minute then allowed to warm to room 
temperature. After stirring at room temperature for 5 h, the reaction was quenched by 
addition of H2O (19 µL), 15% NaOH (19 µL) and H2O (57 µL). The resulting slurry was 
stirred for additional 1h and then filtered over Büchner funnel at reduced pressure and 
washed with EtOAc. The filtrate was concentrated to yield crude 3.30, which was used in 
the next step without further purification.  
        To a solution of crude 3.30 (0.223 mmol, 1.0 equiv., theoretical) obtained above in 
CH2Cl2 (ACS grade, 3 mL) at room temperature was added MnO2 (85%, activated, 
Aldrich; 0.183 g, 2.10 mmol, 10.0 equiv.). The suspension was stirred for 8 hours at room 
temperature, filtered over Büchner funnel at reduced pressure and washed with EtOAc. 
The filtrate was concentrated and the crude obtained was purified by flash column 
chromatography (hexanes/EtOAc 2:1) to afford 3.31 (0.051 g, 82% over 2 steps) as a 
colorless oil (inseparable diastereomers, d.r. 1:0.19; Rf = 0.36, hexanes/EtOAc 1:1). 1H 
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NMR (300 MHz, CDCl3): δ 6.80–6.88 (m, 1H), 6.06–6.10 (m, 1H), 3.84–3.92 (m, 4H), 
3.16–3.32 (m, 1H), 2.24–2.66 (m, 4H), 1.36–2.07 (m, 8H), 1.17 (d, J = 6.6 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 148.38, 130.26, 70.68, 65.01, 64.43, 62.67, 49.46, 46.46, 
37.58, 35.87, 32.70, 28.28, 25.00, 20.25. 
















Compound 3.32. To a solution of 3.31 (0.052 g, 0.187 mmol, 1.0 equiv.) in acetone 
(ACS grade, 5 mL) was added p-TsOH⋅H2O (0.0071 g, 37 µmol, 20 mol%). The solution 
was stirred at room temperature for 6 hours then filtered over a short pad of silica, 
washed with EtOAc. The filtrate was concentrated to give crude 3.32, which was used 
directly in the next step without further purification. An analytical sample was purified by 
preparative thin-layer chromatography (PTLC) (hexanes/EtOAc 2:1) and obtained as a 
colorless oil (diasteromers, d.r. 1:0.18; Rf = 0.24, hexanes/EtOAc 1:1). 1H NMR (300 
MHz, CDCl3): δ 6.87–6.94 (m, 1H), 6.11–6.15 (m, 1H), 3.83–3.93 (m, 1H), 3.44–3.52 
(m, 1H), 2.41–2.69 (m, 4H), 2.27–2.38 (m, 3H), 2.11 (ddd, J = 14.1, 9.0, 4.5 Hz, 1H), 
1.85–1.98 (m, 1H), 1.66–1.77 (m, 1H), 1.58 (br, s, 1H), 1.21 (d, J = 6.6 Hz, 3H); 13C 
NMR (75 MHz, CDCl3, major diastereomer): δ 221.26, 203.09, 148.50, 130.18, 70.22, 
63.37, 48.48, 47.91, 39.47, 36.87, 35.02, 27.97, 23.35, 20.33; MS (FAB) m/z (%): 154.1 
(100), 235.2 (23) [M+H]+. 
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(1H NMR filename: panpan106-003-1; 13C NMR filename: panpan107-ct002; notebook 













91% over 2 steps
 
Compound 3.33. (Note: open flask reaction) To a 25-mL round-bottomed flask equipped 
with reflux condenser, crude 3.32 (0.187 mmol, 1.0 equiv., theoretical) obtained above 
was dissolved in CH2Cl2 (ACS grade, 5 mL). NaHCO3 (0.0781 g, 0.930 mmol, 5 equiv.) 
was added and the mixture was stirred at 0 ºC (ice-water bath). m-CPBA (77%, 0.0542 g, 
0.242 mmol, 1.3 equiv.) was then added and the reaction was allowed to warm to room 
temperature on its own. After stirring at room temperature for 2 days, sat. Na2S2O3 (4 
mL) and sat. NaHCO3 (10 mL) were added and the mixture was extracted with EtOAc (3 
x 10 mL). The combined organic layer was washed with brine (10 mL), dried over 
anhydrous Na2SO4. After filtration and concentration, the crude obtained was purified by 
flash column chromatography (hexanes/EtOAc 1:2) to give 3.33 (0.0426 g, 91% over 2 
steps) as a colorless oil (inseparable diasteromers, d.r. 1:0.18; Rf = 0.23, hexanes/EtOAc 
1:2). 1H NMR (300 MHz, CDCl3): δ 6.96 (ddt, J = 10.2, 5.4, 1.8 Hz, 1H), 6.88 (ddt, J = 
5.4, 4.8, 1.8 Hz, 0.18H), 6.13–6.18 (m, 0.86H), 6.06–6.11 (m, 0.24H), 4.57–4.66 (m, 
0.99H), 4.46 (ddd, J = 11.4, 4.2, 2.1 Hz, 0.10H), 4.24 (td, J = 12.0, 2.1 Hz, 0.14H), 3.99–
4.06 (m, 0.27H), 3.76–3.88 (m, 0.88H), 2.80–3.20 (m, 2.5H), 2.52–2.77 (m, 2.9H), 2.11–
2.50 (m, 4.8H), 1.62–2.09 (m, 3.9H), 1.18 (m, 3.5H); 13C NMR (75 MHz, CDCl3, major 
diastereomer): δ 203.02, 171.87, 149.26, 130.59, 79.69, 70.54, 61.36, 45.00, 39.94, 
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35.20, 30.34, 28.42, 20.25, 19.46; 13C NMR (75 MHz, CDCl3, minor diastereomer): δ 
200.97, 172.56, 149.15, 129.64, 79.92, 71.33, 61.22, 43.83, 39.05, 36.89, 30.22, 28.79, 
21.04, 19.33; HRMS (FAB) calcd. for C14H17O4 [M−H]− 249.11323 found 249.11317.  

















Compound 3.35. To a stirred solution of 3.33 (0.0520 g, 0.21 mmol, 1.0 equiv.) in 
pyridine (4 mL) at 0 ºC (ice-water bath) was added MsCl (97 µL, 1.25 mmol, 6.0 equiv.). 
The ice-water bath was removed and the reaction was stirred at room temperature for 9 
hours. Sat. NaHCO3 (10 mL) was added and the mixture was extracted with EtOAc (3 x 
10 mL). The combined organic layer was washed with brine (10 mL), dried over 
anhydrous Na2SO4. After filtration and concentration, the crude obtained was purified by 
flash column chromatography (hexanes/EtOAc 1:2) to give 3.33 (0.0649 g, 95%) as a 
colorless oil (d.r. 1:0.18; Rf = 0.28, 0.30, hexanes/EtOAc 1:2). 1H NMR (300 MHz, 
CDCl3, major diastereomer): δ 6.90 (ddt, J = 9.9, 5.4, 1.8 Hz, 1H), 6.00–6.05 (m, 1H), 
5.08 (q, J = 6.6 Hz, 1H), 4.65 (td, J = 7.8, 3.0 Hz, 1H), 3.32–3.41 (m, 1H), 3.05 (s, 3H), 
2.89–2.99 (m, 1H), 2.64 (dt, J = 16.5, 3.3 Hz, 1H), 1.92–2.44 (m, 6H), 1.70–1.85 (m, 
1H), 1.43 (d, J = 6.6 Hz, 3H). 

















Compound 3.38. To a 10-mL CEM Discover reaction vessel with magnetic stirring bar 
was added 3.35 (39 µmol, 1.0 equiv.) in DMF (1 mL), Li2CO3 (0.0174 g, 235 µmol, 6 
equiv.), and LiBr (1.0 M in DMF, newly made, 157 µL, 157 µmol, 4.0 equiv.). The 
vessel was flushed with Ar, capped and put in a microwave reactor. The mixture was 
heated to 210 ºC and kept at this temperature with high speed stirring for 8 minutes. After 
cooling to room temperature, the pale brown solution was partitioned between water (20 
mL) and Et2O (8 mL). The organic layer was separated and the water layer was extracted 
with Et2O (2 x 8 mL). The combined organic layer was washed with brine (10 mL), dried 
over anhydrous Na2SO4. After filtration and concentration, the crude obtained was 
purified by flash column chromatography (hexanes/EtOAc 6:1) to give 3.38 (0.0059 g, 
65%) as a colorless oil (Rf = 0.23, hexanes/EtOAc 2:1). 1H NMR (100 MHz, CDCl3) δ 
6.72–6.78 (m, 1H), 5.99–6.04 (m, 1H), 5.65 (dd, J = 17.4, 10.8 Hz, 1H), 5.26 (d, J = 10.8 
Hz, 1H), 5.13 (d, J = 17.4 Hz, 1H), 4.67 (app td, J = 7.2, 0.9 Hz, 1H), 3.41 (dt, J = 12.3, 
7.5 Hz, 1H), 2.77–2.87 (m, 1H), 2.63–2.74 (m, 1H), 2.53–2.59 (m, 1H), 2.37–2.46 (m, 
1H), 2.19–2.31 (m, 1H), 2.06–2.12 (m, 1H), 1.86–1.98 (m, 2H), 1.35–1.50 (m, 1H); 13C 
NMR (75 MHz, CDCl3): δ 173.68, 146.61, 135.49, 127.87, 118.20, 79.94, 61.62, 43.27, 
37.74, 37.46, 30.52, 25.66, 21.71; HRMS (FAB) calcd. for C14H17O3 [M+H]+ 233.11722 
found 233.11622. 
(1H NMR filename: panpan108-024; 13C NMR filename: panpan108-t021-11; notebook 











( E:Z = 1:0.11)
 
Compound 3.43. Following the procedure described by Duhamel,4 to a 500-mL 2 necked 
round-bottomed flask equipped with reflux condenser and glass stopper was added ZnCl2 
(0.30 g, 2.2 mmol, 0.8 mol%). The condenser was connected to vacuum and the flask was 
heated by a bunsen burner until all the solid ZnCl2 melted. After cooling to room 
temperature, the flask was charged with Argon. Et2O (60 mL), 3-methylcrotonaldehyde 
(3.42) (24 mL, 250 mmol, 1.0 equiv.), NEt3 (40 mL, 287.5 mmol, 1.15 equiv.), and 
TMSCl (34.9 mL, 275 mmol, 1.10 equiv.) were added successively. The suspension was 
stirred at gentle reflux for 25 hours. After cooling to room temperature, hexanes (200 
mL) was added and the triethylamine hydrochloride precipitate was removed by filtering 
over sintered glass funnel under reduced pressure and washed with hexanes (50 mL). The 
filtrate was concentrated by rotavap and the residue was distilled under reduced pressure 
to give 3.43 (55–65 ºC/20 mmHg, 30.96 g, 79%, E:Z = 1.0:0.11) as a colorless oil. 1H 
NMR (300 MHz, CDCl3, E isomer): δ 6.53 (dt, J = 12.3, 0.6 Hz, 1H), 5.79 (dd, J = 12.3, 
0.6 Hz, 1H), 4.66–4.76 (m, 2H), 1.81 (dd, J = 1.2, 0.6 Hz, 3H), 0.22 (s, 9H); 13C NMR 
(75 MHz, CDCl3, E isomer): δ 141.96, 140.20, 116.34, 111.72, 18.92, 0.63. 
























Compound 3.44. To a 10-mL CEM Discover reaction vessel with magnetic stirring bar, 
diene 3.42 (2.08g, 13.28 mmol, 2.5 equiv.) and enone 3.18 (1.11g, 5.31 mmol, 1.0 equiv.) 
were added. The vessel was flushed with Ar, capped and put in microwave reactor. The 
mixture was heated to 180 ºC and kept at this temperature with high speed stirring for 9 
hours. After cooling to room temperature, the pale yellow solution was transferred to a 
25-mL round-bottomed flask by pipette. A short-path distillation head was attached and 
the volatiles (contain diene 3.42 and 3-methyl-2-butenal (3.41)) were removed (∼100 
ºC/4 mmHg for 0.5 hour). The residue was purified by flash column chromatography 
(hexanes/EtOAc, 7:1 to 2:1) to afford recovered 3.18 (0.21g, 19%) and 3.44 (1.44g, 74%, 
92% brsm) as a pale yellow oil (inseparable diastereomers, d.r. 1:0.42; Rf = 0.23, 
hexanes/EtOAc 2:1). IR (thin film): 2957, 1696, 1350, 1251, 1096, 1065 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 5.30–5.32 (m, 0.42H), 5.07 (app s, 1H), 4.29 (br d, J = 5.4 Hz, 
0.42H), 4.09–4.10 (m, 1H), 3.77–3.91(m, 5.9H), 2.92 (td, J = 8.4, 8.0 Hz, 1.1H), 2.75 (q, 
J = 8.7 Hz, 0.44H), 2.23–2.52 (m, 4.6H), 2.06(s, 3.2H), 2.03 (s, 1.1H), 1.46–1.88 (m, 
13H), 1.26–1.38 (m, 1H), 0.93–1.10 (m, 1.5H), 0.12(s, 8.9H), 0.09 (s, 3.1H); 13C NMR 
(75 MHz, CDCl3, major diastereomer): δ 211.31, 135.58, 123.15, 118.34, 70.87, 67.55, 
65.12, 64.31, 46.77, 46.75, 36.80, 35.41, 32.38, 31.83, 26.06, 23.22, 0.39; 13C NMR (75 
MHz, CDCl3, minor diastereomer): δ  209.87, 137.26, 120.89, 118.18, 65.04, 64.84, 
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64.81, 49.19, 48.26, 36.02, 34.53, 32.04, 30.88, 28.18, 26.21, 24.06, 0.69; HRMS (ESI) 
calcd. for C20H32NaO4Si [M+Na]+ 387.1962 found 387.1963. 





























Compound 3.46. To a solution of D-A adduct 3.44 (0.436g, 1.20 mmol, 1.0 equiv.) in 
THF (24 mL) at 0 ºC (ice-water bath) was added LiAlH4 (0.10 g, 2.63 mmol, 2.2 equiv.) 
in one portion. The reaction mixture was stirred at at 0 ºC for 10 minute then allowed to 
warm to room temperature. After stirring at room temperature for 5 h, the reaction was 
quenched by successive addition of H2O (100 µL), 15% NaOH (100 µL) and H2O (300 
µL). The resulting slurry was stirred for additional 1h and then filtered over Büchner 
funnel at reduced pressure and washed with EtOAc. The filtrate was concentrated to yield 
crude 3.45, which was used in the next step without further purification.  
        To a solution of crude 3.45 (1.20 mmol, 1.0 equiv., theoretical) obtained above in 
CH2Cl2 (ACS grade, 24 mL) at room temperature was added MnO2 (85%, activated, 
Aldrich; 1.25 g, 14.36 mmol, 12.0 equiv.). The suspension was stirred for 1d at room 
temperature, filtered over Büchner funnel at reduced pressure and washed with EtOAc. 
The filtrate was concentrated and the crude obtained was purified by flash column 
chromatography (hexanes/EtOAc 2:1) to afford 3.46 (d.r. 1: 0.20, 0.316 g, 90%) as a 
colorless oil (Rf = 0.17, 0.13, hexanes/EtOAc 2:1). Analytical data for major isomer: IR 
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(thin film): 3475, 2969, 2881, 1642, 1437, 1380, 1354, 1318, 1209, 1157, 1104, 1040 cm-
1; 1H NMR (400 MHz, CDCl3): δ 5.92 (s, 1H), 3.79–3.90 (m, 4H), 2.78 (br d, J = 7.6 
Hz), 2.52–2.58 (m, 1H), 2.38–2.43 (m, 1H), 2.18–2.27 (m, 2H), 1.76–2.06 (m, 7H), 1.59–
1.67 (m, 2H), 1.49 (dt, J = 13.6, 11.2 Hz, 1H), 1.11 (d, J = 6.8, 3H); 13C NMR (100 
MHz, CDCl3): δ 203.92, 160.26, 126.96, 118.32, 70.68, 64.93, 64.34, 61.31, 49.75, 
46.58, 37.75, 35.79, 33.36, 33.01, 24.96, 24.82, 20.30; HRMS (ESI) calcd. for C17H25O4 
[M+H]+ 293.1753 found 293.1747. 
















Compound 3.47. To a solution of 3.46 (0.334 g, 1.142 mmol, 1.0 equiv.) in acetone 
(ACS grade, 23 mL) was added p-TsOH⋅H2O (0.043 g, 0.228 mmol, 20 mol%). The 
reaction was stirred at room temperature for 16 hours then filtered over a short pad of 
silica, washed with EtOAc. The filtrate was concentrated to give crude 3.47 (Rf = 0.24, 
hexanes/EtOAc 1:1), which was used directly in the next step without further 
purification. An analytical sample was purified by flash column chromatography 
(hexanes/EtOAc 2:1) and obtained as a colorless oil (inseparable diasteromers, d.r. 
1:0.18). IR (thin film): 3424, 2939, 1734, 1654, 1458, 1435, 1381, 1275, 1257, 1236, 
1157, 1118, 1060 cm-1; 1H NMR (400 MHz, CDCl3): δ 5.99 (m, 0.91H), 5.96 (br s, 
0.16H), 3.82–3.89 (m, 1.2H), 3.39–3.48 (m, 1.3H), 2.86–2.96 (m, 1.3H), 2.56–2.63 (m, 
1.4H), 2.40–2.52 (m, 2.4H), 2.23–2.36 (m, 4.7H), 2.01–2.14 (m, 2.2H), 1.98 (s, 3H), 1.95 
(s, 0.7H), 1.81–1.86 (m, 1.1H), 1.69–1.77 (m, 1.3H), 1.27 (d, J = 6.4 Hz, 0.7H), 1.18 (d, J 
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=6.4 Hz, 3H); 13C NMR (major diastereomer, 100 MHz, CDCl3): δ 221.02, 203.05, 
160.66, 127.14, 70.54, 62.01, 49.20, 48.06, 39.37, 37.20, 35.43, 33.25, 24.95, 23.51, 
20.45; HRMS (ESI) calcd. for C15H21O3 [M+H]+ 249.1491 found 249.1485. 

















Compound 3.48. (Note: open flask reaction) To a 100-mL round-bottomed flask 
equipped with reflux condenser, crude 3.47 (1.142 mmol, 1.0 equiv., theoretical) obtained 
above was dissolved in CH2Cl2 (ACS grade, 25 mL). NaHCO3 (0.480 g, 5.71 mmol, 5 
equiv.) was added and the mixture was stirred at 0 ºC (ice-water bath). m-CPBA (77%, 
0.384 g, 1.713 mmol, 1.5 equiv.) was then added in 2 portions and the reaction was 
allowed to warm to room temperature on its own. After stirring at room temperature for 
36 hours, sat. Na2S2O3 (4 mL) and sat. NaHCO3 (10 mL) were added and the mixture was 
extracted with EtOAc (3 x 15 mL). The combined organic layer was washed with brine 
(15 mL), dried over anhydrous Na2SO4. After filtration and concentration, the crude 3.48 
obtained was used directly in the next step without further purification. An analytical 
sample was purified by flash column chromatography (hexanes/EtOAc 1:1.5) and 
obtained as a colorless oil (inseparable diasteromers, d.r. 1:0.18; Rf = 0.21, 
hexanes/EtOAc 1:2). IR (thin film): 3456, 2938, 1735, 1650, 1433, 1384, 1245, 1187, 
1134, 1069 cm-1; 1H NMR (400 MHz, CDCl3): δ 6.03 (m, 1H), 5.94 (m, 0.18H), 4.56–
4.61 (m, 1.2H), 4.43–4.47 (m, 0.25H), 4.20–4.26 (m, 0.25H), 4.02 (q, J = 6.4 Hz, 0.25H), 
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3.76–3.83 (m, 1.2H), 3.06–3.21 (m, 1H), 2.96–3.04 (m, 1.2H), 2.70–2.95 (m, 1.1H), 
2.56–2.66 (m, 3.3H), 2.41–2.51 (m, 0.5H), 2.14–2.38 (m, 5.1H), 1.92–2.02 (m, 5.1H), 
1.66–1.90 (m, 2.1H), 1.19 (d, J = 6.4 Hz, 0.57H), 1.14 (d, J = 6.8 Hz, 3.2H); 13C NMR 
(major diastereomer, 100 MHz, CDCl3): δ 202.86, 171.71, 161.70, 127.38, 79.68, 70.55, 
59.76, 45.04, 40.02, 35.35, 33.55, 30.24, 25.00, 20.26, 19.42; HRMS (ESI) calcd. for 
C15H21O4 [M+H]+ 265.1440 found 265.1450. 















81% over 3 steps
 
Compound 3.40. To a stirred solution of crude 3.48 (1.142 mmol, 1.0 equiv., theoretical) 
in pyridine (12 mL) at 0 ºC (ice-water bath) was added MsCl (0.35 mL, 4.56 mmol, 4.0 
equiv.). The ice-water bath was removed and the reaction was stirred at room temperature 
for 1 day. Sat. NaHCO3 (15 mL) was added and the mixture was extracted with EtOAc (3 
x 10 mL). The combined organic layer was washed with brine (10 mL), dried over 
anhydrous Na2SO4. After filtration and concentration, the crude was purified by flash 
column chromatography (hexanes/EtOAc 1:1) to afford 3.40 (d.r. 1:0.18, 0.316 g, 81% 
over 3 steps) as a pale yellow oil (Rf = 0.18, 0.12, hexanes/EtOAc 1:1). Analytical data 
for major isomer: IR (thin film): 1737, 1656, 1432, 1335, 1247, 1173, 1135, 1054, 1018, 
965 cm-1; 1H NMR (400 MHz, CDCl3): δ 5.87 (s, 1H), 5.01 (q, J = 6.8 Hz, 1H), 4.61 (td, 
J = 7.8, 3.2 Hz, 1H), 3.32 (dt, J = 12.8, 6.8 Hz, 1H), 3.03 (s, 3H), 2.96–3.02 (m, 1H), 
2.84–2.91 (m, 1H), 2.61 (dt, J = 16.4, 3.2 Hz, 1H), 2.20–2.31 (m, 2H), 2.05–2.13 (m, 
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2H), 1.97 (s, 3H), 1.86–1.93 (m, 1H), 1.76 (dq, J = 12.4, 3.2 Hz, 1H), 1.42 (d, J = 6.4 Hz, 
3H); 13C NMR (100 MHz, CDCl3): δ 197.96, 172.26, 160.73, 124.35, 79.21, 76.85, 
60.83, 40.96, 39.52, 36.86, 35.47, 30.56, 30.50, 24.61, 20.33, 18.03; HRMS (ESI) calcd. 
for C16H22NaO6S [M+Na]+ 365.1035 found 365.1032. 



















Compound 3.41. To a stirred solution of 3.40 (0.105 g, 0.308 mmol, 1.0 equiv.) in 
EtOAc (ACS grade, 4 mL) was added 5 wt. % Pd/C (0.105 g). A balloon of H2 was 
applied and the reaction mixture was stirred at room temperature for 1 day. The mixture 
was then filtered over Büchner funnel at reduced pressure and washed with EtOAc. The 
filtrate was concentrated to give crude 3.41, which was used directly in the next step 
without further purification. An analytical sample was purified by flash column 
chromatography (hexanes/EtOAc 1.5:1) and obtained as a colorless oil (Rf = 0.23, 0.14, 
hexanes/EtOAc 1:1). IR (thin film): 2957, 1736, 1704, 1457, 1339, 1246, 1176, 1129, 
1104, 1053 cm-1; 1H NMR (major diastereomer, 400 MHz, CDCl3): δ 5.32 (q, J = 6.8 Hz, 
1H), 4.63 (td, J = 7.4, 3.6 Hz, 1H), 3.35 (dt, J = 11.6, 7.2 Hz, 1H), 3.07 (s, 3H), 2.94–
3.00 (m, 1H), 2.58 (dt, J = 16.4, 3.2 Hz, 1H), 2.38–2.42 (m, 1H), 2.28 (ddd, J = 16.4, 
14.4, 5.2 Hz, 1H), 1.97–2.19 (m, 4H), 1.71–1.89 (m, 4H), 1.34 (d, J = 6.8 Hz, 3H), 1.06 
(d, J = 6.4 Hz, 3H); 13C NMR (major diastereomer, 100 MHz, CDCl3): δ 210.67, 172.45, 
79.63, 75.80, 65.29, 48.06, 39.59, 39.49, 39.30, 35.40, 31.51, 30.44, 30.14, 22.26, 20.13, 
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18.31; 1H NMR (minor diastereomer, 400 MHz, CDCl3): δ 4.96 (q, J = 6.8 Hz, 1H), 4.59 
(dt, J = 8.4, 6.8 Hz, 1H), 3.07 (s, 3H), 2.89–2.97 (m, 1H), 2.65–2.71 (m, 1H), 2.50 (ddd, J 
= 14.4, 3.6, 2.0 Hz, 1H), 1.68–2.41 (m, 10H), 1.33 (d, J = 6.8 Hz, 3H), 1.06 (d, J = 6.4 
Hz, 3H); 13C NMR (minor diastereomer, 100 MHz, CDCl3): δ 211.35, 170.58, 81.39, 
79.62, 61.83, 50.26, 41.87, 40.90, 39.66, 37.88, 34.94, 29.95, 28.86, 22.48, 18.86, 18.80; 
HRMS (ESI) calcd. for C16H24NaO6S [M+Na]+ 367.1191 found 367.1193. 






































Compound 3.39. To a 10-mL CEM Discover reaction vessel with magnetic stirring bar 
were added crude 3.41 (0.308 mmol, 1.0 equiv., theoretical) in DMF (3 mL), Li2CO3 
(0.1278 g, 1.730 mmol, 6 equiv.), and LiBr (1.0 M in DMF, newly made, 1.15 mL, 1.15 
mmol, 4.0 equiv.). The vessel was flushed with Ar, capped and put in microwave reactor. 
The mixture was heated to 210 ºC and kept at this temperature with high speed stirring 
for 10 minutes. After cooling to room temperature, the pale brown solution was 
partitioned between water (40 mL) and Et2O (10 mL). The organic layer was separated 
and the water layer was extracted with Et2O (2 x 10 mL). The combined organic layer 
was washed with brine (10 mL), dried over anhydrous Na2SO4. After filtration and 
concentration, the crude obtained was purified by flash column chromatography 
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(hexanes/EtOAc 6:1) to give 3.39 (0.0574 g, 75%) as a colorless oil (Rf = 0.23, 
hexanes/EtOAc 4:1). IR (thin film): 2955, 1746, 1703, 1457, 1331, 1248, 1187, 1130, 
1033 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.60 (C-11H, dd, J = 18.0, 10.8 Hz, 1H), 5.28 
(C-10H, d, J = 10.8 Hz, 1H), 5.02 (C-10H, d, J = 17.6 Hz, 1H), 4.62 (C-5H, dt, J = 6.8, 
0.8 Hz, 1H), 3.38 (C-4H, dt, J = 11.6, 7.6 Hz, 1H), 2.70–2.77 (C-7H, m, 1H), 2.45 (C-2H, 
dt, J = 16.0, 3.6 Hz, 1H), 2.14–2.30 (C-14, 2H, m, 3H), 1.94–2.06 (C-15H, m, 1H), 1.91 
(C-6H, ddd, J = 14.4, 6.8, 0.8 Hz, 1H), 1.54–1.81 (C-3, 8, 6H, m, 4H), 1.28–1.39 (C-3H, 
m, 1H), 0.94 (C-16H, d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 211.28 (C-13), 
173.72 (C-1), 137.54 (C-11), 119.28 (C-10), 80.37 (C-5), 63.98 (C-12), 47.36 (C-14), 
42.76 (C-7), 41.12 (C-4), 36.63 (C-6), 32.27 (C-8), 30.46 (C-2), 30.15 (C-15), 22.52 (C-
16), 21.74 (C-3); HRMS (ESI) calcd. for C15H21O3 [M+H]+ 249.1485 found 249.1481. 
(1H, 13C NMR, gCOSY filename: pan110-7-1; NOESY, HSQCAD filename: pan110-7-2; 


















Compound 3.50. To a 10-mL flame dried round-bottomed flask, CH2Cl2 (0.8 mL) was 
added and the flask was cooled to 0 ºC (ice-water bath). Me3Al (2.0 M in toluene, 156 
µL, 313 µmol, 3.0 equiv.) was added. After stirring at 0 ºC for 30 minutes, 3.39 (0.0259 
g, 104 µmol, 1.0 equiv.) in CH2Cl2 (1.4 mL) was added dropwise. The ice-water bath was 
removed and the reaction was allowed to warm to room temperature on its own. After 2.5 
hours at room temperature, TLC showed complete consumption of the 3.39. MeOH (170 
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µL) was added to quench the reaction. The mixture was filtered over a short pad of silica, 
washed with EtOAc (10 mL). The filtrate was concentrated and the residue was purified 
by flash column chromatography (hexanes/EtOAc 6:1) to give 3.50 (0.0222 g, 70%) as a 
colorless oil (Rf = 0.08, hexanes/EtOAc 1:1). IR (thin film): 3333, 2924, 1700, 1639, 
1543, 1419, 1334, 1225 cm-1; 1H NMR (400 MHz, CDCl3): δ 6.10 (br s, 1H), 5.80–5.88 
(m, 1H), 5.74 (dd, J = 17.6, 10.8 Hz, 1H), 5.01–5.27 (m, 3H), 4.84 (d, J = 17.6 Hz, 1H), 
4.05 (s, 1H), 3.80–3.88 (m, 3H), 2.92–2.96 (m, 1H), 2.36–2.46 (m, 2H), 2.14–2.28 (m, 
3H), 1.69–1.98 (m, 4H), 1.58–1.66 (m, 2H), 1.48 (td, J = 13.2, 3.2 Hz, 1H), 0.98 (d, J = 
6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 215.14, 174.35, 141.18, 134.24, 116.70, 
116.20, 71.61, 62.34, 51.71, 48.93, 44.35, 42.29, 39.07, 35.55, 34.14, 29.07, 22.38, 21.93.  

















Compound 3.58. To a stirred solution of 3.50 (0.0026 g, 8.5 µmol, 1.0 equiv.) in 
pyridine (1.0 mL) was added TESCl (7.1 µL, 42.4 µmol, 5.0 equiv.). After stirring at 
room temperature for 2 hours, sat. NaHCO3 (3 mL) was added and the mixture was 
extracted with Et2O (3 x 5 mL). The combined organic layer was washed with brine (5 
mL) and dried over anhydrous Na2SO4. After filtration and concentration, the crude 3.58 
obtained (0.0032 g, 90%) was used in the next step without further purification. 1H NMR 
(300 MHz, CD3OCD3, crude): δ 7.00–7.09 (br s, 1H), 5.69–5.90 (m, 2H), 4.84–5.19 (m, 
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4H), 4.21 (dt, J = 4.5, 3.3 Hz, 1H), 3.76–3.83 (m, 2H), 2.44 (dt, J = 8.7, 5.4 Hz, 1H), 
1.54–2.35 (m, 12H), 0.92–1.04 (m, 12H), 0.62 (q, J = 7.8 Hz, 6H). 


















Compound 3.62. To a stirred solution of 3.50 (0.0225 g, 73.6 µmol, 1.0 equiv.) in 
CH2Cl2 (3.0 mL) at room temperature was added Dess-Martin periodinane (0.0468 g, 
110.0 µmol, 1.5 equiv.). After 2 hours, sat Na2S2O3 (1 mL) and sat. NaHCO3 (2 mL) 
were added and the mixture was extracted with EtOAc (3 x 5 mL). The combined organic 
layer was washed with brine (3 mL) and dried over anhydrous Na2SO4. After filtration 
and concentration, the residue was purified by flash column chromatography 
(hexanes/EtOAc 6:1) to give 3.62 (0.0149 g, 67%) as a colorless oil (Rf = 0.14, 
hexanes/EtOAc 1:1). IR (thin film): 3313, 2956, 2924, 1737, 1703, 1654, 1541, 1456, 
1420, 1378, 1225, 1129 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.74–5.96 (m, 3H), 5.42 (d, 
J = 10.8 Hz, 1H), 5.08–5.24 (m, 3H), 3.84–3.93 (m, 2H), 2.96–3.08 (m, 2H), 2.21–2.49 
(m, 5H), 2.07 (ddd, J = 19.2, 12.0, 1.2 Hz, 2H), 1.78–1.94 (m, 3H), 1.45–1.59 (m, 1H), 
1.03 (d, J = 6.6 Hz, 3H).  















Compound 3.88. Following the procedure described by Mash,5 to a 100-mL round-
bottomed flask with Dean-Stark distillation head and condenser was added benzene (60 
mL), cyclopent-2-enone (3.84, 3.52 mL, 42 mmol, 2.8 equiv.), (S, S)-hydrobenzoin 
(3.214 g, 15 mmol, 1.0 equiv.) and PPTS (0.189 g, 0.75 mmol, 5 mol%). The mixture 
was heated to reflux and the water was removed azeotropically. After 3 days, TLC 
showed complete consumption of (S, S)-hydrobenzoin. The reaction was cooled to r.t. 
and sat. NaHCO3 (30 mL) was added. The organic layer was separated and the water 
layer was extracted with EtOAc (3 x 15 mL). The combined organic layer was washed 
with brine (20 mL) and dried over anhydrous Na2SO4. After filtration and concentration, 
the crude 3.88 obtained was purified by flash column chromatography (hexanes/EtOAc, 
10:1) to afford title compound (4.18g, 80%) as a white solid. 1H NMR (300 MHz, 
CDCl3): δ 7.25–7.40 (m, 10H), 6.25 (app dt, J = 5.4, 2.4 Hz, 1H), 6.05 (app dt, J = 5.4, 
2.1 Hz, 1H), 4.81 (s, 2H), 2.51–2.60 (m, 2H), 2.37–2.48 (m, 2H); 13C NMR (75 MHz, 
CDCl3): δ 137.82, 137.04, 136.92, 131.37, 128.57, 128.44, 128.40, 126.86, 126.81, 
121.40, 85.91, 85.47, 35.84, 29.92.  




















CH2Cl2, 1.0 M, –78 °C
96%
 
Compound 3.89a and 3.89b. To a 10-mL long neck round-bottomed flask with chiral 
ketal 3.88 (0.410 g, 1.47 mmol, 1.0 equiv.) was added CH2Cl2 (1.47 mL) and isoprene 
(3.9, 0.74 mL, 7.36 mmol, 5 equiv.). The solution was stirred at –78 ºC (dry ice/acetone 
bath) and TMSOTf (26 µL, 147 µmol, 10 mol%) was added. After 25 h at –78 ºC, TLC 
showed complete consumption of 3.88. NEt3 (0.20 mL) was added and the flask was 
warmed to room temperature. The solution was applied to flash column chromatography 
directly (hexanes/EtOAc, 30:1) to afford title compounds (0.488 g, 96%) as a colorless 
oil (inseparable mixture, d.r. = 2.08:1). IR (thin film): 1H NMR (300 MHz, CDCl3): δ 
7.17–7.36 (m, 17H), 5.47–5.49 (m, 1H), 5.39–5.44 (m, 0.48H), 4.62–4.73 (m, 3.1 H), 
1.97–2.56 (m, 11H), 1.51–1.91 (m, 11H); 13C NMR (major isomer, 75 MHz, CDCl3): δ 
137.26, 136.81, 132.36, 128.50, 128.45, 128.35, 128.22, 127.00, 126.69, 120.51, 119.26, 
85.67, 43.36, 35.85, 34.93, 32.11, 27.18, 24.04, 22.66. ; HRMS (ESI) calcd. for 

































Compound 3.90a/3.90b. To a solution of 3.89a/3.89b mixture (0.099 g, 264 µmol, 1.0 
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equiv.) in ClCH2CH2Cl (ACS grade, 1.32 mL) and H2O (1.06 mL) was added 
RuCl3⋅xH2O (0.0019 g, 9.1 µmol, 3.5 mol%) and NaIO4 (0.113 g, 528 µmol, 2.0 equiv.). 
The reaction was stirred vigorously at room temperature for 34 hours, then sat. Na2S2O3 
(2 mL) was added. The mixture was extracted with EtOAc (2 x 6 mL) and the combined 
organic layer was dried over anhydrous MgSO4. After filtration and concentration, the 
residue was purified by flash column chromatography (hexanes/EtOAc, 3:1) to afford 
recovered 3.89a/3.89b (0.054 g) and title compounds (0.021 g, 21%, 47% brsm) as a 
colorless oil (inseparable diastereomers, d.r. = 0.3:1). IR (thin film): 1H NMR (300 MHz, 
CDCl3): δ 9.89 (t, J = 1.8 Hz, 0.3H), 9.86 (dd, J = 3.0, 1.5 Hz, 1H), 7.28–7.39 (m, 14H), 
7.14–7.26 (m, 7.2H), 4.57–4.80 (m, 4.6H), 2.95–3.06 (m, 1.5H), 2.34–2.90 (m, 9.8H), 
1.94–2.32 (m, 14H), 1.37–1.56 (m, 3.8H); 13C NMR (major isomer, 75 MHz, CDCl3): δ 
208.36, 202.20, 137.29, 135.95, 128.87, 128.78, 128.67, 128.44, 127.37, 126.55, 118.02, 
85.70, 85.17, 45.80, 43.96, 40.05, 35.60, 33.65, 30.50, 28.22; HRMS (ESI) calcd. For 
















PhMe, !25 °C, 3d
52%, 73.5% e.e.
 
Compound (+)-3.8 from 3.9 and 3.84. Following the procedure described by Corey,6 to 
a 50-mL long neck round-bottomed flask with magnetic stirring bar (flame-vacuo-Ar 
dried) was added PhMe (1 mL) and (S)-(–)-o-Tolyl-CBS-oxazaborolidine solution ((S)-
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CBS1, 0.80 mL, 0.4 mmol, 20 mol%). The flask was cooled to –25 ºC (Cryocooler) and 
Tf2NH solution (0.2 M in PhMe, newly made, 1.80 mL, 0.36 mmol, 18 mol%) was 
added. After 10 minutes at –25 ºC, isoprene (3.9, 1.0 mL, 10 mmol, 5 equiv.) and 
cyclopent-2-enone (3.84, 168 µL, 2 mmol, 1 equiv.) were added. The mixture was stirred 
at –25 ºC for 3 days and then quenched with NEt3 (56 µL). After warming to room 
temperature, the solvent was removed by rotary evaporation (~15 mmHg, rotavap water 
bath temp. 0–5 ºC) and the residue was purified by flash column chromatography 
(hexanes/EtOAc 10:1) to afford title compound (0.157 g, 52%, 73.5% e.e.) as a colorless 
oil. The absolute stereochemistry of (+)-3.8 was temporally assigned as shown according 
to the model proposed by Corey’s group. 
Analytical data for (+)-3.8: [α]D = +9.8° (c 8.32, CHCl3), 73.5% e.e. 
GC condition: Column: Chiraldex B-DM (Cat. No. 77023), Adv. Separation 
Technologies, Inc. Oven: 130 °C; Carrier: Helium, head pressure 15 psi; Detection: 
FID 250 °C. 
  
 



















0!4 °C, 7 h
36%, > 99.8% e.e. 60%, 52% e.e.1.94 g  
Kinetic resolution of (±)-3.11. To a 500-mL round-bottomed flask, (±)-3.11 (1.94 g, 10 
mmol, 1.0 equiv.), methanesulfonamide (0.951 g, 10 mmol, 1.0 equiv.), and K2CO3 
(4.146 g, 30 mmol, 3 equiv.) were dissolved in t-BuOH/H2O (v/v 1:1, 100 mL). The 
mixture was stirred at 0 °C and AD-mix-β (1.41g/mmol, 14.1 g) was added in one 
portion. After stirring at 0–4 °C for 7 hours, sat. Na2S2O3 (50 mL) was added and the 
mixture was extracted with hexanes (2 x 100 mL). The combined hexanes extract layer 
was washed successively with H2O (4 x 50 mL) and brine (40 mL), dried over anhydrous 
Na2SO4. After filtration and concentration at reduced pressure (~15 mmHg, rotavap water 
bath temp. 0–5 ºC), the crude (+)-3.11 was obtained, which also contains a little (−)-3.91. 
All of the aqueous layers were combined and added NaCl until saturation. The aqueous 
layer was then extracted with CHCl3 (3 x 50 mL). The combined CHCl3 extract layer was 
dried over anhydrous Na2SO4, filtered and concentrated to give crude (−)-3.91. The crude 
(+)-3.11 obtained above was purified by flash column chromatography (hexanes/EtOAc 
50:1) to afford (+)-3.11 (0.67 g, 36%) as a colorless oil. After eluting all of the (+)-3.11, 
crude (−)-3.91 was loaded to the same column and chromatographed 
(THF/hexanes/EtOAc 1:1:1) to yield (−)-3.91 (1.104g, 60%) as a colorless oil.  
Analytical data for (+)-3.11: [α]D = +12.4° (c 16.23, CHCl3), > 99.8% e.e. 
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GC condition: Column: Chiraldex B-DM (Cat. No. 77023), Adv. Separation 
Technologies, Inc. Oven: 130 °C; Carrier: Helium, head pressure 15 psi; Detection: 
FID 250 °C. 
      
 
 
Analytical data for (−)-3.91: IR (film): 3424, 2940, 1438, 1329, 1208, 1153, 1120, 1044, 
1014 cm-1; 1H NMR (300 MHz, CDCl3): δ 3.73–4.04 (m, 5H), 2.18–2.40 (m, 2H), 1.54–
1.96 (m, 8H), 1.34–1.48 (m, 2H), 1.24 (d, J = 0.3Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 
118.68, 72.33, 71.73, 65.17, 64.23, 45.96, 40.08, 35.74, 32.75, 28.01, 27.63, 27.27; 
HRMS (ESI) calcd. for C12H20NaO4 [M+Na]+ 251.1254 found 251.1250. 



















Compound (−)-3.17 from (−)-3.91. To a 25-mL round-bottomed flask, (−)-3.91 (kinetic 
resolution product, 0.129g, 0.70 mmol, 1.0 equiv.) was dissolved in THF (ACS grade, 4 
mL) and H2O (3 mL). The mixture was stirred vigorously at room temperature and then 
NaIO4 (0.225 g, 1.05 mmol, 1.5 equiv.) was added in one portion. After 2 hours the 
reaction was quenched with sat. Na2S2O3 (5 mL) and the mixture was extracted with 
EtOAc (3 x 15 mL). The combined organic layer was washed with brine (5 mL) and 
dried over anhydrous MgSO4. After filtration and concentration, the residue was purified 
by flash column chromatography (hexanes/EtOAc 2:1) to afford (−)-3.17 (0.144 g, 90%) 
as a colorless oil.  
Analytical data for (−)-7: [α]D = −11.3° (c 3.38, CHCl3), 52% e.e. 
HPLC condition: Column: CHIRALPAK® IA (Column No. IA00CE-ML034), Chiral 
Technologies, Inc., 90 : 10 Hex : i-PrOH, 1 mL/min. 
           
 
        
 
















Compound (+)-3.8 from (+)-3.11. Following the procedure described by Hailes,3 to a 
stirred solution of (+)-3.11 (95.0% e.e., 0.157 g, 0.81 mmol, 1.0 equiv.) in MeOH (ACS 
grade, 4 mL) at 0 ºC was added dropwise aq. HCl solution (2.7 M, 0.25 mL, 0.675 mmol, 
0.8 equiv.). The reaction was stirred at 0 ºC for 2 hours then sat. NaHCO3 (8mL) was 
added. The mixture was extracted with hexanes (3 x 15 mL) and the combined organic 
layer was washed with brine (10 mL), dried over anhydrous MgSO4. After filtration and 
concentration (~15 mmHg, rotavap water bath temp. 0–10 ºC), the crude obtained was 
purified by flash column chromatography (hexanes/Et2O, 15:1) to afford (+)-3.8 (0.092 g, 
76%, 92.3% e.e.) as a colorless oil. [α]D = +21.5°  (c 3.57, CHCl3). 
(notebook #: 01534) 
 





















Compound 4.4. To a 25 mL round-bottomed flask with magnetic stirring bar (flame-
vacuo-Ar dried) was added NaH (60% in mineral oil, 0.1139 g, 2.85 mmol, 15 equiv.) 
and pentane (4 mL). The suspension was stirred at room temperature for 5 minutes and 
the pentane was removed by pipette. 3.44 (0.0692 g, 190 µmol, 1.0 equiv.) in THF (5 
mL) and HCO2Me (0.47 mL, 7.59 mmol, 40 equiv.) were added via syringe. The mixture 
was stirred at room temperature for 1 day and then filtered over a short pad of silica, 
washed with EtOAc (20 mL). The filtrate was concentrated and the crude obtained was 
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purified by flash column chromatography (hexanes/EtOAc, 4:1) to afford 4.4 (0.0527 g, 
80%) as a colorless oil (Rf = 0.39, hexanes/EtOAc 2:1). 1H NMR (300 MHz, CDCl3): δ 
9.90 (s, 1H), 8.07 (s, 1H), 5.26–5.30 (m, 1H), 4.97–5.03 (m, 1H), 3.84–4.01 (m, 4H), 
3.01 (dt, J = 13.8, 7.2 Hz, 1H), 2.90 (q, J = 8.4 Hz, 1H), 2.66 (t, J = 9.6 Hz, 1H), 2.15–
2.27 (m, 1H), 1.96–2.06 (m, 1H), 1.71–1.89 (m, 2H), 1.67 (s, 3H), 1.44–1.62 (m, 3H), 
1.22–1.42 (m, 3H); 13C NMR (75 MHz, CDCl3): δ 188.00, 168.29, 141.91, 117.76, 
117.27, 115.90, 83.35, 65.25, 64.53, 55.12, 47.83, 47.04, 36.20, 35.72, 30.49, 29.72, 
24.38, 23.44. 
(1H NMR filename: panpan105-302-1; 13C NMR filename: panpan105-302-t1; notebook 






















Compound 4.5. To a stirred solution of 4.4 (0.0508 g, 146 µmol, 1.0 equiv.) in absolute 
EtOH (2 mL) was added NaBH4 (0.0165 g, 437 µmol, 3.0 equiv.). The solution was 
stirred at room temperature for 2 hours and sat. NH4Cl (8 mL) was added. The mixture 
was extracted with EtOAc (3 x 10 mL) and the combined organic layer was dried over 
anhydrous MgSO4. After filtration and concentration, the crude 4.5 (Rf = 0.19, 0.11, 
hexanes/EtOAc 2:1) obtained was used in subsequent reactions without further 
purification.  




















 over 2 steps
PivCl, py, r.t.
 
Compound 4.7. To a solution of 4.5 (0.0471 g, 145 µmol, 1.0 equiv., theoretical) in 
pyridine (1.5 mL) was added pivaloyl chloride (179 µL, 1.45 mmol, 10 equiv.). The 
reaction was stirred at room temperature for 2 days and sat. NaHCO3 (5 mL) was added. 
The mixture was extracted with Et2O (3 x 10 mL) and the combined organic layer was 
washed with brine (5 mL), dried over anhydrous Na2SO4. After filtration and 
concentration, the crude obtained was purified by flash column chromatography 
(hexanes/EtOAc, 2:1) to afford recovered 4.5 (0.0088 g, 19%) and 4.4 (0.0411 g, 69%, 
85% brsm) as a pale yellow solid. (inseparable diastereomers, d.r. 5.4:1; Rf = 0.78, 
hexanes/EtOAc 1:2). 1H NMR (300 MHz, CDCl3, diastereomers): δ 5.24–5.30 (m, 
1.0H), 4.69 (dd, J = 11.4, 3.6 Hz, 0.11H), 4.51 (dd, J = 11.4, 4.5 Hz, 0.93H), 4.28–4.34 
(m, 0.27H), 4.00–4.13 (m, 0.42H), 3.84–3.97 (m, 5.8H), 3.75 (dd, J = 11.4, 4.5 Hz, 
0.99H), 3.38–3.50 (m, 1.9H), 2.94 (dt, J = 9.9, 7.5Hz, 1.0H), 2.55–2.67(m, 2.1H), 2.49 
(br s, 0.84H), 1.97–2.16 (m, 3.0H), 1.69–1.95 (m, 4.0H), 1.49–1.68 (m, 5.9H), 1.19–1.34 
(m, 2.4H), 1.17 (s, 8.8H); 13C NMR (75 MHz, CDCl3, major diastereomer): δ 136.75, 
122.02, 118.15, 76.42, 68.28, 65.11, 64.49, 63.99, 62.65, 48.29, 48.02, 47.39, 41.95, 
37.60, 35.73, 29.96, 29.23, 27.37, 26.05, 23.43. 
(1H NMR filename: panpan106-322-1; 13C NMR filename: panpan106-322-t1; notebook 














































Compound 4.9. To a solution of 3.44 (0.289 g, 0.792 mmol, 1.0 equiv.) in MeOH (ACS 
grade, 16 mL) was added K2CO3 (0.329 g, 2.377 mmol, 3 equiv.). The mixture was 
stirred at room temperature for 4 hours and then concentrated to remove all of the 
solvent. The residue was partitioned between EtOAc (40 mL) and brine (10 mL). The 
organic layer was separated, dried over anhydrous Na2SO4. After filtration and 
concentration, the crude 4.9 (Rf = 0.23, 0.17, hexanes/EtOAc 2:1) obtained was used in 
the next step without further purification. An analytical sample was purified by flash 
column chromatography (hexanes/EtOAc 4:1), with one pure diastereomer 4.9a (Rf = 
0.23, hexanes/EtOAc 2:1) was obtained as a colorless oil and fully characterized. IR (thin 
film): 3444, 2959, 2880, 1692, 1438, 1352, 1318, 1221, 1161, 1104, 1065, 1022 cm-1; 1H 
NMR (400 MHz, CDCl3): δ 5.38 (C-14H, app t, J = 1.6 Hz, 1H), 4.06 (C-13H, br s, 1H), 
3.84–3.98 (C-17,18H, m, 4H), 3.44 (OH, br s, 1H), 3.17 (C-4H, q, J = 8.8 Hz, 1H), 2.64 
(C-7H, dt, J = 13.2, 8.0 Hz, 1H), 2.58 (C-5H, t, J = 10.0 Hz, 1H), 2.38 (C-8H, dd, J = 
18.8, 7.6 Hz, 1H), 2.17 (C-16H, s, 3H), 1.99 (C-6H, ddd, J = 13.6, 8.0, 2.0 Hz, 1H), 1.90 
(C-8H, br d, J = 18.8 Hz), 1.73–1.84 (C-2,3H, m, 2H), 1.66 (C-16H, d, J = 1.6 Hz, 3H), 
1.57–1.63 (C-2H, m, 1H), 1.43 (C-6H, td, J = 13.2, 10.4 Hz, 1H), 1.13–1.23 (C-3H, m, 
1H); 13C NMR (100 MHz, CDCl3): δ 215.56 (C-11), 134.52 (C-15), 125.23 (C-14), 
118.17 (C-1), 70.45 (C-13), 65.20 (C-17 or C-18), 64.53 (C-17 or C-18), 62.98 (C-12), 
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48.03 (C-4), 46.84 (C-5), 37.70 (C-7), 36.14 (C-2), 32.44 (C-6), 31.65 (C-8), 31.62 (C-
10), 26.39 (C-3), 23.15 (C-16); HRMS (ESI) calcd. for C17H24NaO4 [M+Na]+ 315.1572 
found 315.1565. 
(1H NMR, 13C NMR, gCOSY, and HSQCAD filename: pan105-114-1; NOESY 






















Compound 4.10. To a solution of 3.44 (1.556 g, 4.27 mmol, 1.0 equiv.) in CH2Cl2 (ACS 
grade, 43 mL) was added TBAF (1.228 g, 4.70 mmol, 1.1 equiv.). The reaction was 
stirred at room temperature for 12 hours and NaHCO3 (1.434g, 17.07 mmol, 4.0 equiv.) 
was added. Dess-Martin periodinane (2.534 g, 5.98 mmol, 1.4 equiv.) was then added in 
portions over 5 minutes. The suspension was stirred for 6 hours then quenched with sat. 
Na2S2O3 (10 mL) and sat. NaHCO3 (20 mL). After stirring for another 6 hours, the 
organic layer was separated and the aqueous layer was extracted with EtOAc (2 x 20 
mL). The combined organic layer was washed with brine (20 mL), dried over anhydrous 
Na2SO4, filtered and concentrated. The residue was purified by flash column 
chromatography (hexanes/EtOAc, 4:1) to afford 4.10 (1.18g, 95%, Rf = 0.28, 
hexanes/EtOAc 4:1) as a white solid. m.p. = 111–113 °C; IR (thin film): 2959, 2888, 
1702, 1658, 1355, 1197, 1094 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.81–5.83 (m, 1H), 
3.80–3.91 (m, 4H), 3.64 (q, J = 8.7 Hz, 1H), 2.73–2.92 (m, 2H), 2.39 (t, J = 9.9 Hz, 1H), 
2.15 (d, J = 19.2 Hz, 1H), 2.03 (s, 3H), 1.87 (s, 3H), 1.81 (td, J = 6.0, 1.5 Hz, 1H), 1.67–
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1.76 (m, 2H), 1.53–1.65 (m, 1H), 1.38 (td, J = 13.2, 10.5 Hz, 1H), 0.99–1.11 (m, 1H); 13C 
NMR (75 MHz, CDCl3): δ 204.38, 196.13, 161.54, 124.74, 117.96, 73.93, 65.15, 64.45, 
46.70, 46.63, 37.16, 35.74, 32.03, 30.25, 27.67, 25.17, 24.69; HRMS (ESI) calcd. for 
C17H23O4 [M+H]+ 291.1591 found 291.1595. 
(1H NMR filename: panpan105-306-1; 13C NMR filename: panpan105-306-t1; notebook 










LiHMDS, Et2O, !78 °C











Compound 4.20. To a stirred solution of 4.10 (0.6663 g, 2.295 mmol, 1.0 equiv.) in Et2O 
(23 mL) at –78 ºC (dry ice/acetone bath) was added solid LiHMDS (Aldrich, 0.4608 g, 
2.754 mmol, 1.2 equiv.). The solution was stirred at –78 ºC for 40 minutes before cooling 
bath was removed. The flask was allowed to warm to room temperature over 20 minutes 
and then cooled down to –78 ºC. Methyl cyanoformate (0.22 mL, 2.754 mmol, 1.2 
equiv.) was added and the solution was allowed to warm to room temperature on its own 
with stirring overnight. Sat. NaHCO3 (12 mL) was then added to quench the reaction. 
The organic layer was separated and the aqueous layer was extracted with EtOAc (2 x 15 
mL). The combined organic layer was washed with brine (15 mL), dried over anhydrous 
Na2SO4, filtered and concentrated. The residue was purified by flash column 
chromatography (hexanes/EtOAc, 7:1 to give 4.20 then 1:1 to give recovered 4.10) to 
afford recovered 4.10 (0.2392 g, 36%) and 4.20 (0.4814 g, 60%, 94% brsm) as a colorless 
oil (contains ~8% enol ester forms, Rf = 0.14, hexanes/EtOAc 4:1). IR (thin film): 2955, 
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2888, 1746, 1703, 1658, 1437, 1321, 1236, 1152, 1017 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 12.37 (s, 0.08H), 5.84 (s, 1H), 5.05 (s, 0.08H), 3.79–3.90 (m, 6.3H), 3.77 (s, 
0.76H), 3.50–3.70 (m, 4.9), 3.44 (d, J = 2.4 Hz, 2H), 2.64–3.02 (m, 3.1H), 2.06–2.55 (m, 
3.5H), 2.04 (s, 0.84H), 1.98 (s, 0.49H), 1.34–1.88 (m, 13H), 0.96–1.12 (m, 1.8H); 13C 
NMR (75 MHz, CDCl3, β-keto ester form): δ 198.90, 195.39, 167.66, 162.08, 124.84, 
117.72, 73.67, 65.14, 64.47, 52.45, 47.26, 46.83, 46.31, 37.06, 35.76, 31.84, 30.13, 25.13, 
24.80; HRMS (ESI) calcd. for C19H25O6 [M+H]+ 349.1646 found 349.1644. 
(1H NMR filename: panpan106-501; 13C NMR filename: panpan106-t501; notebook #: 










KHMDS, THF, !78 °C











Compound 4.21. To a stirred solution of 4.10 (0.0617 g, 212 µmol, 1.0 equiv.) in THF (4 
mL) at –78 ºC (dry ice/acetone bath) was added KHMDS (0.5M in toluene, 467 µL, 234 
µmol, 1.1 equiv.). The solution was stirred at –78 ºC for 1 hour before cooling bath was 
removed. The flask was allowed to warm to room temperature over 30 minutes and then 
cooled down to –78 ºC. Methyl chloroformate (20 µL, 255 µmol, 1.1 equiv.) was added 
and the solution was allowed to warm to room temperature on its own with stirring 
overnight. The brown solution was filtered over a short pad of silica, washed with Et2O 
(15 mL). The filtrate was concentrated and the residue was purified by flash column 
chromatography (hexanes/EtOAc, 6:1) to give 4.21 (0.0518 g, 70%) as a colorless oil (Rf 
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= 0.22, hexanes/EtOAc 4:1). 1H NMR (300 MHz, CDCl3, rotamers): δ 6.12 (s, 0.73H), 
5.82 (d, J = 1.2 Hz, 0.99H), 5.60–5.65 (m, 1H), 4.94–5.01 (m, 1.6H), 3.83–3.96 (m, 
12H), 2.98–3.13 (m, 2.7H), 2.75–2.84 (m, 0.83H), 2.41–2.62 (m, 2.6H), 2.26 (dd, J = 
15.9, 2.4Hz, 0.82H), 2.19 (s, 2.1H), 2.18 (s, 2.9H), 2.04 (ddd, J = 13.2, 7.5, 1.8 Hz, 
1.2H), 1.46–1.84 (m, 11.2H), 1.03–1.25 (m, 2.5H); 13C NMR (75 MHz, CDCl3, 
rotamers): δ 204.43, 146.06, 145.58, 139.04, 127.85, 124.61, 121.89, 118.45, 117.96, 
116.35, 65.87, 65.21, 65.19, 65.15, 64.48, 64.40, 55.69, 48.51, 47.96, 45.98, 45.87, 41.18, 
38.40, 35.76, 35.16, 31.93, 29.62, 29.32, 28.74, 28.10, 25.94, 25.17, 21.16; HRMS (ESI) 
calcd. for C19H25O6 [M+H]+ 349.1646 found 349.1647. 
(1H NMR filename: panpan106-325-1; 13C NMR filename: panpan106-325-t1; notebook 










LiHMDS, Et2O, !78 °C










Compound 4.22. To a stirred solution of 4.10 (0.0078 g, 27 µmol, 1.0 equiv.) in Et2O (2 
mL) at –78 ºC (dry ice/acetone bath) was added LiHMDS (1.0 M in THF, 27 µL, 27 
µmol, 1.0 equiv.). The solution was stirred at –78 ºC for 1 hour before cooling bath was 
removed. The flask was allowed to warm to room temperature over 20 minutes and then 
cooled down to –78 ºC. Ethyl cyanoformate (2.7 µL, 27 µmol, 1.0 equiv.) was added and 
the solution was allowed to warm to room temperature on its own over 3 hours. Sat. 
NaHCO3 (6 mL) was then added to quench the reaction. The mixture was extracted with 
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EtOAc (2 x 5 mL). The combined organic layer was washed with brine (5 mL), dried 
over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
preparative TLC (hexanes/CH2Cl2/Et2O 3:3:1) to give recovered 4.10 (0.0037 g, 47%) 
and 4.22 (0.0032 g, 33%, 62% brsm) as a pale yellow oil (Rf = 0.25, hexanes/CH2Cl2/ 
Et2O 3:3:1). 1H NMR (300 MHz, CDCl3, β-keto ester form): δ 5.86–5.89 (m, 1H), 5.45 
(q, J = 5.7 Hz, 1H), 4.12 (q, J = 7.2 Hz, 2H), 3.86–3.90 (m, 4H), 5.60–5.68 (m, 1H), 3.46 
(d, J = 3.6 Hz, 2H), 2.89–3.00 (m, 1H), 2.76–2.87 (m, 1H), 2.43 (t, J = 10.2 Hz, 1H), 2.14 
(d, J = 19.8 Hz, 1H), 1.91 (s, 3H), 1.69–1.88 (m, 4H), 1.60–1.67 (m, 1H), 1.22 (t, J = 7.2 
Hz, 3H). 










LiHMDS, Et2O, !78 °C










Compound 4.23. To a stirred solution of 4.10 (0.0079 g, 27 µmol, 1.0 equiv.) in Et2O (2 
mL) at –78 ºC (dry ice/acetone bath) was added LiHMDS (1.0 M in THF, 27 µL, 27 
µmol, 1.0 equiv.). The solution was stirred at –78 ºC for 1 hour before cooling bath was 
removed. The flask was allowed to warm to room temperature over 20 minutes and then 
cooled down to –78 ºC. Benzyl cyanoformate (4.0 µL, 27 µmol, 1.0 equiv.) was added 
and the solution was allowed to warm to room temperature on its own overnight. Sat. 
NaHCO3 (6 mL) was then added to quench the reaction. The mixture was extracted with 
EtOAc (2 x 5 mL). The combined organic layer was washed with brine (5 mL), dried 
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over anhydrous Na2SO4, filtered and concentrated. The residue was purified by 
preparative TLC (hexanes/EtOAc 2:1) to give recovered 4.10 (0.0023 g, 30%) and 4.23 
(0.0028 g, 24%, 34% brsm) as a pale yellow oil (Rf =0.12, hexanes/EtOAc 4:1). 1H NMR 
(300 MHz, CDCl3, β-keto ester form): δ 7.28–7.43 (m, 5H), 5.79–5.83 (m, 1H), 5.11 (s, 
2H), 3.82–3.93 (m, 4H), 3.58–3.68 (m, 1H), 3.53 (d, J = 10.8 Hz, 1H), 2.90–2.99 (m, 
1H), 2.74–2.84 (m, 1H), 2.42 (t, J = 9.9 Hz, 1H), 2.14–2.21 (m, 1H), 1.66–1.91 (m, 6H), 
1.59–1.65 (m, 1H), 1.37–1.49 (m, 2H), 1.02–1.16 (m, 1H).  










LiHMDS, Et2O, !78 °C











Compound 4.24. To a stirred solution of 4.10 (0.0370 g, 127 µmol, 1.0 equiv.) in Et2O 
(5 mL) at –78 ºC (dry ice/acetone bath) was added LiHMDS (1.0 M in THF, 140 µL, 140 
µmol, 1.1 equiv.). The solution was stirred at –78 ºC for 1 hour before cooling bath was 
removed. The flask was allowed to warm to room temperature over 20 minutes and then 
cooled down to –78 ºC. p-Toluenesulfonyl cyanide (0.0231 g, 127 µmol, 1.0 equiv.) was 
added and the solution was allowed to warm to room temperature on its own with stirring 
overnight. Sat. NaHCO3 (6 mL) was then added to quench the reaction. The mixture was 
extracted with EtOAc (3 x 5 mL). The combined organic layer was washed with brine (5 
mL), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified 
by flash column chromatography (hexanes/EtOAc, 2:1) to give recovered 4.10 (0.0044 g, 
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12%) and 4.24 (0.0092 g, 23%, 26% brsm) as a pale yellow oil (Rf =0.12, hexanes/EtOAc 
2:1). 1H NMR (300 MHz, CDCl3): δ 5.87–5.92 (m, 1H), 3.83–3.96 (m, 4H), 3.52–3.62 
(m, 2H), 2.92–3.01 (m, 1H), 2.76–2.86 (m, 1H), 2.44 (t, J = 9.6 Hz, 1H), 2.00–2.27 (m, 
2H), 1.65–1.94 (m, 7H), 1.46 (td, J = 13.2, 10.5 Hz, 1H), 1.02–1.14 (m, 1H). 






















Compound 4.25. To a stirred solution of β-keto ester 4.20 (0.217 g, 0.622 mmol, 1.0 
equiv.) in CH2Cl2 (4 mL) and MeOH (4 mL) at –42 ºC (dry ice/CH3CN bath) was added 
NaBH4 (0.217 g, 5.74 mmol, 9.2 equiv.). The solution was stirred at –42 ºC for 4.5 hours. 
TLC showed complete consumption of 4.20. Acetone (4 mL) was added to quench the 
additional NaBH4. The reaction was allowed to warm to room temperature over 3 hours 
and sat. NH4Cl (20 mL) was added. After stirring at room temperature for 1 hour, the 
mixture was extracted with EtOAc (3 x 15 mL). The combined organic layer was washed 
with brine (10 mL) and dried over anhydrous Na2SO4. After filtration and concentration, 
the residue obtained was purified by flash column chromatography (hexanes/EtOAc, 2:1) 
to afford 4.43 (0.180 g, 83%) as a colorless oil (inseparable diastereomers, dr 1:0.20; Rf = 
0.16, hexanes/EtOAc 2:1). IR (thin film): 3485, 2955, 2888, 1737, 1653, 1437, 1352, 
1293, 1209, 1172, 1114, 1091, 1070, 1026 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.87 (s, 
0.17H), 5.77 (s, 0.84H), 4.02–4.23 (m, 1.14H), 3.78–3.87 (m, 5.4H), 3.69 (s, 0.54H), 3.61 
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(s, 3H), 3.06–3.23 (m, 2.5H), 2.66–2.75 (m, 1H), 2.47–2.59 (m, 2.5H), 2.31–2.40 (m, 
1.3H), 2.01–2.24 (m, 3H), 1.70–1.89 (m, 7.5H), 1.53–1.60 (m, 1.7H), 1.36–1.47 (m, 
1.7H), 0.93–1.12 (m, 1.6H); 13C NMR (75 MHz, CDCl3, major diastereomer): δ 202.10, 
173.61, 159.76, 125.23, 118.25, 68.80, 65.00, 64.32, 60.81, 52.04, 46.50, 46.19, 38.24, 
37.14, 35.80, 32.02, 30.84, 24.68, 24.61; HRMS (ESI) calcd. for C19H26NaO6 [M+Na]+ 
373.1622 found 373.1618. 























Compound 4.26. To a stirred solution of 4.25 (0.165 g, 0.47 mmol, 1.0 equiv.) in 
pyridine (4.7 mL) at 0 ºC (ice-water bath) was added MsCl (146 µL, 1.88 mmol, 4 
equiv.). The solution was allowed to warm to room temperature on its own overnight 
with stirring. Sat. NaHCO3 (10 mL) was added carefully and the mixture was extracted 
with EtOAc (3 x 6 mL). The combined organic layer was washed with brine (10 mL) and 
dried over anhydrous Na2SO4. After filtration and concentration, the residue obtained was 
purified by flash column chromatography (hexanes/EtOAc, 2:1) to afford 4.45 (0.197 g, 
98%) as a colorless oil (inseparable diastereomers, dr 1:0.16; Rf = 0.19, hexanes/EtOAc 
2:1). IR (thin film): 2957, 1738, 1656, 1438, 1342, 1289, 1205, 1172, 1094, 1021 cm-1; 
1H NMR (300 MHz, CDCl3, major diastereomer): δ 5.85 (s, 0.19H), 5.72 (s, 1H), 5.17–
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5.24 (m, 1.2H), 3.73–3.83 (m, 5.8H), 3.61 (s, 0.56H), 3.58 (s, 2.8H), 3.12–3.25 (m, 
1.3H), 3.00 (s, 0.43H), 2.98 (s, 3H), 2.79–2.89 (m, 2.3H), 2.59–2.70 (m, 2.2H), 2.10–2.24 
(m, 2.6H), 1.80–1.88 (m, 2.4H), 1.63–1.76 (m, 4.1H), 1.50–1.57 (m, 1.6H), 1.24–1.42 
(m, 3H); 13C NMR (75 MHz, CDCl3, major diastereomer): δ 198.96, 171.20, 160.80, 
123.88, 117.71, 77.68, 65.03, 64.36, 60.82, 52.27, 46.37, 44.75, 39.30, 37.38, 36.30, 
30.68, 29.64, 24.92, 24.65; HRMS (ESI) calcd. for C20H28NaO6S [M+Na]+ 451.1403 
found 451.1405. 






















Compound 4.27. To a 10-mL vial, 4.26 (0.0043 g, 10 µmol, 1.0 equiv.) was dissolved in 
EtOAc (ACS grade, 2 mL). 5 wt. % Pd/C (0.0043 g) was added and the vial was put in a 
hydrogenation vessel. H2 (80 psi) was filled and then released. This process was repeated 
twice and the vessel was filled with H2 (80 psi) and sealed. After stirring at room 
temperature for 1 day, H2 was released and the mixture was filtered over Büchner funnel 
at reduced pressure and washed with EtOAc. The filtrate was concentrated and the crude 
4.27 obtained was used in the next step without further purification. The 1H NMR (300 
MHz, CDCl3) of crude 4.27 shows that the enone was reduced.  






















Compound 4.28. To a stirred solution of crude 4.27 (10 µmol, 1.0 equiv., theoretical) 
obtained above in THF (ACS grade, 1.5 mL) was added DBU (0.1 M in THF, 120 µL, 12 
µmol, 1.2 equiv.). The reaction was stirred at room temperature overnight and filtered 
over a short pad of silica, washed with EtOAc (5 mL). The filtrate was concentrated and 
the crude 4.28 obtained was used in the next step without further purification. The 1H 
NMR (300 MHz, CDCl3) of crude 4.28 shows that the presence of trans-α, β-unsaturated 
ester (J = 16.2 Hz).  


















63% over 4 steps
 
Compound 4.29 from 4.28. To a stirred solution of 4.28 (10 µmol, 1.0 equiv., 
theoretical) obtained above in EtOAc (ACS grade, 2 mL) was added 5 wt. % Pd/C 
(0.0043 g). A balloon of H2 was attached and the reaction was stirred at room 
temperature for 12 hours. The mixture was filtered over a short pad of silica and washed 
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with EtOAc (5 mL). The filtrate was concentrated to give crude 4.29, the 1H NMR (300 
MHz, CDCl3) of which showed the trans-α, β-unsaturated ester moiety was reduced. 










5 wt. % Pd/C, 5 wt. % Rh/Al2O3








H2, 80 psi, EtOAc, r.t., 24h
90% for one-pot
 
Compound 4.29 from 4.26. To a 100-mL hydrogenation vessel, 4.26 (0.201 g, 0.47 
mmol, 1.0 equiv.) was dissolved in EtOAc (ACS grade, 7 mL). 5 wt. % Pd/C (0.2 g) and 
5 wt. % Rh/Al2O3 (0.2 g) were added and the vessel was sealed. H2 (80 psi) was filled 
and then released. This process was repeated twice and the vessel was refilled with H2 
(80 psi) and sealed. After stirring at room temperature for 1 day, H2 was released and 
TLC showed complete consumption of 4.26. DBU (84 µL, 0.56 mmol, 1.2 equiv.) was 
then added and the vessel was resealed, refilled with H2 (80 psi). The reaction was stirred 
at room temperature for another 12 hours and then filtered over Büchner funnel at 
reduced pressure and washed with EtOAc. The filtrate was concentrated and the residue 
obtained was purified by flash column chromatography (hexanes/EtOAc, 4:1) to afford 
title compound (0.142 g, 90%) as a colorless oil (Rf = 0.29, hexanes/EtOAc 4:1). IR (thin 
film): 2955, 1737, 1702, 1438, 1317, 1173, 1127, 1094, 1019 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 3.80–3.88 (m, 4H), 3.59 (s, 3H), 3.14–3.23 (m, 1H), 2.35 (t, J = 9.9 Hz, 1H), 
2.02–2.27 (m, 6H), 1.83–1.96 (m, 1H), 1.52–1.78 (m, 7H), 1.20–1.33 (m, 2H), 0.96 (d, J 
= 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3, major diastereomer): δ 214.80, 173.67, 
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118.18, 65.01, 64.43, 60.54, 51.86, 46.89, 46.22, 45.88, 43.14, 36.09, 31.75, 30.39, 30.33, 
29.01, 28.03, 24.28, 22.69; HRMS (ESI) calcd. for C19H29O5 [M+H]+ 337.2015 found 
337.2017. 


















Compound 4.30. To a stirred solution of 4.29 (0.148 g, 0.44 mmol, 1.0 equiv.) in THF 
(4.5 mL) at room temperature was added LiAlH4 (0.033 g, 0.88 mmol, 2.0 equiv.) in two 
portions. The reaction was stirred at room temperature for 12 hours then acetone (3 mL) 
was added to quench the additional LiAlH4. After stirring for 1 hour, 1M HCl was added 
slowly to adjust the pH to 3 (pH paper) and the mixture was stirred overnight. Brine (10 
mL) was added and the mixture was extracted with EtOAc (3 x 8 mL). The combined 
organic layer was washed successively with sat. NaHCO3 (8 mL) and brine (8 mL), dried 
over anhydrous Na2SO4. After filtration and concentration, the crude 4.30 was obtained 
and used in the next step without further purification. An analytical sample was purified 
by flash column chromatography (hexanes/EtOAc, 1:2) and obtained as a colorless oil (Rf 
= 0.10, hexanes/EtOAc 1:2). IR (thin film): 3385, 2951, 2919, 1729, 1459, 1052, 1022 
cm-1; 1H NMR (400 MHz, CDCl3): δ 3.67–3.72 (m, 1H), 3.57–3.64 (m, 1H), 3.49 (dd, J 
= 12.0, 3.6 Hz, 1H), 3.19 (dt, J = 10.4, 8.4 Hz, 1H), 2.71–2.77 (m, 1H), 2.18–2.28 (m, 
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2H), 1.53–2.10 (m, 12H), 1.46–1.50 (m, 1H), 1.24–1.38 (m, 2H), 1.11 (ddd, J = 14.0, 
12.4, 4.4 Hz, 1H), 0.93 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 222.81, 
74.30, 64.31, 51.50, 48.59, 47.79, 44.30, 40.29, 39.90, 32.22, 32.03, 29.54, 26.91, 26.86, 
23.30, 22.29; HRMS (ESI) calcd. for C16H25O2 [M+H–H2O]+ 249.1855 found 249.1850. 


















Compound 4.31. (Note: open flask reaction) To a 25-mL round-bottomed flask equipped 
with reflux condenser, 4.43 (0.44 mmol, 1.0 equiv., theoretical) was dissolved in CH2Cl2 
(ACS grade, 4.4 mL). NaHCO3 (0.221 g, 2.63 mmol, 6.0 equiv.) was added and the 
reaction was cooled to 0 ºC (ice-water bath). m-CPBA (77%, 0.197 g, 0.88 mmol, 2.0 
equiv.) was then added and the reaction was allowed to warm to room temperature on its 
own. After 24 hours, sat. Na2S2O3 (4 mL) was added to quench the reaction. Sat. Na2CO3 
(6 mL) was added and the mixture was extracted EtOAc (3 x 10 mL). The combined 
organic layer was washed with brine (10 mL), dried over anhydrous Na2SO4. After 
filtration and concentration, the residue was purified by flash column chromatography 
(hexanes/EtOAc, 1:2 to 1:3) to afford 4.31 (0.113 g, 91% over 2 steps) as a colorless oil 
(Rf = 0.11, EtOAc). IR (thin film): 3386, 2950, 2923, 1722, 1460, 1325, 1244, 1195, 
1176, 1114, 1053 cm-1; 1H NMR (400 MHz, CDCl3): δ 4.91 (td, J = 7.6, 2.4 Hz, 1H), 
3.58–3.70 (m, 2H), 3.48 (dd, J = 12.0, 4.0 Hz, 1H), 2.76 (dt, J = 12.4, 7.2 Hz, 1H), 2.58 
(dt, J = 16.8, 2.8 Hz, 1H), 1.90–2.29 (m, 7H), 1.24–1.86 (m, 9H), 1.12 (ddd, J = 14.0, 
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12.4, 4.8 Hz, 1H), 0.94 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 173.69, 
81.82, 74.97, 63.92, 50.23, 45.21, 41.21, 39.96, 36.57, 32.40, 30.86, 28.90, 26.85, 25.81, 
22.23, 20.56; HRMS (ESI) calcd. for C16H27O4 [M+H]+ 283.1909 found 283.1905. 















1) TBSCl, imid., CH2Cl2, r.t.
2) Ac2O, py., r.t.
3) TBAF, THF, r.t.
90% over 3 steps
 
Compound 4.33. To a stirred solution of 4.31 (0.110 g, 0.39 mmol, 1.0 equiv.) in CH2Cl2 
(5 mL) was added imidazole (0.040 g, 0.58 mmol, 1.5 equiv.) and TBSCl (0.070 g, 0.47 
mmol, 1.2 equiv.). The reaction was stirred at room temperature for 6 hours and sat. 
NaHCO3 (10 mL) was added. The organic layer was separated and the aqueous layer was 
extracted with EtOAc (2 x 7 mL). The combined organic layer was washed with brine (6 
mL) and dried over anhydrous Na2SO4. After filtration and concentration, the crude TBS 
ether was obtained and used in the next step directly.  
        To a stirred solution of TBS ether (0.39 mmol, 1.0 equiv., theoretical) in pyridine (5 
mL) was added acetic anhydride (0.11 mL, 1.17 mmol, 3.0 equiv.). After 6 hours at room 
temperature, sat NaHCO3 (10 mL) was added slowly to quench the reaction. The mixture 
was extracted with EtOAc (3 x 10 mL) and the combined organic layer was washed with 
brine (10 mL), dried over anhydrous Na2SO4. After filtration and concentration, the crude 
acetate was obtained and used in the next step directly. 
        To a stirred solution of acetate (0.39 mmol, 1.0 equiv., theoretical) in THF (ACS 
grade, 6 mL) was added TBAF (0.106 g, 0.41 mmol, 1.2 equiv.). After 16 hours at room 
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temperature, the mixture was filtered over a short pad of silica and washed with EtOAc 
(10 mL). The filtrate was concentrated and the crude obtained was purified by flash 
column chromatography (hexanes/EtOAc, 1:2 to 1:3) to afford 4.33 (0.114 g, 90% over 3 
steps) as a colorless oil (Rf = 0.11, hexanes/EtOAc 1:2). IR (thin film): 3437, 2953, 1730, 
1553, 1458, 1374, 1246, 1197, 1175, 1026 cm-1; 1H NMR (400 MHz, CDCl3): δ 4.95–
4.99 (m, 1H), 4.77 (dd, J = 12.0, 4.0 Hz, 1H), 3.60–3.70 (m, 2H), 2.58 (dt, J = 16.4, 3.2 
Hz, 1H), 2.18–2.36 (m, 4H), 2.07 (s, 3H), 1.53–2.00 (m, 11H), 1.38–1.46 (m, 1H), 1.14–
1.22 (m, 1H), 0.94 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 173.14, 171.16, 
81.48, 76.51, 63.66, 49.21, 44.67, 41.53, 36.38, 36.02, 31.96, 30.62, 29.26, 26.63, 26.61, 
21.95, 21.51, 20.06; HRMS (ESI) calcd. for C18H28NaO5 [M+Na]+ 347.1834 found 
347.1820. 
(1H NMR filename: pan206-6-2; 13C NMR filename: pan206-6-t1; notebook #: 00946, 















PhMe/THF (v/v 2:1), r.t.
77%
 
Compound 4.34. To a stirred solution of 4.33 (0.058 g, 178 µmol, 1.0 equiv.), 2-
nitrobenzenesulfonamide (0.054 g, 267 µmol, 1.5 equiv.), and Ph3P (0.065 g, 249 µmol, 
1.4 equiv.) in THF (1 mL) and toluene (2 mL) at room temperature was added dropwise 
DEAD (40 wt. % in toluene, 114 µL, 249 µmol, 1.4 equiv.). After stirring at room 
temperature for 1 day, all of the volatiles were removed by rotavap. To the residue, EtOH 
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(1 mL) was added and the precipitate was filtered over a cotton plug, washed with EtOH 
(3 mL). The filtrate was concentrated and the residue obtained was purified by flash 
column chromatography (hexanes/EtOAc, 1:2) to give 4.34 (0.070 g, 77%; Rf = 0.29, 
hexanes/EtOAc 1:2) as a colorless oil. IR (thin film): 2954, 1726, 1593, 1542, 1419, 
1366, 1342, 1245, 1166, 1125, 1058, 1026 cm-1; 1H NMR (400 MHz, CDCl3, major 
diastereomer): δ 9.57 (br s, 1H), 8.11–8.15 (m, 1H), 7.84–7.88 (m, 1H), 7.73–7.78 (m, 
2H), 5.44 (t, J = 6.0 Hz, 1H), 4.90–4.94 (m, 1H), 4.72 (dd, J = 12.0, 4.0 Hz, 1H), 3.08 (q, 
J = 6.4 Hz, 2H), 2.54 (dt, J = 16.4, 3.2 Hz, 1H), 2.15–2.31 (m, 4H), 2.03 (s, 3H), 1.04–
1.95 (m, 11H), 0.91 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3, major 
diastereomer): δ 172.90, 171.00, 148.26, 133.85, 132.97, 131.18, 125.54, 99.63, 81.27, 
76.25, 49.20, 44.86, 44.48, 41.68, 36.34, 35.97, 31.87, 30.53, 27.73, 26.62, 26.59, 21.91, 
21.48, 20.14; HRMS (ESI) calcd. for C24H33N2O8S [M+H]+ 509.1958 found 509.1967. 


















Compound 4.32. To a solution of 4.34 (0.0211 g, 41.5 µmol, 1.0 equiv.) in MeOH (ACS 
grade, 2 mL) was added K2CO3 (0.023 g, 166.0 µmol, 4.0 equiv.). The mixture was 
stirred at room temperature for 1 day and then concentrated to remove all of the solvent. 
Brine (5 mL) and 1M HCl (2 mL) were added and the mixture was extracted with EtOAc 
(3 x 5 mL). The combined organic layer was dried over anhydrous Na2SO4, filtered and 
 180 
concentrated. The residue was purified by preparative TLC (hexanes/EtOAc 1:2) to 
afford recovered 4.34 (0.010 g, 47%) and 4.32 (0.009 g, 46%) as a colorless oil (Rf = 
0.12, hexanes/EtOAc 1:2). IR (thin film): 3356, 2925, 1724, 1542, 1414, 1364, 1340, 
1244, 1166, 1124 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.10–8.16 (m, 1H), 7.84–7.90 (m, 
1H), 7.72–7.79 (m, 2H), 5.47 (t, J = 6.0 Hz, 1H), 4.85–4.91 (m, 1H), 3.50 (dd, J = 12.0, 
3.9 Hz, 1H), 3.02–3.13 (m, 2H), 2.71 (dt, J = 12.3, 7.2 Hz, 1H), 2.57 (app dt, J = 16.8, 
3.0 Hz, 1H), 2.07–2.28 (m, 3H), 1.88–1.98 (m, 2H), 1.44–1.83 (m, 9H), 1.30–1.37 (m, 
1H), 0.98–1.08 (m, 1H), 0.92 (d, J = 6.3 Hz, 3H); 13C NMR (100 MHz, CDCl3, major 
diastereomer): δ 173.22, 134.06, 133.75, 132.98, 131.29, 125.61, 81.53, 74.84, 49.99, 
45.14, 45.03, 40.98, 40.13, 36.54, 32.37, 30.78, 29.92, 26.81, 26.72, 26.54, 22.15, 20.61; 
HRMS (ESI) calcd. for C22H31N2O7S [M+H]+ 467.1852 found 467.1845. 

















1) NaBH4, EtOH, r.t.
2) TBSCl, imid., CH2Cl2, r.t.
 
Compound 4.37. To a stirred solution of 4.34 (0.060 g, 118 µmol, 1.0 equiv.) in absolute 
EtOH (4 mL) at room temperature was added NaBH4 (0.026 g, 687 µmol, 5.8 equiv.). 
The reaction was stirred at room temperature for 12 hours, then sat. NH4Cl (6 mL) was 
added. The mixture was extracted with EtOAc (3 x 6 mL) and the combined organic layer 
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was washed with brine (6 mL), dried over anhydrous Na2SO4. After filtration and 
concentration, the crude diol was obtained (Rf = 0.12, hexanes/EtOAc 1:2) and used in 
the next step directly.  
        To a stirred solution of diol (118 µmol, 1.0 equiv., theoretical) obtained above in 
CH2Cl2 (5 mL) was added imidazole (0.0482 g, 708 µmol, 6.0 equiv.) and TBSCl 
(0.0709 g, 472 µmol, 4.0 equiv.). The reaction was stirred at room temperature for 5 
hours and then sat. NaHCO3 (10 mL) was added. The mixture was extracted with EtOAc 
(3 x 7 mL). The combined organic layer was washed with brine (6 mL) and dried over 
anhydrous Na2SO4. After filtration and concentration, the crude obtained was used in the 
next step directly without further purification. An analyticcal sample was purified by 
preparative TLC (hexanes/EtOAc, 3:1) to give 4.37 as a colorless oil (Rf = 0.30, 
hexanes/EtOAc 2:1). IR (thin film): 3356, 2929, 1727, 1543, 1461, 1364, 1249, 1167, 
1093, 1024 cm-1; 1H NMR (400 MHz, CDCl3): δ 8.13–8.18 (m, 1H), 7.85–7.90 (m, 1H), 
7.72–7.78 (m, 2H), 5.29 (t, J = 6.0 Hz, 1H), 4.68 (dd, J = 12.0, 4.0 Hz, 1H), 4.24 (t, J = 
4.4 Hz, 1H), 3.58–3.68 (m, 2H), 3.06–3.17 (m, 2H), 2.33–2.39 (m, 1H), 2.03 (s, 3H), 
1.36–1.79 (m, 15H), 1.26 (br s, 1H), 0.80–1.13 (m, 14H), 0.06 (s, 5H); 13C NMR (100 
MHz, CDCl3): δ 171.14, 148.39, 134.20, 133.65, 132.95, 131.35, 125.60, 81.96, 72.51, 
63.40, 55.64, 46.54, 45.08, 39.40, 38.14, 36.65, 33.42, 32.02, 27.12, 26.16, 25.91, 25.28, 
22.14, 21.87, 21.50, 18.58, 5.09, 5.13; HRMS (ESI) calcd. for C30H50N2NaO8SSi 
[M+Na]+ 649.2955 found 649.2961. 
(1H NMR filename: pan208-1-1; 13C NMR filename: pan208-1-t2; notebook #: 00933, 
















cat. DMAP, Ac2O, py., r.t.
4.38
75% over 3 steps
 
Compound 4.38. To a stirred solution of 4.37 (118 µmol, 1.0 equiv., theoretical) in 
pyridine (3 mL) was added acetic anhydride (67 µL, 708µmol, 6.0 equiv.). After stirring 
at room temperature overnitht, sat NaHCO3 (10 mL) was added slowly to quench the 
reaction. The mixture was extracted with EtOAc (3 x 10 mL) and the combined organic 
layer was washed with brine (10 mL), dried over anhydrous Na2SO4. After filtration and 
concentration, the crude obtained was purified by flash column chromatography 
(hexanes/EtOAc, 3:1) to give 4.38 (0.0630 g, 75% over 3 steps) as a colorless oil (Rf = 
0.38, hexanes/EtOAc 2:1). IR (thin film): 2954, 1732, 1544, 1459, 1369, 1240, 1171, 
1095, 1022 cm-1; 1H NMR (400 MHz, CDCl3): δ 8.34–8.39 (m, 1H), 7.75–7.82 (m, 3H), 
5.24–5.26 (m, 1H), 4.73 (dd, J = 11.6, 4.0 Hz, 1H), 3.79 (t, J = 8.0 Hz, 2H), 3.52–3.61 
(m, 2H), 2.36–2.42 (m, 1H), 2.30 (s, 3H), 2.06 (s, 6H), 1.39–1.94 (m, 14H), 1.14–1.23 
(m, 2H), 0.94 (d, J = 6.4 Hz, 3H), 0.89 (s, 9H), 0.04 (d, J = 1.2 Hz, 6H); 13C NMR (100 
MHz, CDCl3): δ 171.04, 170.72, 170.18, 148.17, 134.76, 134.19, 133.37, 132.17, 124.79, 
82.09, 75.97, 63.50, 54.32, 48.91, 46.62, 39.86, 36.64, 36.46, 33.44, 32.58, 27.21, 26.88, 
26.20, 24.63, 24.32, 22.92, 22.12, 21.49, 21.45, 18.56, –5.07. HRMS (ESI) calcd. for 
C34H54N2NaO10SSi [M+Na]+ 733.3161 found 733.3155. 





















Compound 4.39. To a stirred solution of 4.38 (0.0375 g, 48 µmol, 1.0 equiv.) in THF 
(ACS grade, 3 mL) at room temperature was added TBAF·xH2O (0.0150 g, 57 µmol, 1.2 
equiv.). After 4 days at room temperature, the mixture was filtered over a short pad of 
silica, washed with EtOAc (15 mL). The filtrate was concentrated and the crude obtained 
was purified by flash column chromatography (hexanes/EtOAc, 1:2) to give 4.39 (0.0171 
g, 64%) as a colorless oil (Rf = 0.14, hexanes/EtOAc 1:1). IR (thin film): 3320, 2953, 
1728, 1543, 1441, 1372, 1246, 1166, 1126, 1023 cm-1; 1H NMR (400 MHz, CDCl3): δ 
8.13–8.19 (m, 1H), 7.84–7.90 (m, 1H), 7.73–7.79 (m, 2H), 5.55 (t, J = 6.0 Hz, 1H), 5.27 
(t, J = 4.4 Hz, 1H), 4.74 (dd, J = 12.0, 4.4 Hz, 1H), 3.56–3.67 (m, 2H), 3.06–3.17 (m, 
2H), 2.26–2.36 (m, 1H), 2.04 (s, 6H), 1.92–1.97 (m, 1H), 1.85 (td, J = 13.6, 4.4 Hz, 1H), 
1.39–1.75 (m, 13H), 1.05–1.18 (m, 2H), 0.91 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3): δ 171.14, 170.72, 148.32, 133.95, 133.74, 132.96, 131.34, 125.53, 81.33, 75.95, 
62.65, 53.13, 46.81, 44.74, 40.36, 36.69, 36.31, 33.30, 32.08, 27.07, 26.21, 25.40, 22.45, 
22.11, 21.54, 21.50; HRMS (ESI) calcd. for C26H38N2NaO9S [M+Na]+ 577.2190 found 
577.2211. 





















Compound 4.40. To a stirred solution of 4.39 (0.0171 g, 31 µmol, 1.0 equiv.), and Ph3P 
(0.0404 g, 154 µmol, 5.0 equiv.) in CH3CN (7.5 mL) at room temperature was added 
dropwise DEAD (40 wt. % in toluene, 70 µL, 154 µmol, 5.0 equiv.). After stirring at 
room temperature for 1 day, all of the volatiles were removed by rotavap. The residue 
was purified by flash column chromatography (hexanes/EtOAc, 1:1) to give 4.40 (0.0090 
g, 54%; Rf = 0.24, hexanes/EtOAc 1:1) as a colorless oil. IR (thin film): 2925, 2854, 
1730, 1546, 1458, 1374, 1248, 1166, 1028 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.90–
7.94 (m, 1H), 7.65–7.72 (m, 2H), 7.56–7.59 (m, 1H), 5.30–5.39 (m, 1H), 4.86–4.93 (m, 
1H), 3.42–3.62 (m, 2H), 2.85–3.04 (m, 2H), 1.07–2.24 (m, 23H), 0.90 (d, J = 6.6 Hz, 
3H); 13C NMR (75 MHz, CDCl3): δ 171.00, 170.59, 133.64, 131.85, 131.48, 130.85, 
124.10, 75.91, 75.80, 50.73, 50.42, 46.04, 45.96, 42.49, 36.22, 33.65, 32.22, 29.94, 28.88, 
26.86, 24.76, 24.10, 22.06, 21.66, 21.42, 16.99; HRMS (ESI) calcd. for C26H36N2NaO8S 
[M+Na]+ 559.2085 found 559.2093. 
(1H NMR filename: panpan106-428-1; 13C NMR filename: panpan106-428-t1; notebook 



















then acetone, 1M HCl
80% for one-pot
 
Compound 4.43. To a stirred solution of β-keto ester 4.20 (0.214 g, 0.613 mmol, 1.0 
equiv.) in CH2Cl2 (4 mL) and MeOH (4 mL) at –42 ºC (dry ice/CH3CN bath) was added 
NaBH4 (0.214 g, 5.66 mmol, 9.2 equiv.). The solution was stirred at –42 ºC for 4.5 hours. 
TLC showed complete consumption of 4.20. Acetone (4 mL) was added to quench the 
additional NaBH4. The reaction was allowed to warm to room temperature over 3 hours 
and 1 M HCl (6 mL) was added to adjust the pH to 1.0 (pH paper). The mixture was 
stirred at room temperature overnight and then extracted with EtOAc (3 x 15 mL). The 
combined organic layer was washed with sat. NaHCO3 (10 mL) and brine (10 mL), dried 
over anhydrous Na2SO4. After filtration and concentration, the residue obtained was 
purified by flash column chromatography (hexanes/EtOAc, 2:1) to afford 4.43 (0.150 g, 
80%) as a colorless oil (inseparable diastereomers, dr 1:0.14; Rf = 0.28, hexanes/EtOAc 
1:1). IR (thin film): 3470, 2953, 1735, 1653, 1437, 1173, 1116 cm-1; 1H NMR (300 
MHz, CDCl3, major diastereomer): δ 5.79 (s, 1H), 4.12 (br d, J = 10.8 Hz, 1H), 3.62 (s, 
3H), 3.37–3.46 (m, 2H), 2.71–2.79 (m, 1H), 2.51–2.62 (m, 2H), 2.33–2.46 (m, 2H), 2.15–
2.24 (m, 3H), 2.03–2.14 (m, 1H), 1.87–1.99 (m, 5H), 1.63–1.77 (m, 1H); 13C NMR (75 
MHz, CDCl3, major diastereomer): δ 221.52, 201.11, 173.43, 159.94, 125.25, 68.28, 
61.38, 52.13, 47.88, 45.10, 39.76, 38.19, 36.41, 32.89, 31.53, 24.68, 23.38; HRMS (ESI) 
calcd. for C17H23O5 [M+H]+ 307.1540 found 307.1542. 
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Compound 4.44. (Note: open flask reaction) To a 100-mL round-bottomed flask 
equipped with reflux condenser, β-hydroxy ester 4.43 (0.595 g, 1.94 mmol, 1.0 equiv.) 
was dissolved in CH2Cl2 (ACS grade, 20 mL). NaHCO3 (0.978 g, 11.64 mmol, 6 equiv.) 
was added and the reaction was cooled to 0 ºC (ice-water bath). m-CPBA (77%, 0.739 g, 
3.30 mmol, 1.7 equiv.) was then added in portions over 5 minutes and the reaction was 
allowed to warm to room temperature on its own. After 24 hours, sat. Na2S2O3 (6 mL) 
was added to quench the reaction. Sat. Na2CO3 (14 mL) was added and the mixture was 
extracted EtOAc (3 x 20 mL). The combined organic layer was washed with brine (20 
mL), dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified 
by flash column chromatography (hexanes/EtOAc, 1:1 to 1:2) to afford 4.44 (0.575 g, 
92%) as a colorless oil (inseparable diastereomers, dr 1:0.14; Rf = 0.12, hexanes/EtOAc 
1:1). IR (thin film): 3383, 1736, 1648, 1437, 1071 cm-1; 1H NMR (300 MHz, CDCl3, 
major diastereomer): δ 5.82 (s, 1H), 4.78–4.51 (m, 1H), 4.11 (br d, J = 10.8 Hz, 1H), 3.58 
(s, 3H), 2.99–3.08 (m, 1H), 2.92 (td, J = 9.6, 5.4 Hz, 1H), 2.01–2.60 (m, 9H), 1.89 (s, 
3H), 1.78–1.87 (m, 2H); 13C NMR (75 MHz, CDCl3, major diastereomer): δ 201.05, 
172.78, 172.40, 160.87, 125.71, 79.66, 68.50, 59.83, 52.14, 42.50, 38.00, 34.89, 31.84, 
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30.42, 24.80, 19.98; HRMS (ESI) calcd. for C17H23O6 [M+H]+ 323.1489 found 
323.1488. 




















0 °C to rt
 
Compound 4.45. To a stirred solution of 4.44 (0.410 g, 1.27 mmol, 1.0 equiv.) in 
pyridine (13 mL) at 0 ºC (ice-water bath) was added MsCl (0.40 mL, 5.09 mmol, 4 
equiv.). The solution was allowed to warm to room temperature on its own overnight 
with stirring. Sat. NaHCO3 (15 mL) was added carefully and the mixture was extracted 
with EtOAc (3 x 15 mL). The combined organic layer was washed with brine (15 mL) 
and dried over anhydrous Na2SO4. After filtration and concentration, the residue obtained 
was purified by flash column chromatography (hexanes/EtOAc, 2:1) to afford 4.45 (0.494 
g, 97%) as a colorless oil (inseparable diastereomers, dr 1:0.18; Rf = 0.19, 
hexanes/EtOAc 2:1). IR (thin film): 2954, 1738, 1654, 1437, 1339, 1249, 1172, 1131, 
1021 cm-1; 1H NMR (300 MHz, CDCl3, major diastereomer): δ 5.81 (s, 1H), 5.27 (dd, J 
= 8.4, 3.0 Hz, 1H), 4.54 (td, J = 8.4, 3.3 Hz, 1H), 3.61 (s, 3H), 3.19 (dt, J = 13.2, 6.6 Hz, 
1H), 3.01 (s, 3H), 2.94–2.96 (m, 1H), 2.80–2.88 (m, 1H), 2.63–2.72 (m, 1H), 2.55 (dt, J = 
16.8, 3 Hz, 1H), 1.97–2.29 (m, 4H), 1.93 (s, 3H), 1.67–1.88 (m, 3H); 13C NMR (75 
MHz, CDCl3, major diastereomer): δ 197.83, 171.82, 170.76, 161.82, 124.24, 79.03, 
76.62, 60.46, 52.49, 41.16, 39.26, 36.96, 36.82, 35.34, 30.46, 30.37, 24.78, 20.47; 
HRMS (ESI) calcd. for C18H24NaO8S [M+Na]+ 423.1084 found 423.1076. 
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5 wt. % Pd/C, 5 wt. % Rh/Al2O3
then DBU, H2, 80 psi, r.t. 12h









Compound 4.46. To a 100-mL hydrogenation vessel, 4.45 (0.494 g, 1.23 mmol, 1.0 
equiv.) was dissolved in EtOAc (ACS grade, 13 mL). 5 wt. % Pd/C (0.494 g) and 5 wt. % 
Rh/Al2O3 (0.494 g) were added and the vessel was sealed. H2 (80 psi) was filled and then 
released. This process was repeated twice and the vessel was refilled with H2 (80 psi) and 
sealed. After stirring at room temperature for 1 day, H2 was released and TLC showed 
complete consumption of 4.45. DBU (0.28 mL, 1.85 mmol, 1.5 equiv.) was then added 
and the vessel was resealed, refilled with H2 (80 psi). The reaction was stirred at room 
temperature for another 12 hours and then filtered over Büchner funnel at reduced 
pressure and washed with EtOAc. The filtrate was concentrated and the residue obtained 
was purified by flash column chromatography (hexanes/EtOAc, 2:1) to afford title 
compound (0.353 g, 93%) as a white solid (Rf = 0.16, hexanes/EtOAc 2:1). m.p. = 78–80 
°C; IR (thin film): 2955, 1737, 1699, 1437, 1248, 1191, 1132, 1033 cm-1; 1H NMR (300 
MHz, CDCl3): δ 4.65 (td, J = 7.8, 3.0 Hz, 1H), 3.63 (s, 3H), 3.20 (dt, J = 13.2, 6.9 Hz, 
1H), 2.60 (dt, J = 16.5, 3.0 Hz, 1H), 2.43–2.53 (m, 1H), 2.24–2.35 (m, 4H), 1.99–2.19 
(m, 2H), 1.67–1.96 (m, 7H), 1.49 (qd, J = 13.3, 3.3 Hz, 1H), 1.02 (d, J = 6.3 Hz, 3H); 13C 
NMR (75 MHz, CDCl3): δ 213.63, 173.06, 172.61, 80.01, 60.20, 52.14, 46.96, 43.59, 
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38.86, 36.49, 31.89, 30.42, 30.09, 29.94, 27.54, 22.45, 19.62; HRMS (ESI) calcd. for 
C17H25O5 [M+H]+ 309.1697 found 309.1698. 



















1) LiAlH4, THF, reflux
 
Compound 4.47. To a 50-mL oven dried round-bottomed flask equipped with reflux 
condenser, 4.46 (0.204 g, 0.66 mmol, 1.0 equiv.) was dissolved in THF (14 mL) and 
stirred at room temperature. LiAlH4 (0.075 g, 1.98 mmol, 3 equiv.) was added in one 
portion and the mixture was refluxed overnight. After cooling to room temperature the 
reaction was quenched by successive addition of H2O (75 µL), 15% NaOH (75 µL), and 
H2O (225 µL). The resulting slurry was stirred for another 4 hours and then filtered over 
Büchner funnel at reduced pressure, washed with EtOAc. After concentration, the crude 
tetraol obtained was used in the next step without further purification.  
        To a stirred solution of the tetraol obtained from above (0.66 mmol, theoretical, 1.0 
equiv.) in pyridine (7 mL) were added one crystal of DMAP and Ac2O (0.50 mL, 5.30 
mmol, 8 equiv.). The reaction was stirred at room temperature for 1 day and then 
quenched with sat. NaHCO3 (10 mL). The mixture was extracted with EtOAc (3 x 10 
mL), washed with brine (10 mL), and dried over anhydrous Na2SO4. After filtration and 
concentration, the crude obtained was used in the next step directly without further 
purification. An analytic sample was purified by flash column chromatography 
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(hexanes/EtOAc, 2:1) to afford 4.47 as a colorless oil (inseparable diastereomers, dr 9:1; 
Rf = 0.14, hexanes/EtOAc 4:1). IR (thin film): 2956, 1737, 1458, 1370, 1239, 1024 cm-1; 
1H NMR (300 MHz, CDCl3, major diastereomer): δ 5.17 (app t, J = 4.2 Hz, 1H), 4.63 
(dd, J = 11.4, 3.9 Hz, 1H), 3.86–4.05 (m, 4H), 2.24–2.32 (m, 1H), 1.982 (s, 3H), 1.961 (s, 
3H), 1.957 (s, 3H), 1.948 (s, 3H), 1.79–1.87 (m, 1H), 1.22–1.76 (m, 13H), 1.04–1.16 (m, 
2H), 0.84 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3, major diastereomer): δ 
171.22, 171.13, 170.92, 170.42, 81.51, 75.69, 65.26, 64.60, 53.32, 46.52, 39.86, 36.44, 
36.30, 33.17, 28.12, 27.02, 24.75, 24.22, 22.74, 22.05, 21.40, 21.36, 21.16, 21.09; 
HRMS (ESI) calcd. for C24H42NO8 [M+NH4]+ 472.2905 found 472.2900. 











MeOH/THF (v/v 1:1), r.t.









Compound 4.48. To a stirred solution of 4.47 (0.66 mmol, theoretical, 1.0 equiv.) 
obtained above in MeOH (ACS grade, 3.3 mL) and THF (ACS grade, 3.3 mL) was added 
Otera’s catalyst ([t-Bu2Sn(OH)Cl]2) (0.019 g, 33 µmol, 5 mol%). The reaction was stirred 
at room temperature for 30 hours and NEt3 (50 µL) was added to quench the reaction. 
After concentration, the residue was purified by flash column chromatography 
(hexanes/EtOAc/THF, 1:2:0.5) to afford recovered materials (0.052 g, contains mono- or 
tri- acetate, which could be recycled by reacetylation to 4.47) and 4.48 (0.208 g, 85% for 
3 steps, ≥ 95% brsm) as a colorless oil (inseparable diasteromers, dr 9:1; Rf = 0.07, 
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hexanes/EtOAc 1:2). IR (thin film): 3386, 2951, 2871, 1734, 1457, 1375, 1242, 1052, 
1023 cm-1; 1H NMR (300 MHz, CDCl3, major diastereomer): δ 5.24 (t, J = 4.5 Hz, 1H), 
4.70 (app dd, J = 12.0, 4.2 Hz, 1H), 3.47–3.74 (m, 4H), 2.71 (br s, 2H), 2.31–2.40 (m, 
1H), 2.007 (s, 3H), 2.004 (s, 3H), 1.76–1.94 (m, 2H), 1.32–1.74 (m, 12H), 1.08–1.25 (m, 
2H), 0.87 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3, major diastereomer): δ 
171.37, 170.93, 81.66, 76.17, 63.56, 62.60, 53.26, 46.66, 40.13, 36.63, 36.25, 33.17, 
32.18, 28.75, 27.09, 24.08, 22.50, 22.14, 21.55, 21.52; HRMS (ESI) calcd. for 
C20H38NO6 [M+NH4]+ 388.2694 found 388.2696. 
(1H NMR filename: pan113-001; 13C NMR filename: pan113-t001; notebook #: 01336, 
01342, 01425) 
 
























Compound 4.49. To a stirred solution of 4.48 (0.0039 g, 10.5 µmol, 1.0 equiv.), 2-
nitrobenzenesulfonamide (0.0085 g, 42 µmol, 4.0 equiv.), and Ph3P (0.0165 g, 63 µmol, 
6.0 equiv.) in THF (0.5 mL) and toluene (1 mL) at room temperature was added DEAD 
(40 wt. % in toluene, 29 µL, 63 µmol, 6.0 equiv.). The reaction was stirred at room 
temperature for 1 day. All of the solvents were removed by rotavap and to the residue 
was added Et2O (1 mL). The white precipitate was removed by filtering through a filter 
funnel with a cotton plug and washed with Et2O (3 mL). The filtrate was concentrated 
and the crude obtained was purified by preparative TLC (hexanes/EtOAc 1:1) to give 
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4.40 (0.0013 g, 23%; Rf = 0.34, hexanes/EtOAc 1:1) and 4.49 (0.0035 g, 60%, d.r. 6:1) as 
a pale yellow oil (Rf = 0.23, hexanes/EtOAc 1:1).  
Data for 4.49 (major diastereomer): IR (thin film): 3334, 2953, 1727, 1542, 1415, 1368, 
1245, 1166, 1126, 1077, 1023 cm-1; 1H NMR (400 MHz, CDCl3, N-nosyl rotamers): δ 
8.11–8.21 (m, 1.8H), 7.83–7.90 (m, 1.7H), 7.70–7.80 (m, 3.6H), 5.48 (t, J = 6.0 Hz, 1H), 
5.39 (t, J = 6.0 Hz, 1H), 5.231 (t, J = 4.4 Hz, 1H), 4.71 (dd, J = 12.0, 4.0 Hz, 1H), 3.00–
3.18 (m, 4H), 2.28–2.37 (m, 1H), 2.07 (s, 3H), 2.06 (s, 3H), 1.90–1.95 (m, 1H), 1.83 (td, 
J = 13.6, 4.4 Hz, 1H), 1.07–1.73 (m, 14H), 0.92 (d, J = 6.4 Hz, 3H); 13C NMR (100 
MHz, CDCl3, N-nosyl rotamers): δ 171.26, 170.81, 148.29, 133.87, 133.74, 133.05, 
133.01, 131.38, 131.37, 125.54, 125.50, 98.82, 81.45, 75.58, 53.33, 46.80, 44.73, 43.92, 
40.26, 36.73, 36.38, 33.28, 29.33, 27.07, 26.37, 25.27, 23.32, 22.10, 21.57, 21.52. 
(1H NMR and 13C NMR filename: pan106-429-4-1notebook #: 01057, 01062) 
 
NsNH2, Ph3P, DEAD



















Compound 4.53. To a stirred solution of 4.48 (0.0876 g, 236 µmol, 1.0 equiv.), 2-
nitrobenzenesulfonamide (0.191 g, 0.94 mmol, 4.0 equiv.), and Ph3P (0.372 g, 1.42 
mmol, 6.0 equiv.) in CH3CN (20 mL) and pyridine (4 mL) at 0 °C was added DEAD (40 
wt. % in toluene, 0.65 mL, 1.42 mmol, 6.0 equiv.) over 10 minutes. The reaction was 
allowed to warm to room temperature on its own with stirring for 24 hours. MeOH (24 
mL) and K2CO3 (0.326 g, 10.0 equiv.) were then added. A reflux condenser was added 
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and the suspension was stirred with gentle reflux overnight. After cooling to room 
temperature, the stirring bar was removed and the solution was concentrated. The residue 
was partitioned between EtOAc (15 mL) and brine (15 mL). The organic layer was 
separated and the aqueous layer was extracted with EtOAc (2 x 15 mL). The combined 
organic layer was dried over anhydrous Na2SO4, filtered and concentrated. To the 
residue, EtOH (3 mL) was added and the additional NsNH2 was precipitated as white 
solid. The solid was removed by filtering over a filter funnel with a cotton plug and 
washed with EtOH (3 x 3 mL). The filtrate was concentrated and the residue obtained 
was purified by flash column chromatography (hexanes/EtOAc, 1:1 to 1:2) to afford 4.53 
(0.054 g, 52%; Rf = 0.07, hexanes/EtOAc 1:2) as a white solid contaminated with trace 
amount of Ph3PO. An analytic sample was further purified by preparative TLC 
(hexanes/EtOAc 1:2). IR (thin film): 3385, 2925, 1545, 1373, 1343, 1164 cm-1; 1H NMR 
(400 MHz, CDCl3): δ 7.91–7.96 (m, 1H), 7.64–7.72 (m, 2H), 7.56–7.62 (m, 1H), 4.62 
(dt, J = 8.4, 6.0 Hz, 1H), 3.67–3.78 (m, 1H), 3.47–3.55 (m, 2H), 3.13 (ddd, J = 14.8, 9.6, 
4.8 Hz, 1H), 2.95 (dt, J = 13.2, 4.0 Hz, 1H), 1.51–2.31 (m, 16H), 1.22–1.31 (m, 2H), 
1.06–1.14 (m, 1H), 0.92 (d, J = 6.4, 3H); 13C NMR (100 MHz, CDCl3): δ 133.51, 
132.08, 131.45, 130.90, 124.08, 74.11, 73.02, 51.83, 50.79, 48.04, 46.39, 42.46, 40.38, 
36.91, 32.80, 29.50, 27.41, 24.55, 24.47, 22.28, 16.47; HRMS (ESI) calcd. for 
C22H33N2O5S [M+H]+ 453.2059 found 453.2061. 



















Compound 4.54. To a stirred solution of 4.53 (0.022 g, 49 µmol, 1.0 equiv.) in CH2Cl2 
(ACS grade, 2 mL) were added NaHCO3 (0.033 g, 0.39 mmol, 8.0 equiv.) and Dess-
Martin periodinane (0.084 g, 0.20 mmol, 4.0 equiv.). The suspension was stirred at room 
temperature for 6 hours then sat. Na2S2O3 (3 mL) and sat. NaHCO3 (3 mL) were added. 
After stirring for additional 1 hour, the mixture was extracted with CH2Cl2 (3 x 5 mL). 
The combined organic layer was washed with brine (5 mL) and dried over anhydrous 
Na2SO4. After filtration and concentration, the residue obtained was purified by flash 
column chromatography (hexanes/EtOAc, 1:1) to afford 4.54 (0.0195 g, 90%) as a white 
solid. m.p. = 232–235 °C (decompd.); IR (thin film): 2924, 1737, 1700, 1544, 1439, 
1373, 1347, 1168, 1128 cm-1; 1H NMR (400 MHz, CDCl3): δ 7.92 (dd, J = 5.7, 2.0 Hz, 
1H), 7.66–7.74 (m, 2H), 7.59 (dd, J = 5.4, 2.0 Hz, 1H), 3.63 (td, J = 12.8, 4.8 Hz, 1H), 
3.52 (ddd, J = 15.2, 6.0, 4.0 Hz, 1H), 2.91–2.99 (m, 2H), 2.82 (dt, J = 13.6, 4.0 Hz, 1H), 
2.60–2.66 (m, 1H), 1.60–2.41 (m, 13H), 1.48–1.54 (m, 1H), 1.23–1.34 (m, 1H), 1.09 (d, J 
= 6.0 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 218.70, 213.95, 148.88, 133.96, 131.59, 
131.12, 130.94, 124.22, 60.33, 50.14, 49.38, 46.79, 45.49, 42.42, 39.62, 31.20, 30.23, 
29.72, 24.97, 22.54, 22.07, 20.94; HRMS (ESI) calcd. for C22H29N2O6S [M+H]+ 
449.1741 found 449.1735.  


















(±)-Fawcettimine.  To a 10-mL round-bottomed flask equipped with reflux condenser, 
4.54 (0.0127 g, 30 µmol, 1.0 equiv.) was dissolved in CH3CN (3 mL). KOH (1.0 M, 300 
µmol, 0.30 mL, 10 equiv.) and PhSH (15 µL, 150 µmol, 5 equiv.) were added. The 
reaction was stirred at gentle reflux for 6 hours then cooled to room temperature. EtOAc 
(8 mL) was added and the mixture was extracted with 1 M HCl (3 x 4 mL). The 
combined aqueous layer was added solid Na2CO3 until saturation. The resulting mixture 
was extracted with 3% MeOH in CHCl3 (3 x 5 mL). The combined organic layer was 
dried over anhydrous Na2SO4. After filtration and concentration, the residue obtained was 
dissolved in CH2Cl2 and added HBr (0.1 M in H2O, 0.30 mL, 30 µmol). After standing at 
room temperature overnight, all of the volatiles were removed under vacuum. To the 
solid obtained, a minimum amount of Et2O was added, rinsed and removed by pipette. 
The (±)-fawcettimine hydrobromide salt remained was dissolved in CH2Cl2 and dried 
over anhydrous K2CO3 overnight. After filtration and concentration, (±)-fawcettimine 
(0.0073 g, 92%) was obtained as a pale yellow foam (Rf = 0.35, n-BuOH/AcOH/H2O 
7:2:2). IR (thin film): 3287, 2923, 2856, 1735, 1637, 1458, 1340, 1264, 1144, 1100, 1056 
cm-1; 1H NMR (400 MHz, CDCl3): δ 3.76–3.85 (m, 1H), 3.58–3.70 (br, 1H), 3.40 (td, J = 
14.2, 4.0 Hz, 1H), 3.03 (dd, J = 14.4, 4.8 Hz, 1H), 2.81–2.86 (m, 1H), 2.60 (dd, J = 18.0, 
13.6 Hz, 1H), 1.82–2.35 (m, 11H), 1.37–1.76 (m, 5H), 1.00 (d, J = 6.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3): δ 218.16, 59.87, 54.69, 50.59, 48.13, 43.39, 42.46, 41.65, 
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34.77, 31.80, 29.92, 27.55, 26.61, 23.94, 21.81, 20.90; HRMS (ESI) calcd. for 
C16H26NO2 [M+H]+ 264.1958 found 264.1962. Analytical data for (±)-fawcettimine 
hydrobromide: 1H NMR (400 MHz, CDCl3): δ 10.01 (br s, 1H), 5.80 (s, 1H), 4.18 (br s, 
1H), 3.51–3.64 (m, 1H), 3.21 (br d, J = 11.2 Hz, 1H), 3.02 (br s, 1H), 2.81 (d, J = 12.4 
Hz, 1H), 2.60 (dd, J = 16.8, 12.4 Hz, 1H), 1.82–2.46 (m, 12H), 1.75 (br d, J = 14.0 Hz, 
1H), 1.64 (d, J = 12.8 Hz, 1H), 1.48 (td, J = 13.4, 4.8 Hz, 1H), 1.05 (d, J = 6.0 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 216.16, 96.33, 59.22, 55.98, 51.56, 47.68, 43.29, 41.20, 
40.27, 33.54, 31.38, 26.75, 24.19, 23.96, 21.64, 19.19. 
(1H NMR filename: pan117-002, pan117-1; 13C NMR filename: pan117-t003, pan106-














(±)-Fawcettidine. To a 10-mL round-bottomed flask equipped with reflux condenser, 
fawcettimine (0.0054 g, 20 µmol, 1.0 equiv.) and oxalic acid (0.0540 g, 0.6 mmol, 29.0 
equiv.) were dissolved in AcOH (2 mL). Oxygen was carefully removed through a 
freeze-pump-thaw cycles for 3 times. The flask was refilled with Ar and the reaction was 
stirred at 160 °C for 12 hours. After cooling to room temperature, n-heptane was added 
and all the volatiles were removed under vacuum. To the residue, aq. 5% NH3⋅H2O 
solution (5 mL) was added and the resulting mixture was extracted with 3% MeOH in 
CHCl3 (4 x 4 mL). The combined organic layer was dried over anhydrous Na2SO4. After 
filtration and concentration, the crude obtained was purified by flash column 
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chromatography (basic alumina, hexanes/EtOAc, 2:1 then 3% MeOH in CHCl3) to afford 
title compound (0.0040 g, 80%) as a white foam (Rf = 0.24, MeOH/CHCl3 5:95). IR (thin 
film): 2924, 2848, 1737, 1662, 1549, 1447, 1328, 1302, 1253, 1216, 1193, 1169, 1149, 
1105, 1030 cm-1; 1H NMR (400 MHz, CDCl3): δ 5.69 (d, J = 4.8 Hz, 1H), 2.97–3.15 (m, 
4H), 2.74 (ddd, J = 16.8, 7.6, 1.6 Hz, 1H), 2.22–2.36 (m, 2H), 2.05–2.20 (m, 3H), 1.82–
2.00 (m, 2H), 1.54–1.79 (m, 3H), 1.21–1.41 (m, 4H), 1.06 (d, J = 6.8 Hz, 3H); 13C NMR 
(100 MHz, CDCl3): δ 219.11, 146.23, 127.41, 60.61, 56.47, 52.22, 46.39, 44.34, 39.41, 
37.51, 34.39, 31.64, 29.41, 27.95, 24.06, 21.07; HRMS (ESI) calcd. for C16H24NO 
[M+H]+ 246.1852 found 246.1855. 


















(±)-Lycoflexine.  To a 10-mL round-bottomed flask equipped with reflux condenser, 
4.54 (0.0024 g, 5.3 µmol, 1.0 equiv.) was dissolved in CH3CN (2 mL). KOH (1.0 M, 42 
µmol, 42 µL, 8.0 equiv.) and PhSH (2.7 µL, 26 µmol, 5.0 equiv.) were added. The 
reaction was stirred at gentle reflux for 8 hours then cooled to room temperature. H2O (1 
mL), HCO2H (16 µL, 424 µmol, 80 equiv.), and 37% HCHO (aq., 34 µL, 424 µmol, 80 
equiv.) were added. The resulting mixture was stirred at gentle reflux overnight before all 
of the volatiles were removed at vacuum. The residue was dissolved in EtOAc (10 mL) 
and extracted with 1 M HCl (3 x 4 mL). The combined aqueous layer was added solid 
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Na2CO3 until saturation. The mixture was then extracted with 3% MeOH in CHCl3 (3 x 4 
mL) and the combined organic layer was dried over anhydrous Na2SO4. After filtration 
and concentration, the residue was purified by flash column chromatography (basic 
alumina, hexanes/EtOAc, 1:2 then 3% MeOH in CHCl3) to afford title compound (0.0013 
g, 91%) as a white solid (Rf = 0.23, n-BuOH/AcOH/H2O 7:2:2). IR (thin film): 2924, 
2853, 1727, 1699, 1456, 1352, 1208, 1174, 1127, 1063 cm-1; 1H NMR (400 MHz, 
CDCl3): δ 3.19 (ddd, J = 14.4, 2.8, 1.2 Hz, 1H), 3.13 (ddd, J = 13.6, 8.0, 4.0 Hz, 1H), 
2.94–3.02 (m, 1H), 2.78–2.91 (m, 2H), 2.61–2.72 (m, 2H), 2.19–2.42 (m, 6H), 2.06–2.17 
(m, 2H), 1.91–2.01 (m, 2H), 1.71–1.89 (m, 3H), 1.56–1.64 (m, 1H), 1.31–1.36 (m, 1H), 
1.04 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 218.62, 214.06, 60.84, 58.69, 
56.91, 53.81, 53.52, 46.92, 40.53, 40.30, 36.43, 31.46, 29.53, 28.22, 26.26, 22.59, 19.57; 
HRMS (ESI) calcd. for C17H26NO2 [M+H]+ 276.1958 found 276.1962.  




















Compound 4.59. To a 25-mL round-bottomed flask equipped with reflux condenser, 
4.53 (0.0310 g, 69 µmol, 1.0 equiv.) was dissolved in CH3CN (ACS grade, 4 mL). KOH 
(1.0 M, 0.55 mmol, 0.55 mL, 8 equiv.) and PhSH (35 µL, 0.35 mmol, 5 equiv.) were 
added. The reaction was stirred at gentle reflux for 8 hours then cooled to room 
temperature and added MeOH (ACS grade, 4 mL), aq. HCHO (37%, 154 µL, 2.07 mmol, 
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30 equiv.), and NaBH3CN (0.013 g, 0.21 mmol, 3 equiv.). After stirring at room 
temperature overnight, aq. HCl (1.0 M, 2.0 mL) was added and the mixture was extracted 
with 1M HCl (3 x 3 mL). The combined aqueous layer was added solid Na2CO3 until 
saturation. The resulting mixture was extracted with 5% MeOH in CHCl3 (4 x 4 mL) and 
the combined organic layer was dried over anhydrous Na2SO4. After filtration and 
concentration, the residue was purified by flash column chromatography (basic alumina, 
3% MeOH in CHCl3) to afford 4.59 (0.0175 g, 90%) as a white solid. IR (thin film): 
3356, 2925, 2869, 1721, 1660, 1455, 1376, 1273, 1107, 1066 cm-1; 1H NMR (300 MHz, 
CDCl3): 4.58–4.66 (m, 1H), 3.59–3.66 (m, 1H), 2.51–2.76 (m, 3H), 2.17–2.47 (m, 6H), 
1.81–2.14 (m, 5H), 1.11–1.74 (m, 12H), 0.93 (d, J = 6.3 Hz, 3H); 13C NMR (75 MHz, 
CDCl3): δ 74.41, 73.83, 55.82, 51.93, 47.95, 46.80, 43.33, 39.36, 37.65, 33.02, 28.43, 
27.49, 26.73, 25.82, 22.42, 19.62; HRMS (ESI) calcd. for C17H32NO2 [M+H]+ 282.2428 
found 282.2434.  
(1H NMR filename: pan106-442-9-1; 13C NMR filename: pan106-442-9-t1; notebook 















then Et3N, !78 °C to r.t.
 
Compound 4.57a. To a 15-mL flame dried round-bottomed flask, CH2Cl2 (1.0 mL) was 
added and the flask was cooled to –78 ºC (dry ice/acetone bath). (COCl)2 (21 µL, 250 
µmol, 5.0 equiv.) and DMSO (36 µL, 501 µmol, 10.0 equiv.) were added. The mixture 
was stirred at –78 ºC for 30 minutes then 4.59 (0.0141 g, 50 µmol, 1.0 equiv.) in CH2Cl2 
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(3.0 mL) was added via syringe. The mixture was stirred at –78 ºC for 1 hour and then 
NEt3 (140 µL, 1.0 mmol, 20.0 equiv.) was added. After 20 minutes at –78 ºC, the reaction 
was allowed to warm to room temperature and stirred at room temperature for 1 hour. 
EtOAc (10 mL) was added and the mixture was washed with 1M HCl (3 x 3 mL). The 
combined water layer was added solid Na2CO3 until saturation. The resulting mixture 
was extracted with 5% MeOH in CHCl3 (3 x 4 mL) and the combined organic layer was 
dried over anhydrous Na2SO4. After filtration and concentration, the crude 4.57a obtained 
was used immediately in the next step without further purification. An analytic sample 
was purified by flash column chromatography (3% MeOH in CH2Cl2) to give 4.57a as a 
colorless oil. 1H NMR (400 MHz, CDCl3): δ 2.90 (d, J = 5.2 Hz, 1H), 2.49–2.62 (m, 2H), 
2.04–2.45 (m, 12H), 1.72–1.99 (m, 5H), 1.31–1.52 (m, 3H), 1.12–1.20 (m, 1H), 1.07 (d, J 
= 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 220.38, 214.38, 60.91, 55.02, 50.44, 
48.96, 46.87, 44.52, 42.75, 39.64, 31.34, 30.44, 28.33, 25.54, 22.66, 22.57, 21.91; 
HRMS (ESI) calcd. for C17H28NO2 [M+H]+ 278.2115 found 278.2110. 
















40% for 2 steps
OH
 
(±)-Lycoposerramine B.  Following the procedure described by Harayama and 
Takayama,7 to a solution of crude 4.57a (15.2 µmol, theoretical) in EtOH (1.5 mL) was 
added Et2NH (7.9 µL, 76 µmol, 5.0 equiv.). The mixture was stirred at room temperature 
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for 3 hours then NH2OH⋅HCl (0.2 M in EtOH, 83.5 µL, 1.1 equiv.) was added. After 24 
hours at room temperature, the reaction was quenched with chilled sat. NaHCO3 (3 mL) 
and extracted with 5% MeOH in CHCl3 (4 x 5 mL). The combined organic layer was 
dried over anhydrous Na2SO4. After filtration and concentration, the residue was 
chromatographed (10% MeOH in CHCl3) to afford crude (±)-lycoposerramine B. The 
crude was rechromatographed (NH3⋅H2O/MeOH/CHCl3 0.05/5/95) to afford pure (±)-
lycoposerramine B (1.8 mg, 40%) as a colorless oil. IR (thin film): 2918, 2849, 1702, 
1451, 1369, 1268, 1210, 1139, 1076 cm-1; 1H NMR (400 MHz, CDCl3): δ 3.18 (d, J = 
3.2 Hz, 1H), 2.66 (app td, J = 13.6, 3.6 Hz, 1H), 2.55 (ddd, J = 18.8, 9.2, 0.8 Hz, 1H), 
2.38–2.45 (m, 1H), 2.18–2.36 (m, 8H), 1.96–2.16 (m, 4H), 1.55–1.80 (m, 5H), 1.43–1.50 
(m, 1H), 1.15–1.40 (m, 3H), 1.04 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 
213.97, 169.82, 61.87, 55.20, 48.67, 46.99, 44.52, 43.06, 31.80, 30.09, 29.93, 28.86, 
27.70, 25.71, 25.64, 22.62, 21.58; HRMS (ESI) calcd. for C17H29N2O2 [M+H]+ 293.2224 
found 293.2226.  

















Compound 4.57b. To a stirred solution of crude 4.57a (0.0104 g, obtained from Swern 
oxidation of 4.59) in CH2Cl2 was added basic Al2O3 (150 mesh, 0.0520 g, 500 wt.%). 
After stirring at room temperature for 1 day, the suspension was filtered over sintered 
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glass funnel and washed with 3% MeOH in CH2Cl2 (5 mL). The filtrate was concentrated 
to give a mixture of 4.57a and 4.57b as a colorless oil (d.r. 1:1), which was used 
immediately in the next step without further purification. An analytic sample was purified 
by flash column chromatography (1% MeOH in CH2Cl2) to give recovered 4.57a (Rf = 
0.20, 3% MeOH in CHCl3 3 times) and 4.57b (Rf = 0.27, 3% MeOH in CHCl3 3 times) as 
a colorless oil. 1H NMR (400 MHz, CDCl3): δ 2.18–2.56 (m, 11H), 1.89–2.15 (m, 5H), 
1.81 (td, J = 14.4, 4.8 Hz, 1H), 1.63–1.73 (m, 2H), 1.52–1.60 (m, 3H), 1.27–1.37 (m, 
2H), 1.06 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 216.40, 214.98, 60.78, 
58.38, 57.38, 55.35, 47.15, 45.94, 42.32, 38.81, 31.71, 31.50, 30.92, 29.93, 27.41, 23.60, 
22.47.  


























Compound 4.60. To a solution of crude mixture of 4.57a and 4.57b (17.3 µmol, 
theoretical) in EtOH (1.2 mL) was added Et2NH (18 µL, 173 µmol, 10.0 equiv.). The 
mixture was stirred at room temperature for 3 hours then NH2OH⋅HCl (0.2 M in EtOH, 
95 µL, 1.1 equiv.) was added. After 24 hours at room temperature, the reaction was 
quenched with chilled sat. NaHCO3 (3 mL) and extracted with 5% MeOH in CHCl3 (4 x 
5 mL). The combined organic layer was dried over anhydrous Na2SO4. After filtration 
and concentration, the residue was chromatographed (MeOH/CHCl3 2.5:97.5 to 10:90) to 
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afford crude (±)-lycoposerramine B and 4.60 (0.0018 g, 35%) as a colorless oil. IR (thin 
film): 3264, 2924, 2785, 1702, 1453, 1375, 1267, 1227, 1129, 1067 cm-1; 1H NMR (400 
MHz, CDCl3): δ 6.94–7.21 (br s, 1H), 2.76–2.78 (m, 1H), 2.52–2.62 (m, 2H), 2.40–2.46 
(m, 1H), 2.19–2.32 (m, 8H), 2.02–2.17 (m, 5H), 1.64–1.74 (m, 3H), 1.48–1.58 (m, 2H), 
1.30–1.40 (m, 2H), 1.03 (d, J = 6.0 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 214.89, 
166.84, 60.84, 58.34, 55.03, 48.37, 47.63, 45.98, 43.00, 31.82, 30.93, 30.39, 29.93, 29.11, 
27.04, 25.13, 22.54, 22.30. 



















Compound 4.61. To a stirred solution of 4.60 (0.0018 g, 6.2 µmol, 1.0 equiv.) in 
CH3CO2H (ACS grade, 0.5 mL) was added NaBH3CN (0.2 M in THF, newly made, 31 
µL, 6.2 µmol, 1.0 equiv.). After 2 hours at room temperature, sat. NaHCO3 (4 mL) was 
added carefully. NaHCO3 powder was then added slowly until saturation. The mixture 
was extracted with 5% MeOH in CHCl3 (4 x 5 mL) and the combined organic layer was 
dried over anhydrous Na2SO4. After filtration and concentration, the residue was 
chromatographed (7N NH3 in MeOH/CHCl3 3:97) to give 4.61 (0.0014 g, 80%) as a 
colorless oil. IR (thin film): 3265, 2924, 2784, 1654, 1559, 1541, 1508, 1457, 1375, 
1231, 1023 cm-1; 1H NMR (400 MHz, CDCl3): δ 7.16 (br s, 1H), 4.25 (br s, 1H), 3.52 
(dd, J = 12.0, 4.4 Hz, 1H), 3.22–3.31 (m, 1H), 2.27–2.66 (m, 8H), 2.17–2.25 (m, 1H), 
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2.10 (dd, J = 14.4, 8.4 Hz, 1H), 1.85–2.00 (m, 3H), 1.46–1.81 (m, 8H), 1.09–1.26 (m, 
2H), 0.93 (d, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3): δ 168.60, 70.17, 63.95, 
59.19, 58.10, 54.03, 49.79, 47.22, 41.93, 41.00, 31.94, 29.79, 28.69, 26.24, 25.54, 24.78, 
22.19; HRMS (ESI) calcd. for C17H31N2O2 [M+H]+ 295.2380 found 295.2371. 
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1H NMR spectrum for (±)-fawcettimine 
 
1H NMR spectrum for (+)-fawcettimine reported by Toste 
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13C NMR spectrum for (±)-fawcettimine 
 
13C NMR spectrum for (+)-fawcettimine reported by Toste 
 
 280 
1H NMR spectrum for (±)-fawcettimine hydrobromide 
 
1H NMR spectrum for (+)-fawcettimine hydrobromide reported by Toste 
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13C NMR spectrum for (±)-fawcettimine hydrobromide 
 
13C NMR spectrum for (+)-fawcettimine hydrobromide reported by Toste 
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1H NMR spectrum for (±)-fawcettidine 
 
 





13C NMR spectrum for (±)-fawcettidine 
 
 




1H NMR spectrum for (±)-lycoflexine 
 
1H NMR spectrum for (+)-lycoflexine reported by Ramharter 
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13C NMR spectrum for (±)-lycoflexine 
 
13C NMR spectrum for (+)-lycoflexine reported by Ramharter 
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1H NMR spectrum for (±)-lycoposerramine B 
 
1H NMR spectrum for (+)-lycoposerramine B reported by Mukai 
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13C NMR spectrum for (±)-lycoposerramine B 
 
13C NMR spectrum for (+)-lycoposerramine B reported by Mukai 
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1H and 13C NMR spectra for 4.61 
 
 
